<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RNICU Resident Guide</title>
    <script src="https://unpkg.com/react@18/umd/react.production.min.js"></script>
    <script src="https://unpkg.com/react-dom@18/umd/react-dom.production.min.js"></script>
    <script src="https://unpkg.com/@babel/standalone/babel.min.js"></script>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
        }
        .gradient-bg {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
        }
        .content-card {
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -1px rgba(0, 0, 0, 0.06);
        }
        .sticky-header {
            position: sticky;
            top: 0;
            z-index: 40;
            backdrop-filter: blur(10px);
            background-color: rgba(255, 255, 255, 0.9);
        }
        .section-card:hover {
            transform: translateY(-2px);
            transition: transform 0.2s ease;
        }
        .quick-ref-badge {
            background: linear-gradient(135deg, #f59e0b 0%, #ef4444 100%);
        }
        .med-table {
            border-collapse: collapse;
            width: 100%;
        }
        .med-table th {
            background-color: #f3f4f6;
            padding: 12px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }
        .med-table td {
            padding: 12px;
            border-bottom: 1px solid #e5e7eb;
        }
        .med-card {
            background: white;
            border-radius: 8px;
            padding: 16px;
            margin-bottom: 12px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.1);
        }
    </style>
</head>
<body class="bg-gray-50">
    <div id="root"></div>

    <script type="text/babel">
        const { useState, useEffect, useRef } = React;

        const CORRECT_PASSWORD = "rnicu2024";
        const APP_DATA = {"sections": [{"id": "introduction", "title": "Introduction", "type": "h2", "children": [{"id": "orientation", "title": "Orientation", "type": "h3", "children": [{"type": "text", "content": "Short Description of Unit, resident workroom, location of important equipment, tools, etc that residents need to know??"}]}, {"id": "infection-control", "title": "Infection Control", "type": "h3", "children": [{"type": "text", "content": "As soon as you arrive to work, or return after a break, please remember to perform adequate handwashing, including scrub for 3 minutes to elbow"}, {"type": "text", "content": "Remove watches or jewelry"}, {"type": "text", "content": "Please keep sleeves at or above your elbows when handling patients"}, {"type": "text", "content": "Wash hands or use foam before and after entering each patient room"}, {"type": "text", "content": "FOOD/DRINKS at workstations policy?"}]}, {"id": "schedule", "title": "Schedule", "type": "h3", "children": []}, {"id": "admissions", "title": "Admissions", "type": "h3", "children": [{"type": "text", "content": "Criteria for admission to Well-Baby Nursery"}, {"type": "text", "content": "No major congenital anomalies (hydrocephalus, UPJ obstruction, bowel obstruction, CHD, fetal HR abnormalities, skeletal dysplasia, maternal myasthenia gravis, syndromic appearance)"}, {"type": "text", "content": "Infants with mild renal pelviectasis, isolated cleft lip/palate, small CPAM can be admitted to NBN"}, {"type": "text", "content": "Temperature is stable without the need of an incubator or warmer"}, {"type": "text", "content": "O2 saturations > 92 on RA if 35 to 35.6 weeks GA, > 90% for other infants"}, {"type": "text", "content": "No signs of respiratory distress (RR > 70, grunting, severe retractions)  need for continuous electronic cardio-respiratory monitoring"}, {"type": "text", "content": "No immediate anticipated need for continuous IVF, nasal/oral gastric tubes, or similar interventions"}, {"type": "text", "content": "All other infants should be admitted to the RNICU."}]}, {"id": "rounds", "title": "Rounds", "type": "h3", "children": []}, {"id": "transfers", "title": "Transfers", "type": "h3", "children": [{"type": "text", "content": "Criteria for NBN transfer"}, {"type": "text", "content": "Vitals within normal range (HR: 90-160, RR: 30-60)"}, {"type": "text", "content": "2 consecutive PO feeds with no distress, especially if RR 60-70"}, {"type": "text", "content": "4 hr for other infants"}, {"type": "text", "content": "8 hr if admitted for hypothermia"}, {"type": "text", "content": "12 hr if < 2000 g (also needs to be > 24 hr old)"}, {"type": "text", "content": "4 hr if no or < 2 hr of O2 requirement in NICU"}, {"type": "text", "content": "6 hr if 2 \u2013 12 hr of O2 requirement in NICU"}, {"type": "text", "content": "12 hr if intubated or > 12 hr of O2 O2 requirement in NICU"}, {"type": "text", "content": "2 prefeed Glucose checks > 50, 1st prefeed check 3 hours after fluids stopped. If not transferred after second check needs monitoring in the RNICU for"}, {"type": "text", "content": "12 more hours"}, {"type": "text", "content": "24 hours if < 37 weeks or 2500 g, SGA, cleft lip or palate"}, {"type": "text", "content": "If cord blood pH > 7, Base deficit < -15, neuro symptoms at birth, document stable neuro exam for 6 hr before transfer"}, {"type": "text", "content": "Criteria for CCN transfer"}]}]}, {"id": "general-nicu-care", "title": "GENERAL NICU CARE", "type": "h1", "children": [{"id": "maternal-disorders-affecting-newborn", "title": "Maternal Disorders Affecting Newborn", "type": "h2", "children": [{"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "type": "h3", "children": [{"type": "text", "content": "Maternal hyperglycemia \ud83e\udc6a fetal hyperglycemia \ud83e\udc6a increased fetal insulin (hence neonatal hypoglycemia after delivery) \ud83e\udc6a anabolic effects such as accumulation of glycogen and lipid stores \ud83e\udc6a macrosomia, shoulder dystocia, birth trauma, cardiac septal hypertrophy"}, {"type": "text", "content": "Fetal hyperinsulinism may also increase fetal O2 consumption and cause increased erythropoiesis (leading to polycythemia \ud83e\udc6a RBC breakdown after birth \ud83e\udc6a hyperbilirubinemia) and inhibit surfactant synthesis (increasing risk for TTN/RDS/PHTN)"}, {"type": "text", "content": "Fetal hyperglycemia is considered to increase risk for malformations such as sacral agenesis, NTDs, small left colon syndrome (delayed meconium passage, feeding intolerance), cardiac defects such as TGA/DORV/HLHS etc."}, {"type": "text", "content": "Mechanism of hypocalcemia and hypomagnesemia unclear"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Screen for hypoglycemia within 1-2 hours after birth and follow hypoglycemia protocol"}, {"type": "text", "content": "Thorough physical exam to screen for anomalies"}, {"type": "text", "content": "CBC for Hct, bilirubin at 12-24 HOL.  S.Ca and Mg levels may be obtained based on symptoms."}, {"type": "text", "content": "CXR if RDS symptoms, respiratory support with OE/CPAP/NIPPV and rarely SIMV, surfactant administration as needed"}, {"type": "text", "content": "ECHO indicated if persistent cyanosis/hypoxemia despite appropriate respiratory support"}]}, {"id": "hypertension/preeclampsia/eclampsia", "title": "Hypertension/preeclampsia/eclampsia", "type": "h3", "children": [{"type": "text", "content": "Uteroplacental insufficiency\ud83e\udc6a fetal growth restriction \ud83e\udc6a need for elective C/S to minimize maternal complications and/or further fetal growth failure \ud83e\udc6a premature birth"}, {"type": "text", "content": "Risk of apnea/hypotonia in women given MgSO4 for treatment"}]}, {"id": "myasthenia-gravis", "title": "Myasthenia gravis", "type": "h3", "children": [{"type": "text", "content": "90% of moms with MG have antibodies that are transplacentally transferred to fetus and cause symptoms in 20% of newborns"}, {"type": "text", "content": "Symptoms including weak suck and respiratory distress typically begin by 3 DOL and last up to 1 to 4 weeks"}]}, {"type": "text", "content": "Neonatal lupus due to transplacental ANA (anti-Ro/anti-La) is usually rare, and most often comprises of heart block of varying degrees due to fibrosis and destruction of cardiac conduction system"}, {"type": "text", "content": "Newborns with CHB required careful monitoring/EKG/ECHO"}, {"type": "text", "content": "Symptomatic/severe bradycardia (<55 bpm) can require pacemaker insertion"}]}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "type": "h2", "children": [{"type": "text", "content": "90% of infants require no resuscitation. 10% do, and of these 1% require extensive resuscitation."}, {"type": "text", "content": "NRP Algorithm                                          Extensive Resuscitation Indications"}, {"type": "text", "content": "APGAR score"}, {"type": "text", "content": "Medications used in resuscitation"}, {"type": "text", "content": "Other medications such as Sodium bicarbonate and Calcium gluconate may occasionally be required."}, {"type": "text", "content": "Techniques for achieving effective ventilation with bag and mask"}, {"type": "text", "content": "Special considerations"}, {"type": "text", "content": "ELBW infants (see Golden Week section)"}, {"type": "text", "content": "Meconium Aspiration (See MAS section)"}, {"type": "text", "content": "Congenital Diaphragmatic Hernia (see CDH section)"}, {"type": "text", "content": "Congenital Heart Diseases (see CHD section)"}, {"type": "text", "content": "Others"}, {"type": "text", "content": "Pneumothorax"}, {"type": "text", "content": "Can be caused by excessive PPV or be present at birth"}, {"type": "text", "content": "Signs include decreased breath sounds on one side of chest or bulging chest wall"}, {"type": "text", "content": "Transillumination may be quick and helpful. CXR is slow but confirmatory"}, {"type": "text", "content": "When severely hypoxic/bradycardic in the DR, needle thoracentesis can be both diagnostic and provide immediate relief."}, {"type": "text", "content": "Fetal hemorrhage"}, {"type": "text", "content": "Can be caused by placenta previa, vasa previa or rarely, placental abruption"}, {"type": "text", "content": "Signs include pallor, poor perfusion, and failure to respond to standard resuscitation"}, {"type": "text", "content": "AFTER airway establishment/ventilation/oxygenation, consider 20 mL/kg of Rh O negative uncross- matched blood (may need more)"}, {"type": "text", "content": "Upper airway obstruction"}, {"type": "text", "content": "Upper airway obstructions are sometimes not diagnosed antenatally"}, {"type": "text", "content": "Choanal atresia: infant is pink when crying but cyanotic when quiet"}, {"type": "text", "content": "Pierre Robin Sequence: airway obstructed by tongue when supine, so may need an oro-pharyngeal airway"}, {"type": "text", "content": "Cranio-facial abnormalities: May require intubation which can be very difficult in such infant; may need to have ENT/Anesthesia available at short notice"}]}, {"id": "gestational-age-assessment", "title": "Gestational Age Assessment", "type": "h2", "children": [{"type": "text", "content": "When available, ultrasonographic measurements of the fetus in the 1st trimester give the most accurate estimate of gestational age. Gestational age assessments can also be based on  2nd and 3rd trimester ultrasonographic results or the date of last menstrual period (LMP)."}, {"type": "text", "content": "Physical examination of the newborn infant can also be used to estimate GA, with the help of the Ballard Score tool. This is especially useful when other sources of GA estimates are unavailable, for example when the mother has had no/limited prenatal care or when maternal information is unavailable for any reason."}, {"type": "text", "content": "Ballard Score examination consists of 2 parts (neuromuscular and physical), can be performed in infants up to 4 days of age (though it is best performed within the first 12 hours) and provides estimates of GA accurate to within \u00b1 2 weeks."}]}, {"id": "late-preterm-infant-care", "title": "Late Preterm Infant Care", "type": "h2", "children": [{"id": "hypothermia", "title": "Hypothermia", "type": "h3", "children": [{"type": "text", "content": "Late preterm infants are those born at a GA between 34+0 and 36+6 days. Incidence of LPT birth has decreased recently due to the decrease in the incidence of elective planned c-sections done for non-medically indicated reasons. Common factors associated with late preterm birth include advanced maternal age, obstetrical surveillance that results in medically indicated early birth, multiple births, and maternal chronic conditions such as diabetes, hypertension, cardiac or renal disease etc. Morbidities experienced by these infants often increase their length of stay after birth, risk for mortality as well as rates of re-admission after discharge from the hospital, especially compared to term infants."}, {"type": "text", "content": "Signs include pale appearance, mottled skin, apnea, bradycardia, hypotonia, weak cry, poor feeding, respiratory distress"}, {"type": "text", "content": "Warm, dry gently after birth, prevent heat loss by keeping warmer closed"}, {"type": "text", "content": "Postpone bath until thermal, cardiorespiratory stability established (1-2 hours after birth)"}, {"type": "text", "content": "Encourage and facilitate skin-to-skin care as possible"}, {"type": "text", "content": "Recommended to maintain room temp between 72-75\u00b0F"}]}, {"id": "hypoglycemia", "title": "Hypoglycemia", "type": "h3", "children": [{"type": "text", "content": "Risk increased if GDM, obesity, PIH, tocolysis use, difficult/prolonged labor, NRFHM, IUGR, twins, antenatal steroid exposure"}, {"type": "text", "content": "Facilitate early and frequent breastfeeding as soon as possible"}, {"type": "text", "content": "Monitor blood glucose 1 hr after feeds and if still low and/or feeding difficulty, initiate IV dextrose (see hypoglycemia section)"}]}, {"id": "respiratory-distress", "title": "Respiratory distress", "type": "h3", "children": [{"type": "text", "content": "Mostly secondary to RDS (most common), TTN, pneumonia, PPHN, and rarely pneumothorax caused by PPV/CPAP"}, {"type": "text", "content": "Requires close monitoring for signs of respiratory distress and desaturation"}, {"type": "text", "content": "Goal O2 saturations for LPT infants are between 91-95% if RDS alone, and > 95% if PPHN suspected (preductal saturations > 10% higher than postductal saturations)  difference."}, {"type": "text", "content": "O2 administration through an Oxyhood is superior to Nasal cannula"}, {"type": "text", "content": "May require CPAP, if FiO2 through O2 hood > 50%, and intubation/surfactant if respiratory distress/FiO2 requirements do not decrease despite CPAP"}, {"type": "text", "content": "Approximately 1% of LPT infants exposed to CPAP for > 12 hours can develop air leak syndromes such as pneumothorax that typically resolve with supportive therapy and needle thoracentesis. Chest tube insertion is rarely required."}]}, {"id": "apnea", "title": "Apnea", "type": "h3", "children": [{"type": "text", "content": "Typically secondary to RDS and associated respiratory distress"}, {"type": "text", "content": "Can also be caused by hypothermia or sepsis"}, {"type": "text", "content": "Can also indicate respiratory control immaturity and some LPT infants may require caffeine therapy for several days before apnea resolves completely"}]}, {"id": "sepsis", "title": "Sepsis", "type": "h3", "children": [{"type": "text", "content": "GBS screening results usually not available when infant born < 36 weeks GA"}, {"type": "text", "content": "LPTs also at increased risk for culture-proven sepsis mostly due to GP organisms"}]}, {"id": "hyperbilirubinemia", "title": "Hyperbilirubinemia", "type": "h3", "children": [{"type": "text", "content": "Increased rate of rise is often noted between 48 \u2013 72 hours after birth, peak bilirubin levels around 5 \u2013 7 days of life"}, {"type": "text", "content": "Use Bhutani nomograms to evaluate need for phototherapy/exchange transfusion/other measures as needed (see Hyperbilirubinemia section)"}]}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "type": "h3", "children": [{"type": "text", "content": "Breastmilk and direct breastfeeding (ad lib, typically Q3H) is preferred"}, {"type": "text", "content": "However, respiratory distress, premature birth of the infant and other factors often cause difficulties with latching and suck/swallow coordination"}, {"type": "text", "content": "Order lactation support consult and facilitate access to breast pumps for mothers who wish to exclusively breastfeed. Reassure families that breastfeeding is frequently possible well before EDD in most cases."}, {"type": "text", "content": "Supplementation with formula should be used only when breastfeeding is unsuccessful, as indicated by lack of effective latch, oliguria, excessive weight loss ( > 3% per day), hypoglycemia etc"}, {"type": "text", "content": "Consider 22 kcal formula for infants who weigh < 2.5 kg, otherwise standard formula (Enfamil 20 Kcal/oz) may be used"}, {"type": "text", "content": "Recommended volumes are 2\u201310 mL per feed (first 24 h), 5\u201315 mL per feed (24\u201348 h), 15\u201330 mL per feed (48\u201372 h) and 30\u201360 mL per feed (72\u201396 h)"}]}, {"id": "neurologic-morbidity", "title": "Neurologic morbidity", "type": "h3", "children": [{"type": "text", "content": "Fetal brain cortical volume increases by 50% between 34 to 40 weeks"}, {"type": "text", "content": "Immature brain increases risk for complications such as apneas, poor feeding and hypothermia"}, {"type": "text", "content": "If additional morbidities such as severe SGA, asphyxia, in utero drug exposure and genetic syndromes provide referral for neurodevelopmental follow up"}]}]}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "type": "h2", "children": [{"id": "introduction", "title": "Introduction", "type": "h3", "children": [{"type": "text", "content": "Global aims: Move to a team centric care model where the patient is the center of focus. Improve outcomes, establish a just culture, eliminate harm, achieve 100% participation of all members of the care team (MD, RN, pharmacists, respiratory therapists, dietitians)"}, {"type": "text", "content": "Interns or NNPs in conjunction with the supervising residents are the Primary Care Provider for these patients in the NICU"}, {"type": "text", "content": "Fellows should be fully involved and consulted by NNPs, interns, and residents on day-to-day management decisions during the crucial first week after birth. Fellows should include the NNPs, interns, and residents in patient management decisions and inform and educate the NNPS, interns, and residents whenever possible."}, {"type": "text", "content": "The infant\u2019s care team (NNP/intern, resident, fellow) should make additional rounds (preferably twice) on these patients (with bedside nurse and RT in the patient room) whenever possible between formal rounding times."}]}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "type": "h3", "children": [{"type": "text", "content": "Fellow and residents discuss with charge nurse about impending delivery to gather resources and supplies."}, {"type": "text", "content": "Fellow meets with family for prenatal consultation when possible. Residents and interns are encouraged to accompany the fellow for prenatal consults."}, {"type": "text", "content": "Fellow or residents obtain consents for central lines prior to delivery if able to do so."}, {"type": "text", "content": "Fellow or resident checks with OB/chart to verify accuracy of dates, antenatal steroid completion status, and other pertinent maternal history."}, {"type": "text", "content": "Antenatal corticosteroids are indicated for all infants with threatened preterm labor in whom resuscitation is planned."}, {"type": "text", "content": "RT prepares ventilator, transcutaneous monitor equipment, and surfactant."}, {"type": "text", "content": "PCT makes preparation for line placement."}, {"type": "text", "content": "TEAM HUDDLE and ASSIGNMENT of RESUSCITATION ROLES"}]}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "type": "h3", "children": [{"type": "text", "content": "Note: These are general guidelines, which may change as per attending discretion based on individual patient circumstances."}, {"type": "text", "content": "In the DR"}, {"type": "text", "content": "Fellow leads the resuscitation assisted by residents/NNPs and DR assigned nurse. Attending physician and RT routinely attend deliveries of these infants"}, {"type": "text", "content": "0-5 minutes"}, {"type": "text", "content": "Obstetric team are practicing delayed cord clamping at delivery."}, {"type": "text", "content": "Place infant on top of cardiac monitor leads and attach SpO2 monitor."}, {"type": "text", "content": "Thermoregulation- Infant is placed in plastic bag, head is covered by bag and a lined hat, infant placed on a trans warmer mattress."}, {"type": "text", "content": "Oxygen- Start with 60% FiO2 and target oxygen saturations limits as per NRP."}, {"type": "text", "content": "PPV if HR<100, apneic or gasping. Use ventilation corrective strategies (MRSOPA) if not improving."}, {"type": "text", "content": "Follow NRP recommendations."}, {"type": "text", "content": "5-15 minutes"}, {"type": "text", "content": "Decision is made to intubate vs. CPAP with long prongs."}, {"type": "text", "content": "Patient should be intubated if persistently apneic, HR<100, or FiO2 >50%."}, {"type": "text", "content": "Before leaving delivery room, allow mother to see her infant."}, {"type": "text", "content": "Delivery nurse obtains cord blood for infant profile."}, {"type": "text", "content": "In the RNICU"}, {"type": "text", "content": "Admission"}, {"type": "text", "content": "Nurse checks weight, length, axillary temperature, and single non-invasive BP on arrival."}, {"type": "text", "content": "Resident places orders using Golden Week powerplans in the following order\u2013 Neonatology Golden Week Medication; Neonatology Golden Week Lab; Neonatology Golden Week Admission Orders; Neonatology Respiratory Therapy."}, {"type": "text", "content": "Fellow stays with baby from DR to line insertion."}, {"type": "text", "content": "Transcutaneous CO2 monitor to be placed with limits 40-60."}, {"type": "text", "content": "Position head midline neutral position using fluidized positioner."}, {"type": "text", "content": "Thermoregulation"}, {"type": "text", "content": "Trans warmer heating pad to be removed if patient temperature >36.5 degrees."}, {"type": "text", "content": "Keep plastic bag on until after placing umbilical lines, the baby is adequately warm (skin temp > 36.5 degrees), and the incubator reaches 80% humidity."}, {"type": "text", "content": "Surfactant"}, {"type": "text", "content": "Administer surfactant if patient intubated due to any reason."}, {"type": "text", "content": "If on CPAP, intubate and administer surfactant if FiO2 > 50%, pCO2 > 65 mmHg, or pH < 7.20."}, {"type": "text", "content": "Repeat doses of surfactant if remains intubated with FiO2 > 30%."}, {"type": "text", "content": "Umbilical Lines"}, {"type": "text", "content": "Fellow along with intern or resident places umbilical lines."}, {"type": "text", "content": "UAC placed in addition to UVC if patient intubated or as per attending discretion."}, {"type": "text", "content": "Avoid flushing or rapid withdrawal to or from central lines."}, {"type": "text", "content": "If unable to place UVC by 1 hour after birth - consider a double lumen UAC or early PICC."}, {"type": "text", "content": "Leave low lying UVC only until PICC placed and remove low-lying UVC ASAP."}, {"type": "text", "content": "Commence sodium acetate with heparin for UAC fluids and adjust TFI accordingly."}, {"type": "text", "content": "Use UAC for all fluids administration if unable to obtain UVC."}, {"type": "text", "content": "Low lying UAC (L3-L4) can be used."}, {"type": "text", "content": "Prefer PIV or UVC for inotropes and Indocin but use UAC if no PIV or UVC present."}, {"type": "text", "content": "Goal should be to remove UAC/UVC before day 7"}, {"type": "text", "content": "Labs and CXR"}, {"type": "text", "content": "Obtain chest and abdomen (long chest) X-ray after line placement. Fellow should confirm ETT and line placement immediately."}, {"type": "text", "content": "Blood gas and glucose obtained after placement of lines."}, {"type": "text", "content": "Obtain mixed venous blood gas and glucose at 45 minutes if lines not yet started and by 60 minutes if lines get delayed."}, {"type": "text", "content": "Parental Support"}, {"type": "text", "content": "Make every effort to allow mother to see the infant before leaving the delivery room."}, {"type": "text", "content": "Assign a staff member to explain the importance of the Golden Hour and the procedures that will be occurring."}, {"type": "text", "content": "Make contact with the family with an update by 2hrs of life."}, {"type": "text", "content": "Skin to skin care is encouraged after 72 hours only to minimize sudden changes in infant position during the period of IVH risk."}]}, {"type": "text", "content": "On rounds present these babies as \u201chours after birth\u201d until reaches 72 hours/3 days old."}, {"type": "text", "content": "Signs with logos outside door and on incubator identify these infants and have date and time of birth."}, {"type": "text", "content": "Infant Care"}, {"type": "text", "content": "Weigh every 12 hours for first 72 hours and then every 24 hours."}, {"type": "text", "content": "Check urine output every 6 hours with minimal handling diaper changes for first 72 hours."}, {"type": "text", "content": "Follow trends in weight, urine output, lab values, vital signs, and clinical changes carefully."}, {"type": "text", "content": "Ventilator Management"}, {"type": "text", "content": "Low tidal volume strategy to be used aiming for 3-4 ml/kg."}, {"type": "text", "content": "Consider pressure control strategy if birth weight < 500 grams."}, {"type": "text", "content": "Goals: CO2"}, {"type": "text", "content": "After 72 hours the residents can intubate the infant under supervision of the fellows. The interns can intubate the infant under supervision of the fellow after the completion of the golden week."}, {"type": "text", "content": "Extubate to NIPPV or bubble CPAP with long prongs and higher PEEP from 7-9 cmH2O."}, {"type": "text", "content": "Metabolic Acidosis"}, {"type": "text", "content": "Use Na bicarbonate judiciously and administer over 30 to 60 minutes (1meq/kg over 30 minutes and to 2meq/kg over 60 minutes) unless in a code or severe metabolic acidosis situation during which it can be given faster as recommended in NRP."}, {"type": "text", "content": "Administered if base deficit > -10 or HCO3 < 15"}, {"type": "text", "content": "Deliver fluid bolus slowly over 30 to 60 minutes also."}, {"type": "text", "content": "Always try to find the cause of metabolic acidosis with careful assessment of perfusion and consideration of Echocardiography."}, {"type": "text", "content": "Labs and CXR"}, {"type": "text", "content": "Use the Golden Week Lab Powerplan order set to order all labs."}, {"type": "text", "content": "All labs will be clustered to minimize painful sticks or entry into central lines. Any additional labs outside of PowerPlan order set should be given careful consideration."}, {"type": "text", "content": "Avoid flushing or rapid withdrawal to or from central lines."}, {"type": "text", "content": "IV Fluids"}, {"type": "text", "content": "TFI goal starting at 70\u201380 ml/kg/day including all meds and drips."}, {"type": "text", "content": "Use only D10 trophamine for the first 72 hours after birth unless higher or lower dextrose needed for hypo/hyperglycemia."}, {"type": "text", "content": "Avoid addition of Na in fluids for at least first 72 hours after birth. Aim for a Na goal of 140-150 and consider hypo or hypernatremia as an indicator of fluid status in combination with weight and urine output in the first 72 hours after birth and restrict or increase TFI accordingly."}, {"type": "text", "content": "Account for medications and arterial line fluids in all TFI calculations."}, {"type": "text", "content": "Order 1/4 normal saline (0.22% sodium chloride) flushes as per Golden Week Powerplan. Can switch back to Normal saline (0.9% sodium chloride) if hyponatremia develops."}, {"type": "text", "content": "TPN"}, {"type": "text", "content": "Consider tarting lipids from day 2."}, {"type": "text", "content": "Consider starting patient specific TPN from 72 hours."}, {"type": "text", "content": "Intern and resident should review each Golden Week patient specific TPN with the fellow on service before finalizing."}, {"type": "text", "content": "Feeds"}, {"type": "text", "content": "Use colostrum in mouth whenever available."}, {"type": "text", "content": "Start trophic feeds with donor breast milk or EBM as early as day 1 if adequate volumes available and increase as tolerated as per attending preference."}, {"type": "text", "content": "Do not include trophic feeds in TFI."}, {"type": "text", "content": "Blood Pressure"}, {"type": "text", "content": "The interns and residents along with the fellow to decide administration of saline or pressors based on clinical signs of hypoperfusion, metabolic acidosis, bedside assessment of IVC dilation by ultrasound or cardiac function by Echocardiography, or if systolic BP or diastolic BP < 3rd percentile for gestational age."}, {"type": "text", "content": "If diastolic BP < 3rd percentile for gestational age consider a bolus (10/kg x 2 maximum) and/or a dopamine drip."}, {"type": "text", "content": "If systolic BP alone < 3rd percentile for gestational age consider a bolus (10/kg x 2 maximum) and/or a dobutamine drip."}, {"type": "text", "content": "Consider hydrocortisone treatment if persistent hypotension or other signs of adrenal insufficiency (hypoglycemia, hyponatremia, and hyperkalemia)."}, {"type": "text", "content": "Ureaplasma/mycoplasma"}, {"type": "text", "content": "Culture to be obtained on day 1 from all intubated babies. Also order if infant becomes intubated in the first week after birth."}, {"type": "text", "content": "Treat if positive."}, {"type": "text", "content": "Drugs"}, {"type": "text", "content": "Surfactant"}, {"type": "text", "content": "Administer 1st dose as soon after birth as possible if intubated \u2013 confirm ETT position clinically for administration \u2013 do not need to wait for x-ray"}, {"type": "text", "content": "If on CPAP, intubate and administer surfactant if FiO2 > 50%, pCO2 > 65 mmHg, or pH < 7.20 (SUPPORT trial criteria)."}, {"type": "text", "content": "Administer subsequent doses of surfactant if remains intubated and FiO2 > 30%."}, {"type": "text", "content": "If extubated after receiving 1st dose of surfactant revert back to SUPPORT trial criteria."}, {"type": "text", "content": "Caffeine"}, {"type": "text", "content": "To be considered on day 1 in all infants, especially those on extubatable settings or not on ventilator."}, {"type": "text", "content": "Use high dose caffeine for loading and for maintenance."}, {"type": "text", "content": "Vitamin A: To be initiated on day 1 for all infants."}, {"type": "text", "content": "Antibiotics"}, {"type": "text", "content": "Consider starting on all infants on admission."}, {"type": "text", "content": "Antibiotics will automatically be discontinued at 36 hours and should be restarted at Attending\u2019s discretion."}, {"type": "text", "content": "Consider fluconazole treatment if skin lesions or breakdown, hyperglycemia, and/or thrombocytopenia"}, {"type": "text", "content": "Indomethacin"}, {"type": "text", "content": "0.1mg/kg q24hr x 1 dose) as soon as possible for ELBW infants with weight < 750g"}, {"type": "text", "content": "Contraindications: Absent or reversed end diastolic blood flow, IUGR"}]}]}, {"id": "fluid-electrolyte-&-nutrition-problems", "title": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS", "type": "h1", "children": [{"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "type": "h2", "children": [{"type": "text", "content": "Soon after birth most infants are oliguric for the first 24-48 h. This is followed by a period of diuresis for the next several days that permits contraction of the extracellular fluid compartment, due to which term infants lose an average of 5-10% and preterm infants lose up to 15% of their birthweight in the first 5-7 days of life.  Insensible water loss (IWL) is another route of weight loss, but maintenance of a humidified environment (80% humidity for ELBW infants in the first 5 \u2013 7 days of life) reduces IWL significantly. Failure to lose weight in the first few days after birth has been associated with problems such as PDA and BPD in ELBW infants. Therefore, careful consideration should be given to FEN supplementation in the NICU, especially for ELBW (< 1000g) or VLBW (< 1500g) infants and sodium and water requirements should be increased only after the onset of postnatal diuresis."}, {"type": "text", "content": "Facilitate early weight loss"}, {"type": "text", "content": "Preterm: 5-7 days, ~5-15% of BW"}, {"type": "text", "content": "Term: 3-5 days, ~5-7% of BW"}, {"type": "text", "content": "Beyond this initial period, promote weight gain with goals of"}, {"type": "text", "content": "<2 kg = 15-20 g/kg/day, regain BW by 15 days of life"}, {"type": "text", "content": ">2 kg = > 30 g/day, regain BW 10 days of life"}, {"type": "text", "content": "Such rates of weight gain are typically achieved with a caloric Intake of"}, {"type": "text", "content": "Preterm: 125-140 kcal/kg/day"}, {"type": "text", "content": "Term: 90-110 kcal/kg/day"}, {"type": "text", "content": "Na and K supplementation is generally required usually only after the first 2 \u2013 4 days of life as S.Na levels generally remain high due to weight loss and extracellular fluid volume contraction  and S.K+ levels stay high until diuresis is well-established"}, {"type": "text", "content": "Trophamine is a mixture of essential and nonessential amino acids that can be added to standard IVF to maintain positive N2 balance and improve long term neurologic outcomes for infants with BW <1500g."}]}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "type": "h2", "children": [{"type": "text", "content": "IVF to be started at birth"}, {"type": "text", "content": "Report daily total fluid intake (TFI) as mL/Kg/day (always prorate to a 24-hour day)"}, {"type": "text", "content": "Include all maintenance IVF, feeds, IV meds, flushes, etc."}, {"type": "text", "content": "Do not include fluid boluses, blood products (PRBCs, platelets, or FFP) or trophic feeds, but do report them as a separate number."}, {"type": "text", "content": "Check daily electrolytes while on IVF and/or TPN"}, {"type": "text", "content": "Subsequent daily TFI increases are generally between 10 \u2013 30 mL/kg/day and determined using 3 factors"}, {"type": "text", "content": "Change in weight"}, {"type": "text", "content": "Changes in S.Na"}, {"type": "text", "content": "Urine output"}, {"type": "text", "content": "Report as mL/Kg/hour (if 24 h of output not available, prorate the time)"}, {"type": "text", "content": "Normal UOP is between 1 to 4 mL/kg/hr"}]}, {"id": "common-electrolyte-disorders", "title": "Common electrolyte disorders", "type": "h2", "children": [{"id": "hyponatremia", "title": "Hyponatremia", "type": "h3", "children": [{"type": "text", "content": "S.Na < 130 mEq/L, though up to 125 mEq/L can be tolerated at times"}, {"type": "text", "content": "Can lead to apnea, seizures"}, {"type": "text", "content": "If weight remains stable or increases, then hyponatremia is mostly \u201cdilutional\u201d secondary to excessive fluid administration and/or decreased UOP, especially in the first several days of life; rarely caused by SIADH, often due to IVH"}, {"type": "text", "content": "Treatment:  Fluid restriction. If < 120 mEq/L additional Na supplementation is often required"}, {"type": "text", "content": "If weight decreases, hyponatremia may be due to actual Na deficiency, secondary to renal (renal immaturity in ELBW infants or diuretics) or GI (diarrhea) losses, or osmotic diuresis (hyperglycemia); rarely CAH"}, {"type": "text", "content": "Treatment: Address cause for excessive Na losses. To correct S.Na directly, calculate Na deficit Desired Na+ (usually 130) \u2013 current Na+ x 0.6 x BW (kg) and administer slowly over 12-24 hours"}]}, {"id": "hypernatremia", "title": "Hypernatremia", "type": "h3", "children": [{"type": "text", "content": "S. Na > 150 mEq/L, can cause lethargy, hyperthemia, seizures"}, {"type": "text", "content": "Commonly due to excessive fluid (and weight) loss either through diuresis or IWL, can sometimes be caused by central diabetes insipidus due to HIE in term infants"}, {"type": "text", "content": "Treatment: Administer free water in the form of D5-1/2NS or D10-1/2NS (can consider giving NS bolus if severely dehydrated) to increase S.Na by 0.5 mEq/L every hour (faster correction can cause cerebral edema and seizures). Check S.Na frequently (q4-6H)"}, {"type": "text", "content": "If excessive UOP (frequently > 6 mL/kg/hr) is considered the cause for hypernatremia a suggested replacement strategy is to replace excess UOP > 6 mL/kg/h over a 6-hour period 1:1 with \u00bd NS over the next 6 hours. Can add 10 mEq/L of KCl if needed based on S.K+ levels"}, {"type": "text", "content": "Rarely due to excessive Na administration"}, {"type": "text", "content": "Treatment: restrict Na intake, consider diuretics if infant is older (caution: administering furosemide can cause worsening of PDA in ELBW infants < 2 weeks old)"}]}, {"id": "hypokalemia", "title": "Hypokalemia", "type": "h3", "children": [{"type": "text", "content": "S.K+ < 3 mEq/L, although up to 2.5 mEq/L is often tolerated as symptoms such as ileus or arrhythmias rarely manifest above that range"}, {"type": "text", "content": "Commonly due to K loss from diuretics,  diarrhea; rarely due to inadequate K intake; hypokalemia can also be caused by metabolic alkalosis (caused by shift of K to the intracellular compartment to compensate for the increase in S.HCO3)"}, {"type": "text", "content": "Treatment: Increase K in maintenance fluids (normal K need in infants is 2 \u2013 3 mEq/kg/day, can increase by 1-2 mEq/kg/day to correct S.K slowly over 12 -24 hours; rapid correction or pushes is almost never advisable due to risk of life-threatening arrythmias)"}]}, {"id": "hyperkalemia", "title": "Hyperkalemia", "type": "h3", "children": [{"type": "text", "content": "S.K > 6 mEq/L, can cause arrhythmias (bradycardia, SVT, VT, rarely V.fib, all of which typically occur only with S.K > 7 mEq/L)"}, {"type": "text", "content": "Commonly due to spurious hemolysis (especially when the result is from a heelstick sample), so if > 7, repeat test using blood sample from venous stick  and get an EKG looking for peaked T waves, prolonged PR, loss of P wave, or widened QRS"}, {"type": "text", "content": "Can also be due to oliguric renal failure, metabolic acidosis, excessive K intake, and rarely CAH"}, {"type": "text", "content": "Treatment:"}, {"type": "text", "content": "Calcium gluconate: 100mg/kg of 10% calcium gluconate over 30 min to stabilize cardiac conduction system, and"}, {"type": "text", "content": "insulin+glucose (0.05u/kg regular insulin in 2ml/kg of D10 followed by IVF infusion containing glucose) to help shift K into cell;"}, {"type": "text", "content": "Occasionally, sodium bicarbonate (2mEq/kg of sodium bicarb over 20 min) and beta-2 agonist (inhaled albuterol) may also be required"}, {"type": "text", "content": "Furosemide (1mg/kg/dose IV) can help K excretion into urine but will only work if infant is voiding urine"}, {"type": "text", "content": "Kayelexate (often used in older children) causes Na load and is rarely, if ever, used in newborns"}]}, {"id": "hypocalcemia", "title": "Hypocalcemia", "type": "h3", "children": [{"type": "text", "content": "Total S.Ca < 8 mg/dL or iCa < 1.1 mmol/L, though symptomatic typically only if iCa < 0.9, especially in ELBW infants; symptoms can include jitteriness, agitation, seizures, lethargy, vomiting, decreased cardiac contractility (EKG  with long QT/flat T waves)"}, {"type": "text", "content": "Early-onset hypocalcemia (<1 week after birth) can be due to prematurity/IUGR, IDM, HIE, hypomagnesemia, hypoparathyroidism, maternal hyperparathyroidism; later-onset hypocalcemia is often due to high phosphate intake; renal failure; loop diuretics such as furosemide; rarely due to hypoparathyroidism, excessive blood transfusions, DiGeorge syndrome"}, {"type": "text", "content": "Acute treatment: If symptomatic give 100-200 mg/kg of 10% calcium gluconate over 30 min-1 hour (can be given over 5-10 minutes if acutely symptomatic with seizures etc.)."}, {"type": "text", "content": "Further management: If hypocalcemia is noted on screening labs and asymptomatic, address causes such as reduction of high phosphate intake, renal failure, hypomagnesemia etc. in addition to increasing Ca intake in maintenance fluids/supplements as needed"}]}, {"id": "hypercalcemia", "title": "Hypercalcemia", "type": "h3", "children": [{"type": "text", "content": "Total S.Ca >12 mg/dL or iCa >1.5 mmol/L; may cause hypotonia and\nencephalopathy"}, {"type": "text", "content": "Rare in newborns. Causes include low serum P (usually in preterm infants), subcutaneous fat necrosis (rarely noted in infants with HIE and sepsis), thiazide diuretics; rarely due to hyperparathyroidism (primary or secondary), William\u2019s syndrome, adrenal insufficiency, elevated levels of Vit.D"}, {"type": "text", "content": "Acute treatment: If symptomatic, normal saline boluses and increase IVF maintenance, and furosemide (increases calcium excretion), steroids (decrease GI absorption), rarely calcitonin"}, {"type": "text", "content": "Further management: Increase phosphate intake; obtain endocrine consult as needed"}]}, {"id": "hypomagnesemia", "title": "Hypomagnesemia", "type": "h3", "children": [{"type": "text", "content": "Serum Mg < 1.6 mg/dL; presents like hypocalcemia with jitteriness, apnea, feeding intolerance, and seizures"}, {"type": "text", "content": "Occasionally seen in preterm infants, can happen in term newborns secondary to IDM, therapeutic hypothermia for HIE, loop diuretics, Gitelman\u2019s syndrome, frequent blood transfusions"}, {"type": "text", "content": "Treatment: IV MgSO4 25-50 mg/kg/dose over several minutes followed by increased supplementation in IVF/TPN/enteral feeds followed by identification and correction of cause"}]}, {"type": "text", "content": "Serum Mg >3 mg/dL; neonatal symptoms include hypotonia, hyporeflexia, hypotension and apnea, as well as vasodilatation with marked flushing"}, {"type": "text", "content": "Rare in newborns, can be secondary to Mg given to mother for tocolysis/pre-eclampsia."}, {"type": "text", "content": "Treatment: Can increase urinary excretion with furosemide, and IV hydration, along with symptomatic management (respiratory/blood pressure support) until magnesium level gradually falls. If severely symptomatic, calcium gluconate IV may help."}]}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "type": "h2", "children": [{"id": "kcal-calculation-example", "title": "Kcal calculation example", "type": "h3", "children": [{"type": "text", "content": "Consider a  2.2 kg infant on 155 ml/kg/day of 24 kcal/oz feeds."}, {"type": "text", "content": "Total Volume = 155 ml/kg/day x 2.2 kg = 341 ml"}, {"type": "text", "content": "Caloric density of feeds he is getting = 24 kcal/oz x 1 oz/30ml = 0.8 kcal/mL"}, {"type": "text", "content": "Total Calories = 341 ml x 0.8 kcal/ml = 272.8 kcal"}, {"type": "text", "content": "Total kcal/kg/day = 272.8 kcal / wt = 272.8 kcal / 2.2 kg = 124 kcal/kg/day"}]}, {"type": "text", "content": "Breakdown of energy"}, {"type": "text", "content": "Lipids (20%) = 9 kcal/g (40% of cal intake)"}, {"type": "text", "content": "Glucose = 3.4 kcal/gm (no more than 50-60% of cal intake)"}, {"type": "text", "content": "Amino acids = 4.0 kcal/g (10-12% of cal intake)"}]}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "type": "h2", "children": [{"type": "text", "content": "TPN pointers"}, {"type": "text", "content": "Just like with TFI, when doing TPN use birth weight until this is surpassed, then use current weight"}, {"type": "text", "content": "Trophic feeds (< 25 ml/kg/d) do not count into total TFI"}, {"type": "text", "content": "TPN orders are due to pharmacy by 2pm so should be a priority after rounds"}, {"type": "text", "content": "Create TPN using excel sheet, then must also enter final orders (including final rate)"}, {"type": "text", "content": "Always make TPN based on \u201cNPO rate\u201d just in case the feeds are stopped unexpectedly, then you have enough TPN to last until the next day. This is why your final rate may be different than what your excel document reads"}, {"type": "text", "content": "TPN labs:"}, {"type": "text", "content": "Daily - electrolytes (Na, K, Cl, HCO3)"}, {"type": "text", "content": "QMon/Thurs - BMP, Mg, Phos, triglycerides"}, {"type": "text", "content": "QMon only - add fractionated bilirubin (monitoring for TPN cholestasis)"}]}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "type": "h2", "children": [{"id": "type-of-feeds", "title": "Type of feeds", "type": "h3", "children": [{"type": "text", "content": "Start all very preterm babies on human milk from the time of birth (oropharyngeal colostrum on first day)"}, {"type": "text", "content": "If no EBM available or family chooses to formula feed:"}, {"type": "text", "content": ">35wga start on 20 kcal/oz"}, {"type": "text", "content": "if <35wga start on 24 kcal/oz"}, {"type": "text", "content": "Donor Milk policy"}]}, {"id": "method-of-feeds", "title": "Method of feeds", "type": "h3", "children": [{"type": "text", "content": "Coordinated swallowing/swallowing begin to become well-established starting at around 32 weeks GA, so can attempt PO feeds if > 32 weeks"}, {"type": "text", "content": "Nasogastric tube feedings (given Q3H, 8 times/day) are used for infants < 32 weeks GA as well as those > 32 weeks GA who are unable to achieve adequate feeding volumes with PO intake only"}]}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "type": "h3", "children": [{"type": "text", "content": "All preterm infants get started on \u201ctrophic\u201d feeds (defined as feeding volumes provided to promote intestinal maturation and improve tolerance to further feeding advancements). Do not include trophic feeding volumes into daily TFI."}, {"type": "text", "content": "If <1000g, start trophics of 25 mL/kg/day of human milk and advance by 25ml/kg/day once past trophic feeds, which should typically be possible by DOL 2-5 (duration of minimal enteral feeding or trophic feeding can be extended up to 5 days if mother\u2019s own milk is not sufficient to advance feeds)"}, {"type": "text", "content": "If >1000g, start trophics of 30 mL/kg/day and advance by 30ml/kg/day once past trophic feeds"}, {"type": "text", "content": "Continue advancing daily up to a goal of 140 mL/kg/day of enteral feeds (typically by DOL 6 \u2013 8), can then advance to 160-180 if PDA is not a significant concern"}, {"type": "text", "content": "Ideal schedule of feeding advancements for preterm infants:"}]}, {"id": "supplements", "title": "Supplements", "type": "h3", "children": [{"type": "text", "content": "Probiotics should be given to decrease risk of NEC for infants < 32 weeks GA or < 1500 g BW without significant anomalies once they are > 72 hours old and have tolerated feed volumes of at least 20 mL/day"}, {"type": "text", "content": "Dosage: Ultimate Flora\u2122 probiotic tablet (1/2 tablet crushed into milk, once daily)"}, {"type": "text", "content": "Hold: If infants is made NPO. If diagnosis of NEC, can restart once back on 100 mL/kg/day of feeds"}, {"type": "text", "content": "Discontinue: When > 36 weeks PMA or > 2 months (whichever is earlier), if infants require bowel surgery or at MD/parents request"}, {"type": "text", "content": "Add MVI once on full enteral feeds"}, {"type": "text", "content": "Dose etc?"}]}, {"id": "enteral-feed-fortification", "title": "Enteral feed fortification", "type": "h3", "children": [{"type": "text", "content": "While optimal for preventing NEC and early growth, breast milk alone provides insufficient nutrients to meet the caloric, protein and mineral (Ca, P, Na etc.) needs of most extremely premature infants. Therefore, fortification of breast milk with bovine HMF becomes necessary to prevent growth failure in these infants."}, {"type": "text", "content": "Begin fortification of EBM with human milk fortifier when infant is tolerating > 80-100 mL/kg/d (which usually happens by 7-14 days of life)"}, {"type": "text", "content": "Can begin with a caloric density of 24 kcal/oz, and increase up to 30 kcal/oz if necessary, to optimize growth, using HMF (can also fortify with MCT oil if considered necessary)"}]}, {"type": "text", "content": "Growth is monitored by plotting out serial measurements of weight, length, and head circumference using standard growth charts (Z-scores?)"}, {"type": "text", "content": "Weight is assessed daily"}, {"type": "text", "content": "Length and HC are assessed weekly"}, {"type": "text", "content": "Wednesdays are \u201cgrowth chart\u201d days for infants on the resident service"}]}]}, {"id": "respiratory-problems", "title": "RESPIRATORY PROBLEMS", "type": "h1", "children": [{"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "type": "h2", "children": [{"id": "blood-gases", "title": "Blood gases", "type": "h3", "children": [{"type": "text", "content": "The basic objectives of any kind of respiratory support are to achieve ventilation and oxygenation adequate to support metabolic demands"}, {"type": "text", "content": "Ventilation (elimination of CO2, measured with pCO2/transcutaneous CO2) is determined by minute ventilation = Rate x Vt \u2013Vd (tidal volume minus dead space)"}, {"type": "text", "content": "Increasing PEEP often decreases Vt by decreasing pulmonary compliance and therefore could increase pCO2"}, {"type": "text", "content": "Oxygenation (adequate oxygenated Hb, measured using pO2 and O2 saturations), is determined largely by the MAP & FiO2"}, {"type": "text", "content": "However, increased MAP can cause over-distention of the lungs, which impairs cardiac output and can lead to decreased tissue oxygenation."}, {"type": "text", "content": "Acceptable ranges of blood gas values for ELBW infants are different than those for older, more mature infants"}, {"type": "text", "content": "pH: 7.2 \u2013 7.4 (> 7.15 is often tolerated and weaning SIMV/HFOV strongly recommended for values > 7.35)"}, {"type": "text", "content": "pCO2: 40 \u2013 60 (hypocarbia can increase risk of white matter injury and hypercarbia worsens risk for severe IVH)"}, {"type": "text", "content": "pO2: Important in infants with PPHN or CHD, otherwise since most blood gases in the NICU are capillary samples, O2 saturations are a better determinant of oxygenation status"}, {"type": "text", "content": "BE: -4 to + 4 (values < -5 should prompt evaluation for possible causes of metabolic acidosis)"}, {"type": "text", "content": "Lactic acid: Often elevated in most infants soon after birth; indicates adequacy of perfusion and needs to be closely monitored in infants at risk for hypotension/shock and in those with cardiac disease"}, {"type": "text", "content": "To interpret a BG, start by determining whether the pH is acidotic or alkalotic"}, {"type": "text", "content": "Next consider the CO2. Remember that for every 10 mm Hg change in pCO2, the pH will change by 0.08 in the OPPOSITE direction. Does this relationship between CO2 and pH fully account for the observed pH value?"}, {"type": "text", "content": "What does this mean? If the CO2 accounts for the change in pH, then you have a primary respiratory process. If not, then you have an additional metabolic process going on."}, {"type": "text", "content": "Example 1: 7.24/60/78/24/-3 = acidotic pH, respiratory acidosis, pCO2 accounts for change in pH (2 x 0.08 = 0.16 => 7.40 \u2013 0.16 = expected pH 7.24), so primary respiratory process"}, {"type": "text", "content": "Example 2: 7.02/72/43/18/-9 = acidotic pH, respiratory acidosis, pCO2 does not fully account for change in pH.  (3 x 0.08 = 0.24 => 7.40 - 0.24 = expected pH 7.16) primary respiratory plus primary metabolic acidosis"}]}, {"type": "text", "content": "TcCO2 (along with continuous O2 saturation monitoring) provides continuous and noninvasive monitoring of adequacy of ventilation, which helps with ventilator changes and reduces need for frequent blood gas testing. For this reason, all ventilated ELBW infants (and most other ventilated infants) should have a transcutaneous CO2 monitor with specified limits."}, {"type": "text", "content": "TcCO2 values correlate with capillary (as well as arterial) blood gas values in most ELBW infants (usually within a \u00b1 5 range), and TcCo2 trends over time are very useful for assessing changes in ventilation/respiratory status over time. As TcCO2 monitors function by sensing the pH changes caused by CO2 and blood flow fluctuations in tissue underlying its probe location"}, {"type": "text", "content": "TcCO2 values higher than blood gas pCO2 can often be an indicator of poor perfusion, hypotension etc and"}, {"type": "text", "content": "TcCO2 values much lower than blood gas CO2 typically indicate loss of contact between probe and the skin that may require RT intervention to re-site it"}, {"type": "text", "content": "TcCO2 lower than the set limit, in addition to indicating that weaning the ventilator rate and/or pressures is likely needed to avoid overventilation and decrease risk for later BPD, can also lead to cerebral ischemia/PVL as CO2/pH changes are major determinants of cerebral blood flow. Conversely, TcCO2 higher than the set limits indicates that the infant is at increased risk for intraventricular hemorrhage."}, {"type": "text", "content": "TCCO2 limits"}, {"type": "text", "content": "For most infants initial TcCO2 limits of 40 to 60 are considered acceptable"}, {"type": "text", "content": "As renal function and the ELBW infant\u2019s ability to reabsorb bicarbonate to provide metabolic compensation for respiratory acidemia improves over the first few weeks of life, TcCO2 limits can be increased to 50-70 or often as high as 60-80 (permissive hypercapnia)"}, {"type": "text", "content": "Example: Blood gas on DOL3 for an ELBW infant is 7.20/60/55/18/-6. The infant has respiratory acidosis without adequate metabolic compensation due to the relatively low levels of HCO3. Therefore this infant needs to have TCCo2 maintained between 40-60. However, on DOL5 her blood gas is 7.28/60/55/23/+2. Despite the same pCO2, the pH on this gas is higher due to metabolic compensation (due to the increased HCO3, likely caused by improving renal tubular reabsorption of HCO3). Permissive hypercapnia can be safely practiced for this infant, by increasing TcCO2 limits to 50-70, allowing for faster ventilator weaning."}]}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "type": "h2", "children": [{"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "type": "h3", "children": [{"type": "text", "content": "Provides continuous pressure to maintain functional residual capacity (FRC) in infants and can be used as our primary mode of support in ELBW infants or as a weaning mode in infants being extubated"}, {"type": "text", "content": "NCPAP requires these settings:"}, {"type": "text", "content": "Positive End Expiratory Pressure (PEEP)"}, {"type": "text", "content": "Starting settings: in a baby with RDS, start with CPAP of 5-7 cm H2O (you may increase to EEP as high as 8), consider rate of 20"}, {"type": "text", "content": "CPAP causes infants to swallow a lot of air, so will likely need NG or OG to decompress the abdomen"}, {"type": "text", "content": "The unit currently uses two CPAP interfaces:"}, {"type": "text", "content": "Mask/Prong: These are placed over or on the infant\u2019s nose to create a seal"}, {"type": "text", "content": "RAM Cannula: which looks like a green nasal cannula"}, {"type": "text", "content": "Most small neonates are started on Mask/Prongs. Watch for complications with nasal or septal breakdown."}]}, {"id": "nasal-intermittent-positive-pressure-ventilation-(nippv)", "title": "Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "type": "h3", "children": [{"type": "text", "content": "Similar to CPAP except that a rate (and therefore peak inspiratory pressure) is also provided in addition to a PEEP. Both NIPPV and CPAP appear equivalent at this time."}, {"type": "text", "content": "Can only be provided via a ventilator (NCPAP can be provided by both a \u201cbubble\u201d setup as well as ventilator. Rate will sometimes be added for extra support. This is considered"}]}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "type": "h3", "children": [{"type": "text", "content": "Heated and humidified air that is given at flow rates > 2L/min."}, {"type": "text", "content": "It can be blended and provides O2 for oxygenation, reduces airway resistance, and may flush dead space."}, {"type": "text", "content": "Unlike CPAP, HFNC provides variable pressure but a continuous flow"}, {"type": "text", "content": "HFNC appears to be inferior to NCPAP for infants with RDS < 32 weeks"}, {"type": "text", "content": "It (along with NC) does not provide precise FIO2 delivery, so it should not be used when that is needed (e.g. in PPHN)."}, {"type": "text", "content": "It may be beneficial in infants who have had prolonged SIMV or CPAP support and need to be weaned."}]}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "type": "h3", "children": [{"type": "text", "content": "Currently, the RNICU utilizes 2 modes of conventional ventilation:"}, {"type": "text", "content": "Pressure control SIMV - Inspiratory pressures are adjusted to affect tidal volume. Pressure support is usually \u00bd - 2/3 inspiratory pressure. Most preterm infants will receive pressure control ventilation."}, {"type": "text", "content": "Volume control SIMV - Tidal volume is set (4-6 ml/kg) and the ventilator determines the inspiratory pressure necessary. Pressure support still functions as a weaning mechanism and is adjusted in terms of pressure"}, {"type": "text", "content": "Conventional Ventilator Cheat Sheet"}, {"type": "text", "content": "-What settings should I start on pressure-control SIMV?"}, {"type": "text", "content": "How do I know my settings are good? In Golden Week and stable babies target a Vt of 3-5 ml/kg (keep Vt low); on Drager vents the deadspace is always ~1ml in the neonatal mode. In all infants, follow the blood gases + TC and monitor pCO2 in range (40-60 with pH >7.20). With renal compensation, higher pCO2 targets can be used."}, {"type": "text", "content": "What should I wean first? Wean the most noxious variable first\u2014PIP then Rate. FiO2 can be weaned based on saturations"}]}, {"type": "text", "content": "Pulses or oscillates gases at a rate of 300-1500 breaths/minute."}, {"type": "text", "content": "Two modes available - High Frequency Oscillatory Ventilation (HFOV) or Jet Ventilation (HFJV)"}, {"type": "text", "content": "Tidal volumes are equal to or smaller than the anatomic dead space, so HFOV/HFJV can maintain adequate lung volumes (avoiding swings in lung volume associated with barotrauma/volutrauma)."}, {"type": "text", "content": "CO2 elimination is proportional to rate x Vt2; so you get more bang for your Vt buck."}, {"type": "text", "content": "Expiration is passive with HFJV, and active with HFOV. Use these vents when the infant is failing conventional ventilation."}, {"type": "text", "content": "HFOV settings"}, {"type": "text", "content": "Amplitude"}, {"type": "text", "content": "Set at the PIP on the conventional settings and adjust until you see \u2018chest wiggle.\u2019"}, {"type": "text", "content": "Frequency"}, {"type": "text", "content": "breaths per minute (1 Hz=60 breaths per minute)"}, {"type": "text", "content": "Ranges from 7 \u2013 15 Hz"}, {"type": "text", "content": "Higher frequencies lead to lower alveolar ventilation and CO2 retention"}, {"type": "text", "content": "If it is a preterm infant, start at a higher frequency (i.e. 10 \u2013 12) and in a term infant, a lower frequency (i.e. 8-10)"}, {"type": "text", "content": "MAP"}, {"type": "text", "content": "Good starting setting: initial MAP should be 1-2cm H2O higher than that being used on conventional vent"}, {"type": "text", "content": "I-time"}, {"type": "text", "content": "set at 33%; almost never changed except if infant develops intractable air leak syndrome"}, {"type": "text", "content": "HFJV settings"}, {"type": "text", "content": "PIP"}, {"type": "text", "content": "start at PIP of approximately 20% lower than those being used with conventional ventilation"}, {"type": "text", "content": "Rate"}, {"type": "text", "content": "Usually set at 420 breaths/minute with inspiratory jet valve i-time of 0.02 second"}, {"type": "text", "content": "\u201cSigh\u201d breath rate"}, {"type": "text", "content": "A conventional vent is used in conjunction with HFJV to provide \u201csigh\u201d breaths, during which alveolar recruitment may occur"}, {"type": "text", "content": "PEEP"}, {"type": "text", "content": "Is also provided by the conventional ventilator and is the main driver of MAP in HFJV"}, {"type": "text", "content": "Generally, start with the same PEEP as on previous conventional vent."}, {"type": "text", "content": "Note the servo pressure for an infant before and after PEEP adjustments (this is an indirect measure of tidal volume delivered); for instance, if you decrease the PEEP and see the servo pressure go from 2 to 3, you have improved tidal volume"}]}, {"id": "rds", "title": "RDS", "type": "h2", "children": [{"type": "text", "content": "Causes: Inadequate pulmonary surfactant, which leads to diffuse atelectasis, edema, & cell injury"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Characteristic \u201cground-glass\u201d appearance of CXR"}, {"type": "text", "content": "Increasing O2 requirement in at-risk infant"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "General goals: Preventing hypoxia, optimizing fluid status, reducing metabolic demands, preventing worsening atelectasis & edema, & minimizing barotraumas & oxygen damage"}, {"type": "text", "content": "Small preterm infants are generally started on NCPAP, with intubation and surfactant if FiO2>0.50 needed or hypercapnia occurs."}, {"type": "text", "content": "Surfactant (Curosurf aka Poractant at 2.5 ml/kg then 1.25 ml/kg) may be administered by the RTs. Repeat doses may be required every 12 hours for up to 3 doses if the baby\u2019s oxygen requirement increases (>40% FiO2) or if ventilation becomes difficult"}, {"type": "text", "content": "Failure of paying attending to sudden increase in lung compliance may result in pulmonary hemorrhage in infants receiving surfactant*"}, {"type": "text", "content": "In larger babies, start with a trial of oxyhood. This can be followed by NCPAP & intubation if needed"}, {"type": "text", "content": "Pearls"}, {"type": "text", "content": "One should target oxygen saturation between 91-95% to both minimize the risk of ROP and recognize the risk for higher lower mortality at lower saturations"}, {"type": "text", "content": "The PCO2 may be allowed to increase as long as the infant compensates with normal pH"}, {"type": "text", "content": "May allow permissive hypercapnea and pH of 7.2-7.35"}, {"type": "text", "content": "Vitamin A injections are given to ELBW infants 3x/week x 12 doses if they need oxygen during the first 96 hours to decrease the incidence of BPD"}]}, {"id": "pphn", "title": "PPHN", "type": "h2", "children": [{"type": "text", "content": "Sustained elevation of pulmonary vascular resistance (PVR) after birth, which leads to right\ud83e\udc6a left shunting across a PFO or PDA, which then results in an inability to oxygenate blood"}, {"type": "text", "content": "Causes:"}, {"type": "text", "content": "Idiopathic"}, {"type": "text", "content": "MAS"}, {"type": "text", "content": "Sepsis/pneumonia"}, {"type": "text", "content": "Asphyxia"}, {"type": "text", "content": "CDH"}, {"type": "text", "content": "CHD"}, {"type": "text", "content": "Pulmonary parenchymal disease"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "If mild PPHN is present, a hyperoxia challenge may be useful:"}, {"type": "text", "content": "Check PaO2"}, {"type": "text", "content": "Place baby in 100% O2 environment for 30 minutes - 1 hr"}, {"type": "text", "content": "If arterial pO2 >150, PPHN is unlikely"}, {"type": "text", "content": "If PaO2 does not change, PPHN or congenital cyanotic heart disease (CHD) may be present  echocardiogram is indicated."}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Achieving oxygen saturations above 92%, dilates pulmonary vascular beds"}, {"type": "text", "content": "Consider surfactant early in the disease process if infant has impending need for ECMO"}, {"type": "text", "content": "iNO after adequate recruitment can also cause pulmonary vasodilation"}, {"type": "text", "content": "Correction of acidosis"}, {"type": "text", "content": "Mechanical ventilation or High Frequency Ventilation"}, {"type": "text", "content": "Maintenance of good systemic blood pressures (may require volume replacement)"}, {"type": "text", "content": "Maintenance of cardiac output to try to overcome PVR (may require fluid boluses, pressors, inotropes, paralysis & sedation)"}, {"type": "text", "content": "ECMO if OI >40 or PaO2<40-50 on maximal support for > 4-6 hrs"}, {"type": "text", "content": "Pearls"}, {"type": "text", "content": "OI=oxygenation index: (FiO2*MAP)/PaO2"}, {"type": "text", "content": "Low numbers are better. If OI >40, indication for ECMO!"}, {"type": "text", "content": "Consider an echo in all infants with suspected PPHN as it can present similarly to congenital heart disease!"}, {"type": "text", "content": "PPHN is a different entity than pulmonary hypertension experienced by infants with BPD"}, {"type": "text", "content": "PPHN is often associated with infection, so consider antibiotics on any infant diagnosed with PPHN until sepsis is ruled out"}]}, {"id": "mas", "title": "MAS", "type": "h2", "children": [{"type": "text", "content": "Cause: Acute or chronic hypoxemia due to meconium aspirated before or during birth"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Meconium history"}, {"type": "text", "content": "CXR abnormalities"}, {"type": "text", "content": "Hypoxemia"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Ventilatory support starting with increasing FiO2 & progressing to mechanical ventilation (and ECMO if needed)"}, {"type": "text", "content": "Pulmonary hypertension (PPHN) may develop"}, {"type": "text", "content": "These infants are at risk for pneumothorax & pneumomediastinum"}, {"type": "text", "content": "Pearls"}, {"type": "text", "content": "If called to a delivery for meconium, we previously intubated and suctioned below the cords if a baby was non-vigorous; however, this was not found effective in studies and is no longer routine care"}]}, {"id": "ttn", "title": "TTN", "type": "h2", "children": [{"type": "text", "content": "Cause"}, {"type": "text", "content": "Transient pulmonary edema due to delayed reabsorption of fetal lung fluid by lymphatics"}, {"type": "text", "content": "Infants most at risk are those born precipitously, with macrosomia, via C/S, or maternal narcotic administration"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "PE findings of cyanosis, grunting/flaring/retracting in term or near-term infants that develops within 6h of delivery"}, {"type": "text", "content": "CXR reveals prominent perihilar streaking, coarse, fluffy densities, & air-trapping"}, {"type": "text", "content": "Diff Dx includes pneumonia/ sepsis, RDS, congenital malformation (such as congenital diaphragmatic hernia), CNS insults causing central hypoventilation"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Supplemental oxygen if needed"}, {"type": "text", "content": "Other basic supportive measures such as IVF or OG feedings if the baby is too tachypneic to be fed PO (>60 to 80 breaths/min)"}, {"type": "text", "content": "Restricting fluids in the first few days of life"}, {"type": "text", "content": "Pearls"}, {"type": "text", "content": "Babies should not have an O2 requirement >40% or require mechanical ventilation (this is probably not TTN)"}, {"type": "text", "content": "Can this be treated in WBN? Usually not. If requiring O2, will need transfer to RNICU."}, {"type": "text", "content": "If simply tachypneic, may do CBC, blood cx, possibly LP & watch in WBN"}]}, {"id": "bpd", "title": "BPD", "type": "h2", "children": [{"type": "text", "content": "Causes"}, {"type": "text", "content": "Volutrauma from mechanical ventilation"}, {"type": "text", "content": "Airway and vascular tone may be altered"}, {"type": "text", "content": "Can develop emphysematous changes"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Traditional definition: O2 requirement for the first 28 days of life."}, {"type": "text", "content": "Physiologic definition: In babies <32 wga, classified by oxygen requirement when baby reaches 36 wga"}, {"type": "text", "content": "mild BPD: no supplemental O2 requirement"}, {"type": "text", "content": "moderate BPD: supplemental O2 <30%"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Supplemental oxygen and/or respiratory support as needed"}, {"type": "text", "content": "Minimize further barotrauma if possible"}, {"type": "text", "content": "Treat hemodynamically significant PDA\u2019s in infants unable to be weaned from vent"}, {"type": "text", "content": "Restrict fluids (maybe 120-140 mL/kg/day rather than 160-180)"}, {"type": "text", "content": "Diuretics if having pulmonary fluid retention (furosemide, chlorothiazide)"}, {"type": "text", "content": "Albuterol or ipratropium"}, {"type": "text", "content": "Courses of steroids if increased respiratory distress"}, {"type": "text", "content": "Pearls"}, {"type": "text", "content": "Watch electrolytes on babies who are on diuretics\u2014hyponatremia, hypokalemia, and hypochloremia are common"}, {"type": "text", "content": "Periodically get an ECHO on these babies (usually monthly) to monitor for pulmonary hypertension as well as trending BNPs (usually every Monday)"}, {"type": "text", "content": "Perform an oxygen reduction challenge at 36 wga (corrected) for any infant born at <32 weeks, who remains on O2 via NC or OE (not CPAP or higher support)"}]}, {"id": "bpd/phtn", "title": "BPD/PHTN", "type": "h2", "children": [{"type": "text", "content": "Cause: Vascular remodeling due to prolonged lung disease and chronic hypoxic events"}, {"type": "text", "content": "Diagnosis:"}, {"type": "text", "content": "Clinical findings: infant with BPD with inability to oxygenate despite adequate ventilation and lung recruitment."}, {"type": "text", "content": "Elevated BNP"}, {"type": "text", "content": "Echocardiographic findings (e.g. flattened intraventricular septum, septal bulging into RA, significant triscupid regurgitation, etc)"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Supplemental oxygen and/or respiratory support as needed (prevent further hypoxemia)"}, {"type": "text", "content": "Improve lung recruitment through ventilator maneuvers"}, {"type": "text", "content": "Consider a trial of iNO AFTER the infant is adequately recruited"}, {"type": "text", "content": "Sedatives and paralytics may be beneficial"}, {"type": "text", "content": "Systemic vasodilators (sildenafil or milrinone) may decrease vascular resistance"}, {"type": "text", "content": "Maintain adequate perfusion with potential use of vasopressors"}, {"type": "text", "content": "Pearls:"}, {"type": "text", "content": "iNO can help improve sats even when the cause for hypoxemia is not PHTN. i.e. iNO can make your sats increase if you simply have V/Q mismatch. This is why it is important to recruit prior to starting iNO"}, {"type": "text", "content": "Infection (viral or bacterial) often push BPD infants \u201cover the edge\u201d into a pulmonary hypertensive crisis. Look for a source if this suddenly occurs!"}]}, {"id": "apnea", "title": "Apnea", "type": "h2", "children": [{"type": "text", "content": "In the NICU apnea is defined as no breathing effort for > 20 sec, or for shorter durations that is associated with significant bradycardia and desaturations"}, {"type": "text", "content": "Should be differentiated from periodic breathing (pauses of up to 10 seconds with desaturations/bradycardias that do not need intervention"}, {"type": "text", "content": "Apnea of prematurity"}, {"type": "text", "content": "Caused by immature respiratory control in infants born preterm (<37 weeks)"}, {"type": "text", "content": "Occurs in almost all infants < 28 weeks GA"}, {"type": "text", "content": "Mostly central or mixed. Can also be obstructive."}, {"type": "text", "content": "Central \u2013 no respiratory effort detected"}, {"type": "text", "content": "Obstructive \u2013 ineffective respiration"}, {"type": "text", "content": "Mixed \u2013 Central followed by obstructive (or) obstructive followed by central apnea. Longer apneic episodes are often mixed."}, {"type": "text", "content": "Usually clinically evident between 24-72 hours of life"}, {"type": "text", "content": "Apnea of prematurity is a diagnosis of exclusion and other causes should be always considered, especially in infants > 28 weeks GA"}, {"type": "text", "content": "Other causes that should be considered, especially in infants > 28 weeks include"}, {"type": "text", "content": "Maternal MgSO4, opioid, general anesthesia exposure"}, {"type": "text", "content": "Sepsis: screening labs such as CBC, UA, CRP; may require blood/urine/CSF cultures and antibiotics"}, {"type": "text", "content": "Hypoglycemia: check POC glucose"}, {"type": "text", "content": "Hypothermia (link to Temperature management chapter)"}, {"type": "text", "content": "NEC: clinical signs of feeding intolerance, KUB showing signs of NEC"}, {"type": "text", "content": "IVH: may require HUS"}, {"type": "text", "content": "HIE, seizures"}, {"type": "text", "content": "Anemia: in preterm infants > 1 month of age, Hct < 25 associated with increased apneic events"}, {"type": "text", "content": "Airway anomalies: if noted to be predominantly obstructive may need airway evaluation and ENT consult"}, {"type": "text", "content": "PGE1 use in infants with CHD"}, {"type": "text", "content": "Inborn errors of metabolism"}, {"type": "text", "content": "Congenital hypoventilation syndrome"}, {"type": "text", "content": "Management of apnea of prematurity"}, {"type": "text", "content": "Methylxanthines: Caffeine stimulates respiratory output by inhibiting adenosine receptors."}, {"type": "text", "content": "Consider starting and continuing caffeine (loading followed by maintenance) on all ELBW infants admitted to the NICU irrespective of respiratory support"}, {"type": "text", "content": "Sinus tachycardia and SVT are complications of caffeine therapy. that usually occur only with caffeine dosing > 15-20 mg/kg/day"}, {"type": "text", "content": "Discontinuing caffeine can be attempted beginning around 32-34 weeks once infant has had at least 5 days without apneas that required intervention and is off respiratory support"}, {"type": "text", "content": "CPAP/NIPPV: can be useful for decreasing obstructive/mixed apneas in infants who are not on SIMV and continue to remain apneic despite maximal therapy"}, {"type": "text", "content": "Transfusion: Consider maintaining Hct > 25-30 in infants with persistent apneic episodes that require intervention despite maximal caffeine therapy"}, {"type": "text", "content": "Though caffeine can offer symptomatic relief, management of apneas due to other etiologies requires careful evaluation and treatment of underlying causes."}]}, {"id": "cdh", "title": "CDH", "type": "h2", "children": [{"type": "text", "content": "Caused by developmental failure of the posterolateral diaphragm and persistence of the foramen of Bochdalek (less commonly anterior diaphragm and foramen of Morgagni) which allows abdominal contents to herniate into the developing thoracic cavity\ud83e\udc6apulmonary parenchymal and vascular hypoplasia and pulmonary hypertension\ud83e\udc6aLV dysfunction"}, {"type": "text", "content": "A weakness in the diaphragm rather than failed closure leads to diaphragmatic eventration which is typically not associated with lung hypoplasia"}, {"type": "text", "content": "CDH is typically diagnosed on prenatal US (around 16-20 weeks GA)"}, {"type": "text", "content": "Rarely may go undiagnosed, especially when mom has not received adequate prenatal care"}, {"type": "text", "content": "Symptoms include severe respiratory distress, cyanosis, scaphoid abdomen, decreased breath sounds in the left chest, heart sounds displaced to the right"}, {"type": "text", "content": "CXR typically shows bowel loops in the chest, decreased pulmonary markings and lung expansion"}, {"type": "text", "content": "Prognosis is worse with"}, {"type": "text", "content": "Presence of associated anomalies and cardiac dysfunction"}, {"type": "text", "content": "Severe lung hypoplasia: lung head ratio (LHR) < 0.6 has an almost 0% chance of survival; LHR > 1.35 has an almost 100% of survival"}, {"type": "text", "content": "Presence/absence of liver herniation"}, {"type": "text", "content": "Pre/Perinatal management"}, {"type": "text", "content": "Antenatal: Prenatal closure of CDH hasn\u2019t been shown to improve survival"}, {"type": "text", "content": "Delivery room: Avoid BMV, but otherwise follow NRP,; majority will need endotracheal intubation, target saturations > 90% by 10 minutes of life;  insert an OG/NG for bowel decompression"}, {"type": "text", "content": "In the NICU"}, {"type": "text", "content": "Inform CoA Neonatal Fellow/Attending and transfer to the CoA NICU as soon as possible"}, {"type": "text", "content": "Monitor both pre and post ductal saturations; typical target saturations 92-97%"}, {"type": "text", "content": "Place UAC/UVC or PICC; consider obtaining a radial arterial line if UAC fails"}, {"type": "text", "content": "Both SIMV and HFOV offer similar benefits for infants with CDH; HFOV is typically used as a rescue mode if SIMV fails to provide adequate oxygenation/ventilation"}, {"type": "text", "content": "May require pressors such as dopamine/dobutamine/vasopressin/epinephrine for hemodynamic support"}, {"type": "text", "content": "If > 10% difference between preductal and postductal saturations noted, begin iNO @ 20 ppm. May require milrinone as well."}, {"type": "text", "content": "ECMO: Required when unable to maintain O2 saturations > 90%, pH > 7.15 despite optimal ventilation strategies and/or metabolic acidosis, hypotension resistant to optimal management with pressors. Can be done before or after CDH repair."}]}]}, {"id": "infectious-disease-problems", "title": "INFECTIOUS DISEASE PROBLEMS", "type": "h1", "children": [{"id": "sepsis", "title": "Sepsis", "type": "h2", "children": [{"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "type": "h3", "children": [{"type": "text", "content": "Infections are an important cause for poor outcomes in newborn infants. Prematurely born infants have defective mucosal/cutaneous barriers against invading pathogens as well as poor cellular and humoral immunity. Due to these factors infections rarely stay focal and frequently enter the bloodstream and/or disseminate to other sites. For this reason preterm (especially ELBW) infants are at high risk for sepsis and its associated complications. Neonatal sepsis is typically classified as early onset (<72 hrs after birth) or late onset (> 72 hrs after birth)."}, {"type": "text", "content": "Maternal factors - such as preterm labor, PROM >18hr, chorioamnionitis (indicated by intrapartum fever, maternal or fetal tachycardia, uterine tenderness, foul-smelling discolored amniotic fluid and histopathologic evidence of necrotizing inflammation such as funisitis), GBS colonization or UTI \u2013 play a significant role in increasing risk for EOS"}, {"type": "text", "content": "Typically presents as blood stream infection (rarely as UTI or CNS infection)"}, {"type": "text", "content": "Organisms that cause EOS are usually vertically transmitted from mom"}, {"type": "text", "content": "GBS in term infants (less frequent these days due to increased maternal screening and treatment for GBS)"}, {"type": "text", "content": "E.coli in preterm infants (has become more significant in recent years)"}, {"type": "text", "content": "Streptococcus viridans"}, {"type": "text", "content": "Staphyococcus aureus"}, {"type": "text", "content": "Enterococcus fecalis"}, {"type": "text", "content": "Listeria monocytogenes"}]}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "type": "h3", "children": [{"type": "text", "content": "Risk factors include BW <750g, presence of presence of central catheters, delayed enteral feeding, prolonged TPN, mechanical ventilation, complications of prematurity (BPD, NEC)"}, {"type": "text", "content": "Mostly blood stream infections, though meningitis and UTI risk is higher with LOS than with EOS"}, {"type": "text", "content": "Organisms that cause LOS are usually"}, {"type": "text", "content": "Coagulase negative staphylococci such as S. epidermidis and S. hemolyticus (should not be considered contaminants in the NICU)"}, {"type": "text", "content": "E.coli"}, {"type": "text", "content": "S.aureus including MRSA"}, {"type": "text", "content": "Enterococci including VRE"}, {"type": "text", "content": "Klebsiella"}, {"type": "text", "content": "Pseudomonas"}]}, {"id": "clinical-presentation", "title": "Clinical presentation", "type": "h3", "children": [{"type": "text", "content": "Sepsis (like most other neonatal illnesses) presents mostly with a constellation of non-specific signs such as tachycardia/bradycardia, tachypnea/intermittent apnea, increased respiratory distress or O2 requirements, hypotonia/lethargy, temperature instability, hypoglycemia/hyperglycemia, metabolic acidosis (increased base deficit), lethargy, seizures, hypotension, any worsening vital trends"}]}, {"id": "screening/labs", "title": "Screening/labs", "type": "h3", "children": [{"type": "text", "content": "A high index of clinical suspicion based on maternal/infant history, reports of clinical providers such as bedside nurses regarding changes in infant\u2019s clinical condition and physical examination findings remains the best screening tool for sepsis in the NICU"}, {"type": "text", "content": "HERO scores should be reported at rounds routinely for all ELBW/preterm infants (and term infants at risk for sepsis) and any abnormal trends should prompt careful consideration and further evaluation as needed"}, {"type": "text", "content": "CRP \u2018at birth\u2019 is unhelpful (as CRP may be normal at onset of infection and may rise and peak around 24-36 hrs after onset), but serial values can be useful to monitor trend as a marker of inflammation/tissue necrosis, and as a negative predictive tool to discontinue antibiotics"}, {"type": "text", "content": "Appropriately performed blood culture (1 mL is advised; a minimum of 0.5 mL of blood should be collected to significantly improve ability to detect true bacterial sepsis) remains the gold standard for diagnosis of bacteremia"}, {"type": "text", "content": "Urinalysis, urine culture, CSF cell count/glucose/protein, CSF culture (usually not required for EOS evaluation in preterm infants)"}, {"type": "text", "content": "CXR/KUB if pneumonia/NEC or other concurrent pulmonary/GI causes are suspected based on clinical status of infant"}]}, {"type": "text", "content": "Empiric antibiotic choice"}, {"type": "text", "content": "EOS: Ampicillin & Gentamicin to cover GBS, E.Coli, & Listeria"}, {"type": "text", "content": "LOS: Nafcillin + Tobramycin is the first choice unless MRSA risk is high in which case vancomycin + Tobramycin can be used \u00b1 ceftazidime (for double coverage of GNR and meningeal penetration)"}, {"type": "text", "content": "After culture results are available"}, {"type": "text", "content": "Median time to culture positivity is for most pathogenic bacteria is 9-36 hours"}, {"type": "text", "content": "Therefore, empiric antibiotics should be continued for 36 hr and further antibiotic choice should be guided by sensitivity reports"}, {"type": "text", "content": "If cultures are negative, and infant is clinically well-appearing with stable vitals, antibiotics can be discontinued after discussion with Fellow/Attending"}, {"type": "text", "content": "Culture-negative sepsis \u2013 rarely, antibiotic therapy may be considered necessary though culture results are  negative, especially for infants who remain critically ill (significant ventilator needs, pressors etc.) and have evidence of inflammation"}, {"type": "text", "content": "If bacteremia is confirmed by positive cultures, a repeat culture should be obtained by the next calendar day"}, {"type": "text", "content": "Persistently positive blood cultures: Catheter removal, PIV placement for continued antibiotics and placement of a new catheter 24 hours after first negative culture may be required but not always possible. May require additional investigations to identify a focal nidus if infection (Echo, HUS, abdominal/renal US)."}, {"type": "text", "content": "LP if BCX +ve?"}]}, {"id": "meningitis", "title": "Meningitis", "type": "h2", "children": [{"type": "text", "content": "GBS, E.coli, other GPs like enterococcus, CONS, other GN such as Neisseria meningitidis."}, {"type": "text", "content": "CSF WBCs > 15 cells/\u00b5L should prompt consideration for meningitis dosing of antibiotics (correction for blood in CSF due to traumatic taps is typically not needed)."}, {"type": "text", "content": "Other CSF indices: Protein:  > 150 in preterm and > 100 in term is abnormal CSF glucose < 30 is considered indicative of bacterial meningitis"}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Early onset: Ampicillin+Gentamycin+ceftazidime is a common choice"}, {"type": "text", "content": "Late onset: Vancomycin + tobramycin + ceftazidime (if listeria/GBS/enterococci suspected can add ampicillin as well)"}, {"type": "text", "content": "If cultures positive, antibiotics should be continued for a minimum of 3 weeks"}, {"type": "text", "content": "Get ID consult and order HUS/CT/MRI near the end of antibiotic course to assess degree of brain injury and complications such as abscesses that may require longer courses."}]}, {"id": "uti", "title": "UTI", "type": "h2", "children": [{"type": "text", "content": "E.coli, Klebsiella, Proteus and CONS, Enterococcus in term infants, CONS, Klebsiella, E.coli and Candida in preterm infants are common causes"}, {"type": "text", "content": "UA/Urine Culture is best obtained from suprapubic aspiration (though rarely performed in our NICU), next best is I&O catheterization and prior to initiation of antibiotics"}, {"type": "text", "content": "Bacterial growth: any species >50,000 CFU/mL in samples collected through catherization"}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Ampicillin / Gentamicin x 10-14 days"}, {"type": "text", "content": "Can use Vancomycin for later onset (>7d) in some hospitalized infants"}, {"type": "text", "content": "Target antibiotics when known previous UTI with identified organism"}, {"type": "text", "content": "Renal Ultrasound (RUS) should be performed when infection is detected. VCUG should be considered on infants with UTI. VCUG should not be performed until a negative urine culture has been documented"}, {"type": "text", "content": "Infants should not be placed on antibiotic prophylaxis unless indicated. If desired, obtain consultation from Pediatric Infectious Disease subspecialist and urologic surgery services"}]}, {"id": "focal-bacterial-infections", "title": "Focal bacterial infections", "type": "h2", "children": []}, {"id": "gbs-algorithm", "title": "GBS algorithm", "type": "h2", "children": []}, {"id": "viral-infections", "title": "Viral Infections", "type": "h2", "children": [{"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "type": "h3", "children": [{"type": "text", "content": "Transmission"}, {"type": "text", "content": "Intrapartum exposure via maternal genital tract"}, {"type": "text", "content": "Postnatal exposure to infected breast milk"}, {"type": "text", "content": "Infected blood/blood products"}, {"type": "text", "content": "Nosocomial via saliva or urine"}, {"type": "text", "content": "Clinical Presentation"}, {"type": "text", "content": "Congenital early: acute fulminant (petechiae/purpura, HSM, prematurity, IUGR, \u201cblueberry muffin\u201d spots, transaminitis, hyperbilirubinemia, anemia, thrombocytopenia) vs symptomatic without life-threatening complications (IUGR, microcephaly +/- periventricular calcifications, sensorineural hearing loss)"}, {"type": "text", "content": "Asymptomatic congenital: later presentation with dev abnormalities, hearing loss,chorioretinitis, acquired microcephaly"}, {"type": "text", "content": "CMV pneumonitis: PT infants <4mo"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "PCR of saliva or urine (if baby has eaten, highest sensitivity), considered congenital if found within first 2 wks of life vs perinatal if negative in first 2 wks but positive after 4wk of life"}, {"type": "text", "content": "Congenital CMV workup: CBC, LFTs, eye exam, abdominal US, monitor head circumference"}, {"type": "text", "content": "Treatment"}, {"type": "text", "content": "Ganciclovir, Valganciclovir"}, {"type": "text", "content": "Will need ID consult for outpt FU & close audiology FU"}]}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "type": "h3", "children": [{"type": "text", "content": "Transmission"}, {"type": "text", "content": "Most Mothers of infants with neonatal HSV do not have a history of HSV"}, {"type": "text", "content": "Intrapartum transmission increases with ROM >4hr, direct fetal monitoring (ie scalp probes)"}, {"type": "text", "content": "Antenatal transmission is uncommon"}, {"type": "text", "content": "Postal transmission from oropharyngeal shedding, maternal breast lesions"}, {"type": "text", "content": "Clinical Presentation"}, {"type": "text", "content": "Skin, eye, and/or mouth: vesicular presentation, can develop neurologic impairment & keratoconjuncitivis therefore need opthalmology and neuro follow up"}, {"type": "text", "content": "Encephalitis +/- mucocutaneous disease: symptomatic at 10-14 d of life with lethargy, seizures, temp instability, & hypotonia, high mortality with late or absent treatment"}, {"type": "text", "content": "Disseminated: most severe form, presents within 1st week of life with seizures, respiratory distress/failure, shock, DIC reflecting involvement of liver, adrenals, and other visceral organs, 20% may be absent of vesicles"}, {"type": "text", "content": "Strongly consider HSV in any neonate admitted for concerns of sepsis, hypothermia, seizures etc in the first 2 weeks of life, even if there is no maternal history \u2013 as most neonatal infections are from Primary cases"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Blood & CSF HSV PCR"}, {"type": "text", "content": "Viral culture of eye/nose/mouth/anus"}, {"type": "text", "content": "Treatment"}, {"type": "text", "content": "Acyclovir x14d (21+ days with evidence of CNS/disseminated dz, longer of CSF PCR positivity persists)"}, {"type": "text", "content": "-Women with known clinical/serologic evidence of HSV-2 are offered acyclovir near term until delivery"}, {"type": "text", "content": "-refer to RedBook recommendations & Kimberlin, et al Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions PMID: 23378604"}, {"type": "text", "content": "Kimberlin et al, Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions. Pediatrics. February 2013, Vol 131, Issue 2"}]}, {"id": "parvovirus", "title": "Parvovirus", "type": "h3", "children": [{"type": "text", "content": "Transmission"}, {"type": "text", "content": "Antenatally (maternal sx asymptomatic vs arthralgias, rash), worse when contracted in 2nd/3rd trimester"}, {"type": "text", "content": "Clinical Presentation"}, {"type": "text", "content": "Children, Adults, & Immunosuppressed patient presentation not described here"}, {"type": "text", "content": "Fetal: implicated in 10% non-immune hydrops (maternal primary infection \ud83e\udc6atransplacental transfer of virus\ud83e\udc6aRBC precursor infection\ud83e\udc6aarrested RBC production \ud83e\udc6asevere anemia\ud83e\udc6acongestive heart failure\ud83e\udc6aedema, myocarditis, fetal hepatitis)"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Blood PCR (OB may obtain PCR or IgM via PUBS, percutaneous umbilical blood sampling if hydrops detected)"}, {"type": "text", "content": "Treatment"}, {"type": "text", "content": "Supportive (OB may opt to perform intrauterine blood transfusion for severe hydrops fetalis)"}]}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "type": "h3", "children": [{"type": "text", "content": "Transmission"}, {"type": "text", "content": "Congenital & Perinatal transmission: as early as 14-20wga but most commonly during 3rd trimester/delivery"}, {"type": "text", "content": "Sexual and parenteral transmission not described here"}, {"type": "text", "content": "Clinical Presentation"}, {"type": "text", "content": "Infants: usually asymptomatic at birth with sx presenting >2wk of life (lymphadenopathy, HSM, poor weight gain, occasionally encephalopathy), initially high viral lode that declines over first 5yr of life related to development of immune system"}, {"type": "text", "content": "HIV in pregnancy not discussed here"}, {"type": "text", "content": "Children: un-diagnosed symptoms occur in first yr of life (medium age 9mo)"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Mother known HIV-infected: HIV DNA PCR if mother known HIV-infected, RNA PCR if mother not treated, positive within 3d of life are considered infected in utero vs those test negative in 1st 3d of life & positive thereafter considered peripartum-acquired HIV (see RedBook for more specific cases)"}, {"type": "text", "content": "Mother unknown HIV status: immediately obtain rapid HIV testing on mother unless mother refuses. If positive, zidovudine and nevirapine should be started on infant immediately if baby is less than 48 hours of age. Send confirmatory testing on mother."}, {"type": "text", "content": "HIV workup: CBC, AST/ALT, HIV DNA PCR for 0600 on DOL #1 for all HIV-exposed newborns"}, {"type": "text", "content": "Treatment"}, {"type": "text", "content": "ALL infants born to HIV positive women must begin Zidovudine (AZT) after delivery with 1st dose given given before 6 hours of life. Neviripine should also be given in certain high-risk situations (see posted guidelines)"}, {"type": "text", "content": "Use Newborn HIV Exposed Infants power plan to order labs and pharmacy consult. Use Newborn Medications power plan to order meds."}, {"type": "text", "content": "Breastfeeding contraindicated in all HIV positive women in US"}, {"type": "text", "content": "Must obtain pharmacy discharge consult for AZT supply and teaching & order >24 hours prior to anticipated discharge. Notify Family Clinic 939-9400, HIV study nurse at 996-6418 or 996-7831, and Jefferson County Dept of Health-Lori McManus, Disease Specialist 930-1383."}]}, {"id": "rubella", "title": "Rubella", "type": "h3", "children": [{"type": "text", "content": "Transmission"}, {"type": "text", "content": "Congenital: highest rate of fetal infection during first 12-16wk and last 10wk of gestation, with early-gestation infection resulting in multiple organ anomalies (most commonly cardiac defect & deafness)"}, {"type": "text", "content": "Clinical Presentation"}, {"type": "text", "content": "Infants: cataracts, sensorineural hearing loss, and CHD (PDA, pulmonary artery stenosis) with common early sx (IUGR, microphthalmia, meningocencephalitis, hypotonia, HSM, thrombocytopenia purpura, radiographic bone lucencies)"}, {"type": "text", "content": "Maternal history: if present, malaise, low-grade fever, headache, mild corzya, and conjunctivitis 1-5d prior to salmon-pink macular rash that spreads downward"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Isolation of rubella virus (oropharynx or urine, latter has highest sensitivity), Rubella-specific IgM (cord or neonatal blood), persistent rubella-specific titers"}, {"type": "text", "content": "Treatment"}, {"type": "text", "content": "None. If infection known to have occurred >20thwk of gestation, unlikely any abnormalities however close audiology FU should occur."}]}, {"id": "hepatitis-b", "title": "Hepatitis B", "type": "h3", "children": [{"type": "text", "content": "Refer to Manual of Neonatal Care for more detail regarding all types of Hepatitis viruses"}, {"type": "text", "content": "Diagnosis: Check maternal HbsAg status"}, {"type": "text", "content": "Treatment\ta.\t See Table below"}]}, {"id": "varicella-zoster", "title": "Varicella-Zoster", "type": "h3", "children": [{"type": "text", "content": "Greatest risk for severe disease occurs when primary maternal infection occurs 5 days prior to or 2 days after delivery"}, {"type": "text", "content": "infected infants should be isolated in separate room,"}, {"type": "text", "content": "all neonates <28wga should be given VariZIG or IVIG postexposure regardless of maternal status"}]}, {"type": "text", "content": "Synagis (Palivizumab) prophylaxis per 2014 AAP Policy Statement"}, {"type": "text", "content": "Infants <12mo at start of RSV season who were born <29wk may receive up to 5 doses given monthly"}, {"type": "text", "content": "Infants <12mo at start of RSV season with chronic lung disease (CLD) as defined as GA <32 & O2 requirement >21% for at least first 28d after birth may receive up to 5 doses given monthly (see policy statement for >24mo of age)"}]}, {"id": "syphilis", "title": "Syphilis", "type": "h2", "children": []}]}, {"id": "cardiovascular-problems", "title": "CARDIOVASCULAR PROBLEMS", "type": "h1", "children": [{"id": "prenatal-and-postnatal-circulation", "title": "Prenatal And Postnatal Circulation", "type": "h2", "children": []}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "type": "h2", "children": [{"type": "text", "content": "Timing and symptoms depend on"}, {"type": "text", "content": "nature and severity of the anatomic defect"}, {"type": "text", "content": "PDA closure"}, {"type": "text", "content": "fall in pulmonary vascular resistance"}, {"type": "text", "content": "Cyanosis:"}, {"type": "text", "content": "Decreased pulmonary blood flow with intracardiac R to L shunt"}, {"type": "text", "content": "Normal pulmonary blood flow with intracardiac mixing of systemic and pulmonary venous return."}, {"type": "text", "content": "CHF:"}, {"type": "text", "content": "Tachycardia, tachypnea, crackles, hepatomegaly, delayed cap refill, diaphoresis, growth failure, feeding difficulty."}, {"type": "text", "content": "Heart murmur, Arrhythmias, Cardiogenic shock"}]}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "type": "h2", "children": [{"type": "text", "content": "Required to keep PDA open for CHDs in which ductal flow is required to maintain adequate  pulmonary or systemic (sometimes both) circulation"}, {"type": "text", "content": "List of infants with CHDs who might be born during the month is circulated via email to Fellow/Attending. As soon as you are aware of impending delivery of an infant with CHD"}, {"type": "text", "content": "Always check with Fellow if PGE2 is required"}, {"type": "text", "content": "If required, pre-order PGE2 (can begin at 0.05 mcg/kg/min and titrate later)"}, {"type": "text", "content": "Response: expect a clinical response in 15-30 minutes for cyanotic CHD (smooth muscle of ductus is particularly sensitive) and 1-3 hrs for non-cyanotic CHD (relaxation of pulmonary vasculature not as rapid)."}, {"type": "text", "content": "If decompensation is noted after starting, a lesion with impaired left-heart return may exist; stop infusion immediately."}, {"type": "text", "content": "Contraindications to PGE are processes obstructing left heart return (because keeping the PDA open may lead to more shunting away from systemic circulation): Obstructive TAPVR (infradiaphragmatic), cor triatriatum, TGA, MS and restrictive atrial septum."}, {"type": "text", "content": "Complications include apnea, hypotension, fever, tachycardia/bradycardia, seizure"}, {"type": "text", "content": "Monitor carefully for apnea; may require caffeine therapy"}]}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "type": "h2", "children": [{"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "type": "h3", "children": [{"type": "text", "content": "Closed in 50% of full-term infants by 24h, 90% by 48h, >99% by 96h; in contrast spontaneous closure occurs only in 38%-85% of babies <1500g and in 25-34% of those <1000g"}, {"type": "text", "content": "Other risk factors: No exposure to antenatal steroids, excessive fluid intake (especially in the first 2 weeks for ELBW infants), critical illness due to other causes in ELBW infants"}, {"type": "text", "content": "When to suspect a PDA"}, {"type": "text", "content": "Harsh systolic ejection murmur over entire chest"}, {"type": "text", "content": "Widened pulse pressure (palmar pulses)"}, {"type": "text", "content": "No consensus exists regarding what is considered a hemodynamically significant PDA; however, the possibility should be explored when a PDA is associated with"}, {"type": "text", "content": "Worsening respiratory status and/or inability to wean from high SIMV settings (especially in ELBW/VLBW infants)"}, {"type": "text", "content": "Pulmonary \u201csteal\u201d which can lead to"}, {"type": "text", "content": "Pulmonary hypertension, edema"}, {"type": "text", "content": "Renal failure"}, {"type": "text", "content": "NEC"}, {"type": "text", "content": "Metabolic acidosis"}, {"type": "text", "content": "IVH, PVL"}, {"type": "text", "content": "Obtain an ECHO for ELBW infants who are suspected to have a HS-PDA. Findings"}, {"type": "text", "content": "Large PDA (> 2 mm in size)"}, {"type": "text", "content": "LA enlargement (LA:Ao ratio > 1.4)"}, {"type": "text", "content": "Significant L\ud83e\udc6aR flow across PDA"}, {"type": "text", "content": "HS-PDA incidence and complications can be prevented or minimized over the first 2 weeks of life by"}, {"type": "text", "content": "Careful attention to fluid intake/output in all ELBW infants (continued transition to enteral feeds can help limit parenteral fluid intake from IVF/TPN)"}, {"type": "text", "content": "Avoid loop diuretics such as furosemide (increases prostaglandin production which can cause ductus to remain patent)"}, {"type": "text", "content": "Medical closure:"}, {"type": "text", "content": "Indomethacin is most commonly used"}, {"type": "text", "content": "Contraindications \u2013 active clinical bleeding, on steroids, Cr>1.8, UOP < 0.6 ml/kg/hr, platelets <60,000, NEC, worsening IVH"}, {"type": "text", "content": "Ibuprofen"}, {"type": "text", "content": "Relative contraindications \u2013 oliguria, steroid use"}, {"type": "text", "content": "Acetaminophen"}, {"type": "text", "content": "Relative contraindications \u2013 elevated liver enzymes"}, {"type": "text", "content": "Continue trophic feeds during medical management and increase feeds after treatment complete"}, {"type": "text", "content": "Surgical/transcatheter closure may be considered in older infants (> 1 month of age) if medical closure does not succeed and if PDA closure is considered necessary"}]}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "type": "h3", "children": [{"type": "text", "content": "Pulmonary vascular resistance fails to decrease causing PVR to continue to remain supra-systemic, resulting in R to L shunting of blood"}, {"type": "text", "content": "Most often noted in term infants with perinatal hypoxia/difficult resuscitation/meconium aspiration"}, {"type": "text", "content": "Can progress to persistent pulmonary hypertension (PPHN)"}, {"type": "text", "content": "Can present with respiratory distress shortly after delivery, post-ductal sat< pre-ductal sat (desaturated blood reaching descending aorta)"}]}, {"id": "coarctation-of-the-aorta", "title": "Coarctation of the aorta", "type": "h3", "children": [{"type": "text", "content": "Findings: decreased perfusion/pulses/BP in lower extremities, signs of congestive heart failure, metabolic acidosis, lethargy"}]}, {"type": "text", "content": "Resulting from the underdevelopment of the L side of the heart (LV, aortic valve and aorta)"}, {"type": "text", "content": "Therefore, systemic perfusion with oxygenated blood depends on the presence of a ASD which permits a LA\ud83e\udc6aRA shunt followed by a R\ud83e\udc6aL shunt through the PDA."}, {"type": "text", "content": "Management (both coarc and HLHS)"}, {"type": "text", "content": "Maintain PDA with prostaglandin drip to keep blood flow to the descending aorta. Surgical correction."}]}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "type": "h2", "children": [{"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "type": "h3", "children": [{"type": "text", "content": "Usually presents with symptoms of CHF (treated with digoxin/diuretics) as well as cyanosis (typical O2 saturations between 80-90)"}, {"type": "text", "content": "Avoid supplemental O2 because this will only further dilate pulmonary vasculature and lead to pulmonary overcirculation/hypertension"}, {"type": "text", "content": "Always screen for DiGeorge (and Ca levels)"}, {"type": "text", "content": "No real role for PGE here as not ductal dependent"}]}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "type": "h3", "children": [{"type": "text", "content": "Aorta arises from desaturated RV, and pulmonary artery arises  from oxygenated LV.  So get parallel circuits of flow that is dependent on mixing for survival"}, {"type": "text", "content": "Blood mixing must occur either through the foramen ovale or PDA (so DO start PGE here)"}, {"type": "text", "content": "Findings: tachypnea, loud and single 2nd heart sound (bc anterior position of aorta coming off RV) , CXR shows EGG shape heart with increased pulmonary vascularity (opposite to TOF), generally has NO murmur (unless also has PS or restrictive VSD)"}, {"type": "text", "content": "Most common cyanotic heart defect identified in 1st week of life*"}]}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "type": "h3", "children": [{"type": "text", "content": "No communication btw RA and RV, so pulmonary circulation compromised."}, {"type": "text", "content": "Blood from systemic circulation goes RA\ud83e\udc6acrosses ASD (must have this for survival)\ud83e\udc6amixes in LA with oxygenated blood\ud83e\udc6a pulmonary blood flow through PDA and/or a VSD"}, {"type": "text", "content": "Presents early on with cyanosis"}, {"type": "text", "content": "Do start PGE here as PDA allows for improved pulmonary blood flow"}, {"type": "text", "content": "Pulmonary atresia and Ebsteins anomaly are similar"}]}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "type": "h3", "children": [{"type": "text", "content": "Most common cyanotic heart condition overall.  Hypoxia related to degree of RV outflow obstruction."}, {"type": "text", "content": "Components: Pulmonary stenosis, RVH, VS  D, overriding aorta"}, {"type": "text", "content": "DO start PGE here to help augment pulmonary blood flow"}, {"type": "text", "content": "Can be asymptomatic early on and not present until 3-5 months of age"}, {"type": "text", "content": "Findings: single 2nd heart sound, BOOT-shaped heart with decreased pulmonary vascularity on CXR."}, {"type": "text", "content": "Tet spell: hypercyanotic hypoxic episodes resulted from increased R to L shunting during an acute episode"}]}, {"type": "text", "content": "\u201cAnomalous\u201d drainage of oxygenated pulmonary venous blood back into the RA instead of the LA"}, {"type": "text", "content": "Systemic blood flow dependent on shunting from RA  to LA across PFO/ASD (essential for survival)"}, {"type": "text", "content": "Range of mild to severe hypoxia based on any obstruction of pulmonary venous return (depends on where the veins are draining.  If infracardiac- may pass through diaphragm which puts at risk for severe hypoxia).  So may be missed initially."}, {"type": "text", "content": "Findings: fixed split S2, short systolic murmur, CXR with SNOWMAN (heart bc dilated mediastinal veins), and PULMONARY EDEMA (bc pulmonary vein obstruction)"}, {"type": "text", "content": "So PGE doesn\u2019t really have a role here bc not ductal dependent"}]}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "type": "h2", "children": [{"id": "general-pointers-to-tachycardia-or-bradycardia", "title": "General Pointers to tachycardia or bradycardia", "type": "h3", "children": [{"type": "text", "content": "Gradual onset: Repetitive firing from a single focus such as the sinus node"}, {"type": "text", "content": "Abrupt and frequent: Bursts of activity from a single pathologic focus"}, {"type": "text", "content": "Abrupt onset, sustained rate, and abrupt termination: Usually due to reentrant mechanisms"}]}, {"id": "premature-complexes", "title": "Premature Complexes", "type": "h3", "children": [{"type": "text", "content": "Atrial - P wave that begins before the T wave ends, PVC \u2013 QRS complex without a preceding P wave that is different in shape/height vs. other QRS complexes"}, {"type": "text", "content": "Occasional PACs and PVCs are frequently noted in preterm newborns and to a lesser extent in term newborns"}, {"type": "text", "content": "If frequent, perform 12-lead EKG/echocardiogram, ensure that infant has normal S.electrolytes, central catheter positioning, and consult cardiology"}]}, {"id": "common-bradycardias", "title": "Common Bradycardias", "type": "h3", "children": [{"type": "text", "content": "Sinus bradycardia: Most commonly due to non-cardiac causes such as hypothyroidism, cardio-respiratory failure, acidosis etc.; treating underlying cause"}, {"type": "text", "content": "Heart block"}, {"type": "text", "content": "Due to AV conduction disturbances caused by infections, metabolic or congenital abnormalities"}, {"type": "text", "content": "1st degree block due to PR interval prolongation; 2nd degree block due to intermittent transmission of atrial impulses to the ventricles, 3rd  degree (complete) heart block occurs due to complete failure of conduction of atrial impulses to the ventricles."}, {"type": "text", "content": "Complete block is usually due to maternal autoimmune disorders (such as SLE) and often requires pacemaker placement when HR persistently < 55 bpm, or when the EKG shows complex ventricular ectopy or dysfunction."}]}, {"type": "text", "content": "If the QRS complex during the tachycardia episode is narrow and similar in shape to the QRS complex before the onset of tachycardia, then the pathology is almost always supraventricular in origin"}, {"type": "text", "content": "If the QRS complex is wide then the pathology is usually ventricular, but may also be supraventricular"}, {"type": "text", "content": "SVT vs. Sinus Tachycardia"}, {"type": "text", "content": "Long QT syndrome"}, {"type": "text", "content": "Defective K+ channel function which delays cardiac repolarization and can cause VT with varying QRS morphology. Can be treated with \u03b2-blockers."}]}]}, {"id": "gastrointestinal-problems", "title": "GASTROINTESTINAL PROBLEMS", "type": "h1", "children": [{"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "type": "h2", "children": [{"type": "text", "content": "Gastric residuals and what they mean"}, {"type": "text", "content": "There is paucity of evidence to support utility of checking gastric residuals in the diagnosis of NEC or feeding intolerance"}, {"type": "text", "content": "In the absence of other symptoms, there is no evidence to support the discontinuation of feeds based ONLY on gastric residuals."}, {"type": "text", "content": "Residuals are checked selectively in the RNI now (no longer performed as a routine practice!)"}, {"type": "text", "content": "Although new-onset and large amounts of gastric residuals or changes from previous patterns have been proposed as a diagnostic tool for NEC, gastric residuals are poor clinical predictors of NEC."}, {"type": "text", "content": "Checking gastric residuals delays time to full feeding without decreasing the risk of NEC."}, {"type": "text", "content": "It is hard to define the accuracy of measurements because the technique is not standardized"}, {"type": "text", "content": "Because acid production in the stomach limits bacterial overgrowth and facilitates protein digestion, it is advisable not to aspirate the stomach content of preterm infants."}, {"type": "text", "content": "If clinical picture and diagnostics/imaging show low risk for NEC or other abdominal emergencies, consider ileus/feeding intolerance. May need NPO for bowel rest, start TPN/IVF, monitor response. If improved, titrate up enteral feeds slowly & monitor closely."}]}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "type": "h2", "children": [{"type": "text", "content": "Definition: Acute intestinal necrosis of unknown etiology. It has been suggested that altered patterns of intestinal colonization initiate an unbalanced pro-inflammatory cascade resulting in intestinal injury."}, {"type": "text", "content": "Epidemiology:"}, {"type": "text", "content": "Clinical: Early attention to clinical symptoms of feeding intolerance including abdominal distension, bloody stools and emesis is essential."}, {"type": "text", "content": "Systemic sx: Similar to sepsis; respiratory distress, A/Bs, lethargy, temp instability, irritability, poor feeding, hypotension, poor perfusion, acidosis, oliguria"}, {"type": "text", "content": "Abdominal sx: distention, tenderness, vomiting (esp blood/bile), ileus (BS), abdominal wall erythema/discoloration, ascites, blood-tinged stool"}, {"type": "text", "content": "Differentials: Ileus, meconium peritonitis, surgical abdominal catastrophe (malrotation with obstruction/malrotation, gastric perforation, mesenteric vessel thrombosis), spontaneous intestinal perforation (SIP) (increased risk with maternal glucocorticoid exposure & indomethacin), allergic colitis, Hirschsprung-associated enterocolitis, & feeding intolerance."}, {"type": "text", "content": "Diagnosis: The clear presence of pneumatosis intestinalis is diagnostic in the presence of other clinical symptoms."}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Risk Assessment: If NEC is suspected, perform risk assessment."}, {"type": "text", "content": "Other important considerations to assess risk:"}, {"type": "text", "content": "Presence of emesis"}, {"type": "text", "content": "Presence of frank blood in stools (guaiac + stools are common in NG fed infants and therefore not a useful indicator of NEC)"}, {"type": "text", "content": "Presence of the triad of metabolic acidosis, thrombocytopenia, and hyponatremia"}, {"type": "text", "content": "Presence of increased gastric residuals*"}, {"type": "text", "content": "Labs: CBC with diff, blood gas with lytes and lactic acid, BUN, creatinine, serial CRP for dx & assess response to therapy, blood cultures (positive in 30%), consider urine/CSF cx if suspicious for or cannot r/o UTI or meningitis before starting abx"}, {"type": "text", "content": "Imaging: If there is a high risk for NEC, order STAT abdominal XRAY AP to look for pneumatosis intestinalis. If concerned for pneumoperitoneum, order left lateral decubitus or cross-table. Serial abdominal films (ie q6h-q8h) may be ordered to monitor abnormal gas pattern/ileus, bowel wall edema, fixed position loop on serial films, pneumatosis, portal/hepatic air, pneumoperitoneum."}, {"type": "text", "content": "Modified Bell\u2019s Staging & Management:"}, {"type": "text", "content": "Treatment: For suspected or proven cases of NEC, enteral feeding is discontinued and IVF or TPN is initiated. A Replogle tube, with low intermittent suction, is placed in the stomach. Empiric antibiotics are started, usually vanc and tobra (usually 10-14 days). Add anaerobic coverage (Flagyl or Clinda; or replace tobra with Zosyn) if with suspected perforation. Perform serial exams, serial abdominal girth measurements, & serial films (q6-12hr). About 30-50% will need surgical intervention. GI perforation or full-thickness necrosis precipitates severe peritonitis (transfer to COA STAT!). Surgeons may perform bedside drain vs ex-lap with bowel resection (at risk for short-gut syndrome)."}]}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "type": "h2", "children": [{"type": "text", "content": "SIP is a single intestinal perforation that is typically found at the terminal ileum. It occurs primarily in VLBW and ELBW preterm infants. SIP is a separate clinical entity and must be differentiated from NEC for management considerations."}, {"type": "text", "content": "Epidemiology: Occurs in 2-5% of VLBW and ELBW"}, {"type": "text", "content": "Risk Factors: Prematurity, postnatal exposure to steroids and indomethacin"}, {"type": "text", "content": "Clinical Presentation:"}, {"type": "text", "content": "Although there can be overlap, the following common findings of SIP typically distinguish it from NEC:"}, {"type": "text", "content": "Lab Findings: WBC may be elevated. Drop in platelets or hct may be observed."}, {"type": "text", "content": "Imaging: Abdominal films AP and left-lateral decubitus or cross-table lateral to look for pneumoperitoneum. If film shows gasless abdomen, US may be helpful to look for echogenic free fluid (sign of perforation)."}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Directed toward stabilization and includes the following"}, {"type": "text", "content": "- NPO and start IVF/TPN"}, {"type": "text", "content": "- Abdominal decompression with replogle under LIWS"}, {"type": "text", "content": "- Fluid resuscitation and inotropic support for hypotension"}, {"type": "text", "content": "- IV antibiotics (Vanc, tobra, flagyl)"}, {"type": "text", "content": "- Transfer to CoA for surgery (peritoneal drain or ex lap with bowel resection and primary anastomosis or ostomy)"}]}, {"id": "conjugated-hyperbilirubinemia", "title": "Conjugated Hyperbilirubinemia", "type": "h2", "children": [{"type": "text", "content": "Diagnosed when direct bilirubin > 2 mg/dL or is > 20% of total bilirubin"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "UDCA (a choleretic that increases bile flow) can be used to decrease conjugated bilirubin. Vit.  A/D/E/K supplements"}]}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "type": "h2", "children": [{"type": "text", "content": "An omphalocele is a midline abdominal wall defect of variable size, covered by a membrane of amnion and peritoneum with Wharton\u2019s jelly between the two layers, and containing abdominal contents. Sac may be intact or ruptured. 80% infants with Omphalocele is associated with other congenital anomalies. Careful search for associated anomalies including CHD, genitourinary defects, craniofacial, musculoskeletal; vertebral and limb anomalies."}, {"type": "text", "content": "Gastroschisis is a full thickness, paraumbilical abdominal wall defect usually associated with evisceration of bowel. 8-16% of infants with gastroschisis will have other gastrointestinal anomalies"}, {"type": "text", "content": "Diagnosis"}, {"type": "text", "content": "Prenatal ultrasonography, elevated maternal alpha fetal protein and physical exam"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Management at birth"}, {"type": "text", "content": "Use latex free products including gloves"}, {"type": "text", "content": "Maintain thermoneutral environment"}, {"type": "text", "content": "Use transparent bowel bag to cover the sac to prevent heat and water loss"}, {"type": "text", "content": "Minimize handling of the bowel to prevent vascular compromise"}, {"type": "text", "content": "Place nasogastric tube to decompress the stomach"}, {"type": "text", "content": "Obtain immediate IV access and start IVF (Usually require 2-3 times of the normal maintenance IVF)"}, {"type": "text", "content": "Begin broad spectrum antibiotics prophylactically (Covering vaginal flora)"}, {"type": "text", "content": "Monitor temperature and PH"}, {"type": "text", "content": "Obtain urgent surgical consultation"}]}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "type": "h2", "children": [{"type": "text", "content": "Clinical: May have a history of polyhydramnios and is commonly diagnosed prenatally by ultrasound. Bile stained vomiting usually occurs within few hours of birth"}, {"type": "text", "content": "Diagnosis: Plain radiograph of non-decompressed abdomen will show \u2018\u2019double bubble\u201d"}, {"type": "text", "content": "Management: NPO, gastric decompression with nasogastric suction and surgical consultation"}, {"type": "text", "content": "70% of cases have other associated malformations, including Down syndrome, cardiovascular anomalies and GI anomalies."}]}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "type": "h2", "children": [{"type": "text", "content": "An emergency because bowel viability is at stake!"}, {"type": "text", "content": "Clinical: Presents with sudden onset of bilious vomiting in an infant who has passed stool. Bilious emesis equals malrotation until proved otherwise. Signs of sepsis and shock are often present"}, {"type": "text", "content": "Diagnosis: Upper GI series, specifically looking for an absent or abnormal position of the ligament of treitz is the gold standard. Ultrasonography can be used to determine the position of the superior mesenteric vessels in malrotation."}, {"type": "text", "content": "Management: An acutely ill child with the presumed diagnosis of volvulus requires urgent operative intervention even at the expense of full resuscitation. In malrotation without volvulus, urgency of surgical intervention is less."}]}]}, {"id": "nephrology-problems", "title": "NEPHROLOGY PROBLEMS", "type": "h1", "children": [{"id": "common-labs", "title": "Common Labs", "type": "h2", "children": [{"type": "text", "content": "At birth, the kidney replaces the placenta as the major homeostatic organ"}, {"type": "text", "content": "GFR improves over the first weeks of life (dependent on gestational age) and continues to improve until 18-24 months of age"}, {"type": "text", "content": "Serum Anion Gap: Na \u2013 (Cl + HCO3-) is used to determine if there are excessive non-measured anion in the blood"}, {"type": "text", "content": "Urine Anion Gap: (Na + K) - Cl is used to determine if urine is handling acid well in context of a non-anion gap metabolic acidosis. If kidneys are working appropriately, the urine anion gap should be negative; urine anion gap"}, {"type": "text", "content": "FeNa: 100 x (uNa x sCr) / (sNa x uCr); is used in context of a rising creatinine to determine if the tubules are able to avidly conserve sodium"}, {"type": "text", "content": "While the above values are useful for older children and adults, the FENa\u00a0must be interpreted more cautiously in younger pediatric patients due to the limited ability of immature tubules to reabsorb sodium maximally. Thus, in term neonates, a FENa\u00a0of <3% represents volume depletion, and a FENa\u00a0as high as 4% may represent maximal sodium conservation in critically ill preterm neonates . The FENa\u00a0may also be spuriously elevated in children with adrenal insufficiency or pre-existing kidney disease (such as obstructive uropathy) due to salt wasting."}, {"type": "text", "content": "4. Insensible Losses: 400cc/m2"}, {"type": "text", "content": "Normal Serum Creatinine Values in Term & Preterm Infants (\u00b1 SD)"}]}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "type": "h2", "children": [{"type": "text", "content": "Prerenal azotemia occurs when there is low perfusion to the kidneys: loss of effective blood volume, low oncotic pressure, leaky capillaries, poor cardiac output, medications (ACE), intra-abdominal compartment syndrome"}, {"type": "text", "content": "Intrinsic AKI (ATN): prolonged/severe ischemia, nephrotoxins, sepsis, infants on cooling protocol"}, {"type": "text", "content": "Evaluation: Renal failure indices in the oliguric neonate table (Manual of Neonatal Care)"}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Hyperkalemia: eliminate/limit K (Similac PM 60/40), CIGAR acronym"}, {"type": "text", "content": "Fluid Mgmt: unless dehydration, limit volume to replacement of insensible losses + UOP. If unable to prevent fluid overload, consult nephrology"}, {"type": "text", "content": "Sodium: restrict (check IVF, TPN, & any Na in medications)"}, {"type": "text", "content": "Phosphorous: restrict (Sim 60/40), oral calcium carbonate can be used as phosphate-binder"}, {"type": "text", "content": "Calcium: give based on ionized calcium or if symptomatic"}, {"type": "text", "content": "Metabolic acidosis: NaHCO3 only if severe"}, {"type": "text", "content": "Dialysis: need to reduce fluid overload, severe hyperkalemia, acidosis, and/or uremia \ud83e\udc6a Consult Nephrology!"}]}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "type": "h2", "children": [{"type": "text", "content": "These include hydronephrosis, hypoplasia, dysplastic kidneys, & duplications."}, {"type": "text", "content": "No matter the etiology, its important to assure that fluid balance occurs. Depending on the degree of dysplasia, some newborns may have excessive fluid losses and require up to 240 mL/kg/day to maintain adequate hydration, whereas others may be oliguric and may require insensible plus output to prevent fluid overload."}, {"type": "text", "content": "Hydronephrosis"}, {"type": "text", "content": "Unilateral: more common, if mild in-utero hydronephrosis, don\u2019t perform US in first few days of life when hydronephrosis may not be detected b/c of physiologic dehydration"}, {"type": "text", "content": "Bilateral: more worrisome esp if oligohydramnio or pulmonary disease is present, males should have VCUG performed within first few days to r/o posterior urethral valves (PUV), ureterpelvic junction obstruction (UPJ), ureterovesical junction obstruction (UVJ), prune belly"}]}, {"id": "hypertension", "title": "Hypertension", "type": "h2", "children": []}]}, {"id": "neurological-problems", "title": "NEUROLOGICAL PROBLEMS", "type": "h1", "children": [{"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "type": "h2", "children": [{"type": "text", "content": ": Vasculature of germinal matrix in ELBW infants has little support & its blood flow is poorly autoregulated. Risk factors for IVH include chorioamnionitis, hypotension, hypoxia, hypercarbia, hypernatremia, thrombocytopenia, rapid fluid infusion, PDA, and ECMO."}, {"type": "text", "content": ": Inversely proportional to gestational age. 90% of bleeds occur in first 72h."}, {"type": "text", "content": ": Mostly insidious in onset. Can also be \u201ccatastrophic\u201d, with signs such as full/bulging anterior fontanel, increased head circumference, fall in Hct, DIC, hyperglycemia, metabolic acidosis, thrombocytopenia, lethargy, hypotonia, seizures, temperature instability, shock"}, {"type": "text", "content": "Screening: Ultrasound is best study. Order one if high clinical suspicion & order one on admission orders at 7 days of life as screening if <1500 grams or 31 weeks. Pleaseinclude  mastoid view as part of  in the order since small cerebellar hemorrhage which are quite common are often missed if performed through routine windows.    Follow up US in one month."}, {"type": "text", "content": ":"}, {"type": "text", "content": "Management: Treatment is supportive - give PRBCs as necessary, treat seizures with phenobarb. Assess for signs of post-hemorrhagic hydrocephalus: rapidly enlarging head circumference (> 2 cm in < 7 days), sutural splaying, full tense fontanel, worsening A/B episodes, lethargy, and feeding intolerance. If grade 3 or 4 is diagnosed, will need to follow daily head circumference and interval HS to monitor post-hemorrhagic hydrocephalus; though most of them outgrow it. , may require Neurosurgery consult for possible CoA transfer/neurosurgical intervention."}, {"type": "text", "content": "Prevention: Antenatal steroid exposure reduces IVH incidence. Low dose indomethacin (0.1mg/kg q24hr x 1 dose) as soon as possible for ELBW infants with weight < 750g to stabilize the autoregulation of the cerebral vasculature. Avoid giving boluses, or to infuse very slowly if needed at all since preterm infants have pressure passive cerebral circulation and each boluse causes hyepertensive spike in the fragile capillaries."}, {"type": "text", "content": "Contraindications for Indomethacin: Absent or reversed end diastolic blood flow (hypoperfusion to gut), IUGR presumably caused by"}]}, {"id": "seizures", "title": "Seizures", "type": "h2", "children": [{"type": "text", "content": ": Encephalopathy (most common from hypoxia), cerebral contusion, intracranial hemorrhage (IVH, SAH, SDH), bacterial or viral meningitis, TORCH infections, narcotic withdrawal, electrolyte disturbances, and masses (rare in newborns)."}, {"type": "text", "content": ": Varied in the neonatal period; can be \u201cSubtle Seizures\"-- only blinking/altered gaze/oral movements/apnea as clinical manifestations. Clonus & jitteriness (NOT assoc with VS changes; movements start/stop with stimulation) may be caused by HIE, hypocalcemia, hypoglycemia, or narcotic withdrawal should be differentiated from true seizures."}, {"type": "text", "content": ": Load with phenobarb 20mg/kg over 10 min. If no effect in an hour, repeat phenobarb load. If patient is INTUBATED, can again repeat a load of Phenobarbital 10-20mg/kg. Check level if still not effective. If Phenobarbital is \u201cnot working,\u201d add KEPPRA at a dose of 20mg/kg and can repeat a load of 20mg/kg. Again, RESPIRATORY DEPRESSION will be key, so watch ABCs!"}, {"type": "text", "content": ": 55% normal, 30% with neuro changes. Dependent on cause: 1. Electrolyte disturbances - once corrected, are usually benign and resolves. 2. Meningitis - about 1/3 with abnormal outcome. 3. HIE - poor prognosis; may have severe seizures then electrical silence. Therefore, in a baby with absent brainstem reflexes, stop phenobarb & obtain an EEG."}]}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "type": "h2", "children": [{"type": "text", "content": "Associated with perinatal asphyxia (lack of oxygen &/or lack of perfusion). Diagnosis established only in infants with compatible perinatal history and abnormal neurological exam. Therefore, diagnosis on admission note will be NEONATAL ENCEPHALOPATHY and not birth asphyxia"}, {"type": "text", "content": ": 90% of asphyxia occurs in antepartum/intrapartum period due to placental insufficiency. Risk factors include maternal HTN, vascular disease, diabetes, substance abuse, hypoxia, infection, cord problems."}, {"type": "text", "content": "Genetic/structural defects, drugs, toxins, infection, metabolic disease, trauma, intracranial hemorrhage, electrolyte derangements; HIE is reasonable diagnosis if cord or first pH < 7.0, base deficit > 16, poor respiratory drive at 10 min, encephalopathy, seizure in 1st 24-48 h (although 50% will not be due to asphyxia), burst-suppression on EEG."}, {"type": "text", "content": "Obtain baseline LFT/BMP/RFT on DOL1. Continue to monitor as required based on clinical status."}, {"type": "text", "content": "Assessment: If severe (cord pH <7.0, encephalopathy) determine if therapeutic hypothermia is warranted (see criteria below). Consult RNICU fellow about turning infant warmer off during this period to prevent inadvertent warming"}, {"type": "text", "content": "Resp: Keep saturation levels between 92-98% (to minimize PPHN risk, alsoto prevent hyperoxia that could decrease CBF & increase free radical damage). Keep CO2 ranges within normal (hyperventilation leads to decreased cerebral blood flow and worse outcomes)"}, {"type": "text", "content": "CV: May require pressor agents due to bradycardia, hypotension or poor perfusion"}, {"type": "text", "content": "Metabolic/FEN: Since renal function is often temporarily impaired in HIE, start with a TFI of 50-60 mL/kg/d and adjust daily based on weight changes, urine output and labs. Withhold enteral feedings until off hypothermia. Consider TPN if electrolytes need to be added or if hypoglycemia is severe"}, {"type": "text", "content": "Neuro: If cooling protocol initiated, load with single dose of phenobarbital (range of 20-40 mg/kg single dose, depending on clinical preference). Consider sedation/analgesia with prn versed/morphine if agitated as stress can negate protective effects of hypothermia. Control seizures (if present):"}, {"type": "text", "content": "Load with phenobarbital (20mg/kg x 1 dose), then continue maintenance dose of 5 mg/kg/d (start maintenance 24 hrs AFTER loading dose)."}, {"type": "text", "content": "If refractory, start phenytoin @ 20 mg/kg load & maintenance of 5 g/kg/d (start maintenance 24 hrs AFTER loading dose)."}, {"type": "text", "content": "May need 3rd anti-epileptic agent if still refractory such as lorazepam @ 0.05 mg/kg-0.1 mg/kg"}, {"type": "text", "content": "Consider other underlying causes for seizures"}, {"type": "text", "content": "Consider neurology consult for refractory seizures!"}, {"type": "text", "content": "Cooling protocol (within 6 hrs after birth) for moderate to severe encephalopathy"}, {"type": "text", "content": "Criteria"}, {"type": "text", "content": "EITHER:"}, {"type": "text", "content": "Cord pH or any postnatal blood gas pH <7.0 at <1hr of life"}, {"type": "text", "content": "OR"}, {"type": "text", "content": "Base deficit on cord gas or any postnatal blood gas >16 mEq/L at <1hr of life"}, {"type": "text", "content": "History of an acute perinatal event (abruptio placenta, cord prolapse, severe fetal distress, prolonged resuscitation variable or late decels)."}, {"type": "text", "content": "AND"}, {"type": "text", "content": "An Apgar score <5 at 10 minutes."}, {"type": "text", "content": "OR"}, {"type": "text", "content": "Continued requirement for ventilation initiated at birth and continued for at least 10 minutes."}, {"type": "text", "content": "Once infant meets criteria, proceed to ."}, {"type": "text", "content": "The presence of moderate/severe encephalopathy defined as seizures OR presence of one or more signs in 3/6 of the categories below."}, {"type": "text", "content": "***If patient meets criteria for cooling, refer to cooling protocol attached to cooling machine or ask RT***"}]}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "type": "h2", "children": [{"type": "text", "content": "Retinal disease noted in prematurely born infants, caused by cessation of blood vessel growth during the first month of postnatal life and later-onset abnormal proliferative neovascularization which can lead to retinal scarring, detachment and loss of vision"}, {"type": "text", "content": "Screening by ophthalmology ROP team is usually initiated at 31 weeks\u2019 postmenstrual age or 4 weeks after birth, whichever is later"}, {"type": "text", "content": "Description of ROP"}, {"type": "text", "content": "Zones: Retinal vascularization proceeds from the posterior pole and the retinal area around this contains the macula which is responsible for posterior vision (Zone 1); therefore Zone 1 ROP has a much worse prognosis for visual loss, compared to the more peripheral zones 2 and 3."}, {"type": "text", "content": "Stages: Based on degree of abnormal neovascularization. ROP > stage 3 is considered threshold ROP that requires closer monitoring of disease progression"}, {"type": "text", "content": "Extent: Number of clock hours of retinal area affected by ROP"}, {"type": "text", "content": "Plus disease \u2013 posterior pole venous dilation is considered severe ROP regardless of other findings"}, {"type": "text", "content": "Prevention of ROP is best achieved by maintaining O2 saturations within target ranges to prevent hyperoxia and by optimizing nutrition and weight gain"}, {"type": "text", "content": "Treatment strategies include laser ablation of abnormal blood vessels or intravitreal injection of antibodies against vascular growth factors such as VEGF (bevacizumab), typically done for"}, {"type": "text", "content": "Zone II: Plus disease with stage 2 or 3 ROP"}, {"type": "text", "content": "Zone I: Plus disease with stage 1 or 2 RO"}, {"type": "text", "content": "Zone I: Stage 3 ROP"}]}, {"id": "birth-trauma", "title": "Birth Trauma", "type": "h2", "children": [{"type": "text", "content": "Clavicle fracture: Most commonly injured bone during delivery, +/- crepitus on clavicle exam. Risk factors: shoulder dystocia, macrosomia, breech delivery with arms extended. DDx: Humerus fx or brachial plexus palsy."}, {"type": "text", "content": "Diagnosis: CXR"}, {"type": "text", "content": "If arm movement decreased, cervical spine, brachial plexus and humerus should be assessed"}, {"type": "text", "content": "Management: Supportive, infants sleeve should be pinned to shirt at 90-degree angle to limit movement until callus forms."}, {"type": "text", "content": "Prognosis: Complete healing is expected"}, {"type": "text", "content": "Brachial Plexus Injuries: Caused by excessive traction on the head, neck and arm during birth. Risk factors: macrosomia, shoulder dystocia, malpresentation and instrumented deliveries."}, {"type": "text", "content": "Erb\u2019s Palsy (C5, C6, C7 injury): Extension and pronation at the elbow and flexion of wrist and fingers, \u201cwaiter\u2019s tip\u201d posture. Grasp reflex intact. Moro, biceps and radial reflexes absent. Diaphragm paralysis in 5% of cases."}, {"type": "text", "content": "Klumpke Palsy (C7/C8, T1 injury): Rarest, \u201cclaw hands,\u201d absent grasp reflex, but biceps and radial reflexes present. T1 injury \ud83e\udc6a ipsilateral Horner\u2019s syndrome"}, {"type": "text", "content": "Total brachial plexus injury (C5-T1 injury): Entire arm is flaccid, all reflexes (grasp and sensation) absent. Can also have Horner\u2019s syndrome (ptosis, miosis, anhydrosis)."}, {"type": "text", "content": "Radiographs of shoulder and upper arm should be performed to r/o bony injuries, evaluate for diaphragm paralysis."}, {"type": "text", "content": "supportive, PT, passive ROM exercises to prevent contractures at DOL 7-10."}, {"type": "text", "content": "Full recovery depends on extent of injury. If nerve roots stretched and intact, not avulsed, >90% full recovery expected. EMG and nerve conduction studies can differentiate avulsion from stretch injury."}]}]}, {"id": "hematologic-problems", "title": "HEMATOLOGIC PROBLEMS", "type": "h1", "children": [{"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "type": "h2", "children": [{"type": "text", "content": "Maximum rate of bilirubin increase for normal infants with nonhemolytic hyperbilirubinemia: 5mg/dL/24hr or 0.2mg/dl/hr"}, {"type": "text", "content": "Consider pathologic cause: visible jaundice or total bilirubin concentrations >5mg/dL on first day of life"}, {"type": "text", "content": "Risk factors: Birth weight <2500g, breast feeding, prematurity"}, {"type": "text", "content": "Evaluation:"}, {"type": "text", "content": "Maternal prenatal testing: ABO and Rh (D) typing and serum screen for isoimmune antibodies"}, {"type": "text", "content": "Infant or cord blood: blood smear, direct Coombs test, blood and Rh typing, Hct, retic count"}, {"type": "text", "content": "Management:"}, {"type": "text", "content": "Phototherapy (PTx): traditionally treated based on the \u201clight level\u201d &/or AAP recommendations (see graphs below)."}, {"type": "text", "content": "Initiate PTx earlier if evidence of ABO/other incompatibility or concerns for hemolysis"}, {"type": "text", "content": "PTx is contraindicated if baby has direct hyperbilirubinemia"}, {"type": "text", "content": "Check TB at least q24 while baby is on PTx (more if concerns for exchange Tx or hemolysis)"}, {"type": "text", "content": "Should produce a decrease in total bili level of 1-2mg/dL within 4-6 hrs"}, {"type": "text", "content": "Phototherapy (By weight)"}, {"type": "text", "content": "AAP Guidelines for phototherapy in infants of 35 or more weeks\u2019 gestation (PEDIATRICS Vol. 114 No. 1 July 2004, pp. 297-316)"}, {"type": "text", "content": "PHOTOTHERAPY (>35WKS)"}, {"type": "text", "content": "Neonatology: Management, procedures, on-call problems, diseases, and drugs 5th Ed. Gomella et al."}, {"type": "text", "content": "AAP Guidelines for exchange transfusion in infants of 35 or more weeks\u2019 gestation (PEDIATRICS Vol. 114 No. 1 July 2004, pp. 297-316"}]}, {"id": "anemia", "title": "Anemia", "type": "h2", "children": [{"type": "text", "content": "Typically defined as Hct < 35 in term infants during the first week of life, < 30 for all other infants; lower levels of Hb are often tolerated especially in former ELBW infants without significant respiratory/oxygenation needs"}, {"type": "text", "content": "Anemia of prematurity"}, {"type": "text", "content": "In the NICU this is typically noted in infants < 1000 g BW as a gradual decline in Hct to a low of around 22-24 at around 4-8 weeks of life"}, {"type": "text", "content": "Caused by excessive EPO deficiency, shorter RBC lifespan. However routine EPO administration is not currently recommended due to lack of significant impact on long-term outcomes"}, {"type": "text", "content": "Risk increased by and decreased by 30 -60 s of delayed umbilical cord clamping at birth (can also significantly decrease NEC, IVH risk)"}, {"type": "text", "content": "Other causes of anemia in newborns and infants"}]}, {"id": "polycythemia", "title": "Polycythemia", "type": "h2", "children": [{"type": "text", "content": "Defined as venous hct > 60, though typically no treatment is required unless Hct > 65 and symptomatic, or > 70."}, {"type": "text", "content": "Samples should be from free-flowing venous blood; capillary values should be confirmed with venous testing"}, {"type": "text", "content": "Causes of polycythemia include TTTS, uteroplacental insufficiency and SGA, IDM, hyperthyroidism, CAH, and syndromes such as Down\u2019s, Beckwith-Wiedemann syndrome"}, {"type": "text", "content": "Symptoms due to polycythemia are caused by hyperviscosity of the blood"}, {"type": "text", "content": "Lethargy, poor feeding"}, {"type": "text", "content": "Hypoglycemia"}, {"type": "text", "content": "Seizures (venous sinus thrombosis)"}, {"type": "text", "content": "PPHN"}, {"type": "text", "content": "Hematuria (RVT)"}, {"type": "text", "content": "Hyperbilirubinemia"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Supportive, hydration with saline boluses as needed"}, {"type": "text", "content": "Rarely partial exchange transfusion"}, {"type": "text", "content": "Volume required = Hct (obs) \u2013 Hct (des) / Hct (obs)  x wt (kg) x 80 mL/kg"}]}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "type": "h2", "children": [{"type": "text", "content": "Defined as PLT < 150,000/\u00b5L, though often considered severe and requiring PLT transfusions only when <50,000 and signs of bleeding diathesis or < 30,000 without symptoms"}, {"type": "text", "content": "Early onset (< 72 hours)"}, {"type": "text", "content": "Ill-appearing: Sepsis, TORCH, DIC associated with HIE"}, {"type": "text", "content": "Well-appearing: Placental insufficiency (usually due to maternal preeclampsia/PIH-induced hypoxia, PLT generally expected to rise to normal by 7-10 days after birth), autoimmune or neonatal alloimmune thrombocytopenia, genetic disorders"}, {"type": "text", "content": "Late onset (>72 hours)"}, {"type": "text", "content": "Ill-appearing: Sepsis (consumption increased disproportionately compared to PLT production), NEC, IEM"}, {"type": "text", "content": "Well-appearing: drug-induced, Fanconi\u2019s anemia, thrombosis"}, {"type": "text", "content": "PLT < 50,000 are typically associated with causes such as DIC, sepsis and immune-mediated thrombocytopenia"}, {"type": "text", "content": "Note: Lab errors/PLT clumping is a frequent cause for low PLT in the NICU; consider repeating PLT if this is considered likely"}, {"type": "text", "content": "Autoimmune thrombocytopenia is caused by maternal antibodies against her own PLT antigens (from ITP or other immune processes) that are acquired transplacentally by the infant; should improve over time with decrease in acquired antibody titers. Can be treated with IVIG (1 g/kg for up to 2 consecutive days) if PLT count severely low or fails to improve"}, {"type": "text", "content": "Alloimmune thrombocytopenia (NAIT) is caused by transplacentally acquired of maternal antibodies against paternal antigens on fetal platelets (most commonly HPA 1a)"}, {"type": "text", "content": "Normal maternal PLT"}, {"type": "text", "content": "Increased risk for parenchymal as well as intracranial hemorrhage"}, {"type": "text", "content": "Diagnosis: MPV (generally small PLT indicate failure of production, large PLT indicates consumptive causes, though some genetic syndromes can be associated with large PLT). Follow PLT frequently and perform other tests as required, including"}, {"type": "text", "content": "Sepsis w/u"}, {"type": "text", "content": "TORCH labs"}, {"type": "text", "content": "LFTs and other w/u for DIC"}, {"type": "text", "content": "PLT antigen screening for infant, mother (and father if NAIT is suspected)"}, {"type": "text", "content": "based on cause(s) considered likely"}, {"type": "text", "content": "Head US should be obtained to look for signs of hemorrhage irrespective of the neurological status, if severe thrombocytopenia and/or NAIT suspected"}, {"type": "text", "content": "Management of neonate with suspected NAIT in an unknown pregnancy"}, {"type": "text", "content": "Random donor platelet transfusions (with platelet count <30k if baby stable and <100k if evidence of IVH), IVIG x 2days"}, {"type": "text", "content": "Management of neonate with known NAIT"}, {"type": "text", "content": "neonate born to a mother with previous pregnancy affected by confirmed NAIT, genotypically matched platelets (e.g. HPA-1b1b) should be arranged with blood bank."}]}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "type": "h2", "children": [{"type": "text", "content": "Can present as"}, {"type": "text", "content": "Early: < 24 h; due to maternal use of anticonvulsants, warfarin etc.; typically scalp, subdural, intraventricular, intra-abdominal bleeding"}, {"type": "text", "content": "Classical: 1-7 days; idiopathic; GI, umbilical, skin (ecchymosis), circumcision sites"}, {"type": "text", "content": "Late: >7 days, due to exclusive breastfeeding without supplemental Vit K, prolonged antibiotic therapy, malabsorption syndromes; intracranial, GI, skin bleeds"}, {"type": "text", "content": "Prolonged PT/aPTT; otherwise normal coagulation studies"}, {"type": "text", "content": "Prevention: IM Vit K at birth; oral doses not effective over the long-term"}, {"type": "text", "content": "Management: FFP for active bleeding, Vit K (slow IV infusion)"}]}, {"id": "hemophilia", "title": "Hemophilia", "type": "h2", "children": [{"type": "text", "content": "Iatrogenic bleeding from circumcision, intracranial hemorrhage, subgaleal bleeds"}, {"type": "text", "content": "Prolonged aPTT"}, {"type": "text", "content": "Rx \u2013 FFP, recombinant F VIII after confirmation of diagnosis"}]}, {"id": "disseminated-intravascular-coagulation", "title": "Disseminated intravascular coagulation", "type": "h2", "children": [{"type": "text", "content": "Systemic activation of coagulation/fibrinolysis, platelet consumption, generation of fibrin clots \ud83e\udc6a ischemia \ud83e\udc6a organ failure"}, {"type": "text", "content": "Diagnosis is based on compatible clinical signs and labs such as prolonged PT/aPTT/TT; elevated d-dimers, decreased fibrinogen as well as PLT"}, {"type": "text", "content": "Management: FFP, Cryoprecipitate, PLT transfusions; supportive management; correction of underlying cause"}]}, {"id": "thrombosis", "title": "Thrombosis", "type": "h2", "children": [{"type": "text", "content": "Most commonly secondary to an indwelling vascular catheter"}, {"type": "text", "content": "Diagnosis: clinical signs + doppler US of affected areas"}, {"type": "text", "content": "Management: Careful consideration should be given to initiation of anticoagulants (typically unfractionated heparin) especially in preterm infants."}]}]}, {"id": "endocrine-and-metabolic-problems", "title": "ENDOCRINE AND METABOLIC PROBLEMS", "type": "h1", "children": [{"id": "hypoglycemia", "title": "Hypoglycemia", "type": "h2", "children": [{"type": "text", "content": "Usually defined as plasma glucose < 60 mg/dL in POC plasma glucose measurements in term infants though preterm and ELBW infants typically are asymptomatic with BG values > 45 mg/dL"}, {"type": "text", "content": "Common causes of transient hypoglycemia in newborns include SGA/IUGR and LGA including IDM, sepsis, maternal use of \u03b2-blockers"}, {"type": "text", "content": "Persistent hypoglycemia (especially after treatment measures such as glucagon, steroids etc.) is mostly due to genetic causes of hyperinsulinism, endocrine causes such as CAH, GH deficiency etc. or IEMs such as glycogen storage disorders, galactosemia etc."}, {"type": "text", "content": "Common symptoms and signs are nonspecific -  abnormal cry, decreased feeding, jitteriness, irritability, pallor, cyanosis, hypothermia, lethargy, tachypnea, hemodynamic instability, apnea, seizures, or even cardiac arrest."}, {"type": "text", "content": "Prevention"}, {"type": "text", "content": "If on IVF/TPN, maintaining a GIR  between 3-6 mg/kg/min can prevent hypoglycemia in most infants"}, {"type": "text", "content": "If on enteral feeds of breast milk, consider starting/increasing fortification of feeds. If on formula feeds consider increasing caloric density"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Acute hypoglycemic episode: 2 mL/kg of 10% dextrose, followed by continuous dextrose infusion to achieve euglycemia"}, {"type": "text", "content": "If  a GIR > 8-10 mg/kg/min has been required to achieve euglycemia for more than 24-48 hours, consider obtaining an endocrine consult (hyperinsulinemia typically requires GIR > 15 mg/kg/min)"}, {"type": "text", "content": "Administering IV fluids with dextrose concentration > 12.5% requires a central venous catheter"}, {"type": "text", "content": "Pharmacologic management: Glucocorticoids such as dexamethasone or hydrocortisone, glucagon (typically as a continuous infusion),  GH, diazoxide \u00b1 chlorothiazide, octreotide (risk of NEC in preterm infants),"}, {"type": "text", "content": "Further laboratory evaluation may include"}, {"type": "text", "content": "\u201cCritical labs\u201d for persistent hypoglycemia: S.electrolytes, insulin, plasma ketones and FFAs, S. cortisol, GH and lactate measurements"}, {"type": "text", "content": "Evaluation for IEMs: S. amino acids, Urine OAs, NH3 levels"}]}, {"id": "hyperglycemia", "title": "Hyperglycemia", "type": "h2", "children": [{"type": "text", "content": "Generally defined as PG > 125 mg/dL in term infants and as PG > 200 mg/dL in preterm, though ELBW infants typically do not need management unless PG > 200 mg/dL consistently for > 2 checks 1-3 hours apart"}, {"type": "text", "content": "Term infants develop hyperglycemia less frequently compared to preterm infants"}, {"type": "text", "content": "Causes of hyperglycemia include"}, {"type": "text", "content": "Critical illness"}, {"type": "text", "content": "Infection"}, {"type": "text", "content": "Excessive parenteral glucose administration"}, {"type": "text", "content": "Inadequate insulin release, typically due to lack of enteral feeds"}, {"type": "text", "content": "Neonatal Diabetes mellitus: typically noted in severely SGA babies (Insulin is the major growth factor during in-utero life"}, {"type": "text", "content": "Most infants with hyperglycemia do not develop polyuria even in the presence of glycosuria, therefore symptoms such as dehydration, weight loss, poor perfusion, are not frequently noticed"}, {"type": "text", "content": "However, these infants frequently develop electrolyte disturbances such as hyponatremia, hypokalemia, metabolic acidosis"}, {"type": "text", "content": "Long-term implications also include ROP, white matter injury, PVL etc."}, {"type": "text", "content": "Management/Prevention"}, {"type": "text", "content": "Limit GIR in TPN/IVF: Can go as low as 2-3 mg/kg/min if needed"}, {"type": "text", "content": "Limiting IV lipid infusions"}, {"type": "text", "content": "Early and increased amino acids in TPN/IVF"}, {"type": "text", "content": "Early initiation and continued progression of enteral feeds"}, {"type": "text", "content": "If all such measures fail to control hyperglycemia then can initiate insulin infusion"}, {"type": "text", "content": "If hyperglycemia remains persistent for > 5 \u2013 7 days, initiate an endocrine consult for possible neonatal DM"}]}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "type": "h2", "children": [{"type": "text", "content": "Reduction of bone mineral content, also known as metabolic bone disease (MBD) of prematurity"}, {"type": "text", "content": "Premature birth interrupting accretion of Ca and P by the fetus during the 3rd trimester is the most important cause of MBD"}, {"type": "text", "content": "Both parenteral and enteral nutrition with unfortified breast milk are unable to meet the Ca and P demands of the growing premature infant"}, {"type": "text", "content": "Additional causes include poor absorption of nutrients due to NEC/immature bowel function as well as use of medications such as caffeine, diuretics and steroids which can induce osteolysis"}, {"type": "text", "content": "Screening for MBD should be carried out around 4 \u2013 6 weeks of age for all VLBW infants, especially those with prolonged/frequent interruptions of enteral feedings and in those with incidental findings of fractures on x-rays"}, {"type": "text", "content": "Biomarkers such as decreased serum P levels (< 5 mg/dL)  and elevated serum ALP levels (> 800 IU/L) should prompt"}, {"type": "text", "content": "X-rays of the wrist and/or knee"}, {"type": "text", "content": "Other imaging modalities such as CT/DEXA can provide better visualization but are typically not required to make the diagnosis"}, {"type": "text", "content": "Management of established MBD"}, {"type": "text", "content": "Supplemental Ca as calcium gluconate or glubionate supplements (20 \u2013 30 mg/kg/day in addition to Ca supplied through enteral nutrition)"}, {"type": "text", "content": "Supplemental P (20 to 40 mg/kg/day of elemental P, as KPhos)"}, {"type": "text", "content": "Vitamin D (up to 800 IU/day)"}]}, {"id": "cah", "title": "CAH", "type": "h2", "children": [{"type": "text", "content": "The most common DSD presenting in the neonatal period is a 46,XX infant with CAH."}, {"type": "text", "content": "Most common form of CAH (>90%) is caused by deficiency of 21-hydroxylase (all state newborn screening programs include screening for 21-OHase deficiency)."}, {"type": "text", "content": "Rare forms of CAH are caused by 11-OHase deficiency, 3B-HSD deficiency"}, {"type": "text", "content": "In an infant suspected of 21-OHase deficiency, treatment (Hydrocortisone and Fludrocortisone) should be started as soon as the laboratory tests mentioned have been obtained."}, {"type": "text", "content": "Consult the endocrinology team to guide you for hormone replacement therapy."}]}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "type": "h2", "children": [{"type": "text", "content": "Bilateral cryptorchidism at birth occurs in 3:1,000 infants, most of whom are premature."}, {"type": "text", "content": "Ultrasonography or MRI (look for inguinal or intra-abdominal testes). If testicular tissue cannot be found on exam/imaging, levels of serum FHS, LH, testosterone, and anti-mullerian hormone (AMH) should be measured (elevated serum gonadotropins with low testosterone suggests absent or non-functioning testes, undetectable AMH indicates bilateral anorchia)."}, {"type": "text", "content": "Urologist should be consulted. If surgery is indicated, orchiopexy should be performed by 1 year of age. If the intra-abdominal testes cannot be brought into the scrotum, removal should be considered (3- to 10-fold increased risk of malignancy)."}, {"type": "text", "content": "Endocrinology consult (hormone replacement therapy)."}, {"type": "text", "content": "Evaluation for disorder of sex development should be done if any of the following:"}, {"type": "text", "content": "Unilateral cryptorchidism with hypospadias (perineo-scrotal or penile hypospadias)"}, {"type": "text", "content": "Unilateral cryptorchidism with microphallus"}]}]}, {"id": "nas-iem-and-genetic-problems", "title": "NAS, IEM and GENETIC PROBLEMS", "type": "h1", "children": [{"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "type": "h2", "children": [{"type": "text", "content": "Neonates with IEMs are usually healthy at birth with symptoms typically developing in hours to days after birth. The symptoms are usually nonspecific: decreased activity, lethargy, poor feeding, vomiting, respiratory distress, or seizures."}, {"type": "text", "content": "When a newborn presents with this clinical picture, think about: SEPSIS, SEPSIS \u2014> Duct dependent congenital heart disease \u2014> IEMs."}, {"type": "text", "content": "Maintaining a high index of suspicion is important for early diagnosis and the institution of appropriate therapy, which is mandatory to prevent death and ameliorate complications from many IEMs."}, {"type": "text", "content": "Initial evaluation"}, {"type": "text", "content": "Family history:  miscarriages, stillborn, neonatal deaths (vast majority of IEMs are autosomal recessive, OCT deficiency is X-linked),"}, {"type": "text", "content": "Careful physical examination"}, {"type": "text", "content": "Laboratory studies (CBC with differential, serum glucose, electrolytes, blood gas, LFTs, coagulation profile, plasma ammonia, plasma lactate, plasma amino acids, plasma carnitine and acylcarnitine profile, urine reducing substances, urine pH, urine ketones, urine organic acids)"}, {"type": "text", "content": "Management"}, {"type": "text", "content": "Decrease production of the toxic intermediate (hold enteral feeds for 24-48 hours, IV glucose, provide adequate caloric intake to promote anabolism, provide adequate hydration, correct hypoglycemia)"}, {"type": "text", "content": "Elimination of toxic metabolites (IV hydration, use medications to create alternate pathways such as carnitine for organic acidemias, sodium benzoate for glycine encephalopathy and urea cycle defects, hemodialysis/hemofiltration)"}, {"type": "text", "content": "Correction of metabolic acidosis"}, {"type": "text", "content": "Correction of hypoglycemia"}, {"type": "text", "content": "Cofactor supplementation (vitamin-responsive enzyme deficiencies)"}, {"type": "text", "content": "Contact the metabolic team any time the clinical and lab findings suggest an IEMs."}, {"type": "text", "content": "blue diaper syndrome (abnormal tryptophan transport )."}]}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "type": "h2", "children": [{"type": "text", "content": "Trisomy 21: AV canal defect, VSD"}, {"type": "text", "content": "Trisomy 13, 18: VSD"}, {"type": "text", "content": "Turner: Bicuspid aortic valve (most common), coarctation of aorta"}, {"type": "text", "content": "Noonan: Pulmonary stenosis (vulvar), ASD, hypertrophic CM"}, {"type": "text", "content": "Holt-Oram: ASD or VSD"}, {"type": "text", "content": "Alagille: Peripheral pulmonic stenosis"}, {"type": "text", "content": "DiGeorge: Conotruncal malformations (Truncus, TOF)"}, {"type": "text", "content": "Williams: Supravalvar aortic stenosis"}, {"type": "text", "content": "VACTERL: VSD"}, {"type": "text", "content": "CHARGE: Conotruncal malformations (Truncus, TOF, DORV)"}]}, {"id": "congenital-renal-syndromes", "title": "Congenital Renal Syndromes", "type": "h2", "children": []}, {"id": "nonimmune-hydrops", "title": "Nonimmune hydrops", "type": "h2", "children": []}]}, {"id": "procedures", "title": "PROCEDURES", "type": "h1", "children": [{"id": "umbilical-lines", "title": "Umbilical Lines", "type": "h2", "children": [{"id": "uac-placement", "title": "UAC Placement", "type": "h3", "children": [{"type": "text", "content": "For any procedure, always obtain consent from mother. The father may give consent only if parents are legally married. For emergency situations or if the mother is unavailable (e.g. under general anesthesia), you may do a 2-physician consent."}, {"type": "text", "content": "Nurses or CNAs will help set up tray for you with all equipment necessary."}, {"type": "text", "content": "Need full sterile attire\u2014hat, mask, gloves, and gown."}, {"type": "text", "content": "Sizes: \tSingle lumen 3.5 Fr for preemies < 2kg"}, {"type": "text", "content": "Single lumen 5.0 Fr for larger babies"}, {"type": "text", "content": "UAC length (cm) = [weight(kg) x 3] + 9"}, {"type": "text", "content": "Order long chest film to check placement."}, {"type": "text", "content": "Normal UAC T7-T10 (above Celiac trunk)."}, {"type": "text", "content": "Low Lying L3-L5."}, {"type": "text", "content": "Fluids: Heparin to run at 0.5 mL/hr. Best to order with admit orders."}, {"type": "text", "content": "(for golden week preemies use \u00bc sodium acetate with heparin rather than \u00bc NaCl for art line fluids)"}, {"type": "text", "content": "Never advance your catheter once sterile field has been broken. Be sure to wash off betadine after procedure to prevent burns and hypothyroidism."}]}, {"id": "uvc-placement", "title": "UVC Placement", "type": "h3", "children": [{"type": "text", "content": "Sizes: Double lumen 3.5 Fr for premies < 1.5kg, Double lumen 5.0 Fr for larger babies, UVC length (cm) = 1/2 UAC insertion + 1cm"}, {"type": "text", "content": "Tip: If resistance is encountered or the catheter is \u201cbouncing\u201d, or there is no blood return from both ports, the catheter may be in the liver. If unable to advance fully after several attempts:"}, {"type": "text", "content": "Leave that catheter in place & introduce another catheter of same size from the patient\u2019s left side of previous catheter & attempt to pass it to desired length."}, {"type": "text", "content": "Attempt to flush the catheter as you advance with gentle twisting motion."}, {"type": "text", "content": "Apply gentle pressure to the liver directed medial-cephalad while advancing"}, {"type": "text", "content": "Order long chest film to check placement."}, {"type": "text", "content": "Position: Junction of IVC and RA above Liver"}, {"type": "text", "content": "If unable to position here, pull back so tip is proximal or well below liver (low UVC) \u2013 use only as temporary access! Get PICC placed."}]}, {"type": "text", "content": "Removing Umbilical Catheters"}, {"type": "text", "content": "Keep fluids running. Use 18-gauge needle to cautiously cut the anchor from the umbilical stump. Remove the catheter slowly, a few centimeters at a time to allow the vessel to spasm and prevent bleeding. After complete removal, hold c"}, {"type": "text", "content": "continuous pressure for several minutes with gauze. Interns may remove lines under supervision from residents."}, {"type": "text", "content": "**Catheters are to be removed during the day when help is available. If they are to be removed at night, the fellow needs to be present at the bedside during procedure."}]}, {"id": "intubation", "title": "Intubation", "type": "h2", "children": [{"type": "text", "content": "Tips: Proper preparation prevents poor performance. Master bag-and-mask ventilation first before attempting to intubate. YouTube videos are a helpful resource. Make sure you are comfortable with the positioning of the infant and that the staff are ready before you attempt. Residents/Interns must be supervised by a fellow or attending."}, {"type": "text", "content": "Equipment Necessary: laryngoscopes, ET tubes of various sizes, end tidal CO2 detector, suction, tape, scissors, meconium aspirator, stethoscope, bag/mask"}, {"type": "text", "content": "ETT sizes"}, {"type": "text", "content": "Place in sniffing position, do not hyperextend -- will place cords too anterior"}, {"type": "text", "content": "Stop attempt after 20-30 seconds if bradycardia or hypoxia develops & return to bag/mask ventilation."}, {"type": "text", "content": "Hold scope in left hand, pass into right side of pt\u2019s mouth, sweep towards midline moving tongue out of way."}, {"type": "text", "content": "Advance to vallecula & lift upward with scope (DO NOT USE ROCKING MOTION)."}, {"type": "text", "content": "Once you visualize cords, take ETT in right hand while continuing to visualize the cords"}, {"type": "text", "content": "Insert until black marks on ETT rest at the cords."}, {"type": "text", "content": "May want to ask for cricoid pressure to help with visualization. Assistant may feel tube slide underneath fingers."}, {"type": "text", "content": "Signs that you are in the trachea: improving HR and oxygen saturations; change in color of end tidal CO2 detector from purple to yellow, misting in the ETT; equal breath sounds on auscultation."}, {"type": "text", "content": "Note: If a patient is asystolic or severely bradycardic, the end tidal CO2 detector might not change color since there\u2019s no effective cardiac output to allow exhalation of CO2. If decreased breath sounds on the left, may be right main stem intubation and you will need to adjust ETT depth."}, {"type": "text", "content": "Confirm placement with a CXR (ideal position is mid trachea at T1-T2)."}]}, {"id": "suprapubic-bladder-aspiration-(spu)", "title": "Suprapubic Bladder Aspiration (SPU)", "type": "h2", "children": [{"type": "text", "content": "Consider using bedside ultrasound to check for urine in bladder first."}, {"type": "text", "content": "Ask nurse when was most recent wet diaper; must have been over one hour to have enough volume."}, {"type": "text", "content": "Prep with betadine. Wear sterile gloves. Use 3 or 5 mL syringe attached to 22 or 23 gauge needle, palpate pubic bone, start in midline about 1.5cm above bone. Advance perpendicular to skin (with confidence) with steady pressure while aspirating on the syringe until urine starts to fill the syringe."}]}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "type": "h2", "children": [{"type": "text", "content": "Consent!"}, {"type": "text", "content": "Ask RN/CNA to set up tray (if unavailable, get tray, betadine, sterile water, entire bottle of alcohol, extra 22G 1 \u00bd\u201d myelinated needles, & sterile gloves)."}, {"type": "text", "content": "May choose either lateral decubitus position or sitting upright with straight legs."}, {"type": "text", "content": "Prep with betadine, drape under pt & around site, instruct assistant to hold pt firmly over shoulders & buttocks & get lower spine as curved as possible."}, {"type": "text", "content": "With pt\u2019s spine as parallel to table as possible, introduce needle midline between 4th & 5th lumbar processes (locate by palpating the iliac crests \u2013 can use level at iliac crests or below/inferior). Advance slowly toward umbilicus & withdraw stylette frequently, looking for spinal fluid. Hopefully you feel a pop as you enter space."}, {"type": "text", "content": "Obtain 1 mL per tube & consider necessity of extra fluid for HSV PCR. May obtain less fluid for preemies (6-10 drops per bottle)."}, {"type": "text", "content": "Remember to clean away excess betadine post procedure."}]}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "type": "h2", "children": [{"type": "text", "content": "If emergent, may forego consent."}, {"type": "text", "content": "Diagnosis- respiratory distress, falling HR, decreasing BP, cyanosis, chest asymmetry (expansion of affected side), increasing frequency of A/B\u2019s, decreased breath sounds on affected side."}, {"type": "text", "content": "Evaluation - Transillumination- may be hard to tell if baby is edematous or has severe PIE. CXR with hyperlucent hemithorax, flat diaphragm, mediastinal shift;"}, {"type": "text", "content": "Materials: 22-gauge needle or butterfly, 3-way stopcock, 20 mL syringe"}, {"type": "text", "content": "Treatment - Immediate needle aspiration is needed if signs of tension pneumothorax. While the patient is supine, use a gauge 22 needle and insert perpendicularly into the 2nd intercostal space, mid-clavicular line. You will hear air come out of the syringe or if you have an assistant applying negative pressure, air will be aspirated. Use the stopcock to direct flow of air: aspirate out of the chest then release through the other port. You should see immediate clinical improvement. Once done, remove needle and place dressing."}, {"type": "text", "content": "Fellow will perform needle decompression or CT placement."}, {"type": "text", "content": "Chest tube placement is typically in the 4th or 5th intercostal space, anterior axillary line."}, {"type": "text", "content": "Note: If a pneumothorax is not in tension and baby is asymptomatic, observation may be done with close monitoring of oxygen requirement and transcutaneous CO2."}]}]}, {"id": "medications", "title": "MEDICATIONS", "type": "h1", "children": [], "medications": [{"drug": "Acetaminophen", "dose": "10-15 mg/kg  q4-6hr prn (max 5 doses/day)\n15 mg/kg q6hr x 3-7 days", "remarks": "32 mg/mL liquid\nPDA Closure"}, {"drug": "Acyclovir", "dose": "20 mg/kg IV q8hr", "remarks": ""}, {"drug": "Adenosine", "dose": "0.1-0.2 mg/kg/dose IV PUSH", "remarks": "May increase by 0.05 mg/kg q2min (up to 5x) until SVT converts to sinus rhythm"}, {"drug": "Albumin", "dose": "0.5-1 gram/kg/dose", "remarks": "MAX 4 gram/kg/dose"}, {"drug": "Alprostadil (PGEs)", "dose": "0.025-0.2 mcg/kg/min", "remarks": "MAX conc. 2 mg/100 mL\nWatch for apnea; Compatible with heparin"}, {"drug": "Amoxicillin", "dose": "10-25 mg/kg q24hr", "remarks": "UTI prophylaxis"}, {"drug": "Amphotericin B", "dose": "1 mg/kg/dose IV q24hr", "remarks": "Precipitates in NS; USE D5W & flush\nMonitor UOP, CBC, SCr"}, {"drug": "Ampicillin", "dose": "", "remarks": "Use higher end of dose for GBS and meningitis dosing"}, {"drug": "Azithromycin", "dose": "20 mg/kg q24hr x3 day or 10mg/kg q24hr x10 day IV/PO", "remarks": "For Ureaplasma"}, {"drug": "Baclofen", "dose": "10 \u2013 40 mg/DAY div. q8hr", "remarks": "MAX 40mg/day"}, {"drug": "Bosentan", "dose": "0.5-1 mg/kg q12hr x 4wks\n1-2 mg/kg q12", "remarks": ""}, {"drug": "Ca Carbonate", "dose": "50-150 mg(elemental)/kg/DAY div in 3-4 doses", "remarks": "MAX 1000 mg/24hr"}, {"drug": "Ca Gluconate", "dose": "100-200 mg/kg IV \u2013 repeat every 6hr as needed", "remarks": "VERY Caustic; do NOT give arterially\nWatch extravasation & bradycardia"}, {"drug": "Caffeine citrate", "dose": "LD: 20-80 mg/kg x 1 dose\nMD: 5-25 mg/kg PO/IV q24hr", "remarks": "MAX 25 mg/kg/24hr MD \nIV infuse over 30 min"}, {"drug": "Cefdinir", "dose": "14 mg/kg/day divided q12hr or q24", "remarks": ""}, {"drug": "Cefepime", "dose": "", "remarks": "RENAL adjustments needed"}, {"drug": "Ceftazidime", "dose": "", "remarks": "RENAL adjustments needed"}, {"drug": "Chlorothiazide", "dose": "PO: 10-20 mg/kg q12hr\nIV: 1-4 mg/kg q12hr", "remarks": "Caution \u2013 renal/liver dys fxn\nMAX 10 mg/kg"}, {"drug": "Clindamycin", "dose": "", "remarks": "For Mycoplasma x 10 days\n\nAnaerobic coverage for GI perforation"}, {"drug": "Cromolyn", "dose": "20mg neb q12hr-q6hr", "remarks": ""}, {"drug": "Dexamethasone", "dose": "Extubation: 0.25-0.5 mg/kg IV/PO q8hr x 3", "remarks": "MAX 1.5 mg/kg/24hr\n\n\u201cNeonatology Steriods\u201d Power Plan pre-built IV vs PO doses & days"}, {"drug": "Diazepam", "dose": "0.12-0.8 mg/kg/DAY PO div q6-8hr", "remarks": "FOR sedation"}, {"drug": "Dobutamine / Dopamine", "dose": "2-20 mcg/kg/min IV", "remarks": "DOPAmine 400 mg/250 mL D5W in OmniCell"}, {"drug": "Doxapram", "dose": "LD: 2.5-3 mg/kg IV over 30 min\nMD: 1-2.5 mg/kg/hr IV", "remarks": "Make infusion [C] 1 OR 2 mg/mL"}, {"drug": "Enalapril", "dose": "0.04-0.1 mg/kg q24hr (titrate to effect)", "remarks": "MAX 0.94 mg/kg/24hr"}, {"drug": "Enoxaparin", "dose": "Prophylaxis: 0.75 mg/kg q12\nPreemie treatment: 2 mg/kg12q\nTerm treatment: 1.7 mg/kg q12hr", "remarks": "Titrate based on anti-Xa drawn 4 hours after dose"}, {"drug": "Epinephrine", "dose": "IV: 0.01-0.03 mg/kg q3-5 min\nETT: 0.05-0.1 mg/kg q3-5 min\nContinuous: 0.1-1 mcg/kg/min", "remarks": "For HR < 60bpm"}, {"drug": "Erythromycin", "dose": "Low: 1.5-2.5 mg/kg PO q6hr \nHigh: 10-12.5 mg/kg PO q6-8hr", "remarks": "Prokinetic dosing\nHigh dose for PNA >14d"}, {"drug": "Famotidine", "dose": "<3 months: 0.5-1 mg/kg daily\n>3 months: 0.5-1 mg/kg BID", "remarks": "Max 40 mg/dose"}, {"drug": "Fentanyl", "dose": "Interval: 1-4 mcg/kg IV q2-4hr\nContinuous: 0.5-3 mcg/kg/hr\nAnesthesia: 0.1-1 mcg/kg/min", "remarks": "Tolerance builds quickly\nTitrate to effect"}, {"drug": "Fluconazole", "dose": "Treatment: 12 mg/kg IV/PO q24hr\nProphylaxis: 3 mg/kg IV/PO qM/Th x 6 wks", "remarks": "Infuse over 2 hrs\nInfuse over 1 hr"}, {"drug": "Furosemide", "dose": "1-2 mg/kg IV or 1-6 mg/kg PO", "remarks": "Long term= renal calcifications"}, {"drug": "Gabapentin", "dose": "10-15 mg/kg/DAY divided TID", "remarks": "Up to 50 mg/kg/DAY"}, {"drug": "Ganciclovir", "dose": "6 mg/kg IV q12 hr", "remarks": ""}, {"drug": "Gentamicin / Tobramycin", "dose": "", "remarks": "Levels with 4th TOTAL dose\n\nTherapeutic range:\nPeak 4-8 mcg/mL\nTrough: 0.5-1.2 mcg/mL\n\nCorrect GA up to 25 wks (ie 24.2 DOL8 = 25 wks for LD/MD)"}, {"drug": "Glycopyrrolate", "dose": "IV: 4-10 mcg/kg q3-4hr\nPO: 20-100 mcg/kg 3-4 times per day", "remarks": ""}, {"drug": "Heparin", "dose": "LD: 75 units/kg over 10 minutes\nInitial MD: 28 units/kg/hr", "remarks": "Titrate dose based on Anti-Xa\nBolus doses out of bag"}, {"drug": "Hydrocortisone", "dose": "Refractory hypotension: 1mg/kg IV q8hr\n BPD:2.5-10 mg/kg/DAY IV/PO div  q6-8hr", "remarks": ""}, {"drug": "Ibuprofen", "dose": "", "remarks": ""}, {"drug": "(IVIG)", "dose": "400-1000 mg/kg IV q24hr for 2-5 days", "remarks": ""}, {"drug": "DRUG", "dose": "DOSE", "remarks": "REMARKS"}, {"drug": "Indomethacin", "dose": "IVH: 0.1 mg/kg once\nPDA:0.2 mg/kg x 1 dose followed by:", "remarks": "PDA: interval ext to q24hr for\nUOP 0.6-1 mL/kg/hr\nUOP < 0.6 mL/kg/hr NOT used"}, {"drug": "Insulin, Regular", "dose": "Intermittent: 0.1-0.2 units/kg SQ q6-12hr\nContinuous: 0.01-0.1 units/kg/hr", "remarks": "[C] #units / 100 mL D5W or \u00bdNS"}, {"drug": "Ketamine", "dose": "IV: 0.5 \u2013 2 mg/kg x 1 dose\nIM: 3-7mg/kg x 1 dose", "remarks": "Anesthesia for procedure"}, {"drug": "KCl", "dose": "1-2 mEq/kg IV/PO up to q4hr\n2-6 mEq/kg/day continuous infusion", "remarks": "1-4 mEq PO loaded in ADC"}, {"drug": "Lactobacillus", "dose": "0.5 pack q8-24hr", "remarks": ""}, {"drug": "Levetiracetam", "dose": "5-15 mg/kg BID", "remarks": "Up to 60 mg/kg/DAY IV or PO"}, {"drug": "Levothyroxine", "dose": "<3 months: 10-15 mcg/kg daily\n4-6 months: 8-10 mcg/kg daily\n7-12 months: 6-8 mcg/kg daily", "remarks": "Round dose to nearest 6.25 mcg"}, {"drug": "Lorazepam", "dose": "", "remarks": ""}, {"drug": "Meropenem", "dose": "", "remarks": "Requires a UAB Infectious Disease MD approval for use"}, {"drug": "Methadone", "dose": "0.05-0.2 mg/kg q12-24hr\n0.5 mg/kg/DAY div q8hr", "remarks": "Titrate to control withdrawal symptoms"}, {"drug": "Methylpred", "dose": "1 mg/kg IV q6-12hr", "remarks": ""}, {"drug": "Metronidazole", "dose": "", "remarks": ""}, {"drug": "Midazolam", "dose": "0.1-0.2 mg/kg IV/IM q1-2hr\n0.06-0.36 mg/kg/hr IV cont infusion", "remarks": "For conscious sedation"}, {"drug": "Milrinone", "dose": "0.25-0.75 mcg/kg/min; titrate to effect", "remarks": ""}, {"drug": "Morphine sulfate", "dose": "0.05-0.2 mg/kg IV/IM q2-4hr\n0.025-0.05 mg/kg/hr IV cont infusion", "remarks": ""}, {"drug": "NaCl", "dose": "2-8 mEq/kg/DAY\nBOLUS 10-20 mL/kg", "remarks": "1-4 mEq PO soln in ADC"}, {"drug": "NaHCO3", "dose": "1-2 mEq/kg/dose IV", "remarks": "Give over 20-30 minutes"}, {"drug": "Nafcillin", "dose": "", "remarks": "Meningitis 14 \u2013 21 days treatment"}, {"drug": "Nevirapine", "dose": "", "remarks": "1st dose within 48hr, 2nd dose 48hrs after 1st & 3rd dose 96hr after 2nd"}, {"drug": "Nystatin", "dose": "100000-200000 units PO q6hr", "remarks": "Swab each cheek for thrush"}, {"drug": "Omeprazole", "dose": "0.7-1.5 mg/kg q24hr (1 mg/kg q24hr)", "remarks": "ORAL or NG tube"}, {"drug": "Pantoprazole", "dose": "0.5-1 mg/kg q 24hr", "remarks": "INJECTION"}, {"drug": "Penicillin G Na", "dose": "", "remarks": "Penicillin G (Benzathine) syphilis IM 50000 units/kg x 1 dose\nAvoid Penicillin G Potassium in newborns"}, {"drug": "Piperacillin / Tazobactam", "dose": "", "remarks": "Dosed on piperacillin component"}, {"drug": "Phenobarbital", "dose": "MD: 2.5 mg/kg IV/PO q12hr", "remarks": "Order TROUGH prior to dose"}, {"drug": "Polyethylene Glycol", "dose": "0.5-1.5 grams/kg q24hr", "remarks": ""}, {"drug": "Poractant", "dose": "2.5ml/kg then 1.25ml/kg at 12hr intervals x2 if needed", "remarks": "MAX 5ml/kg"}, {"drug": "Prednisolone", "dose": "0.05-2 mg/kg/DAY div q6-24hr", "remarks": "PO"}, {"drug": "Propranolol", "dose": "0.01-0.15 mg/kg IV q6hr (MAX 1 mg/dose)\n0.5-5 mg/kg/DAY div q6hr (MAX 16 mg/kg/DAY)", "remarks": "Tet spells: double the dose\nArrhythmias: low dose IVP"}, {"drug": "Rocuronium", "dose": "Initial: 0.45-0.6 mg/kg\nMD surgical relaxation: 0.075-0.15 mg/kg \nContinuous IV infusion: 7-10 mcg/kg/min", "remarks": "Cont. surgical relaxation dose interval as determined by monitoring"}, {"drug": "Sildenafil", "dose": "0.5-2mg/kg/dose every 8hr MAX 10mg every 8hr PO", "remarks": "IV product \u2013 call store room"}, {"drug": "Sulfamethoxazole / Trimethorpim", "dose": "PCP prophylaxis: 75 mg/m2 PO q12hr or MWF\nStenotrophomonas:5 mg/kg q6-8hr (IV or PO)", "remarks": "Dose based on trimethoprim product"}, {"drug": "Tobramycin Inhaled", "dose": "< 4 kg: 20 mg neb q12hr\n> 4 kg: 40mg neb q12hr", "remarks": "Should not be administered with systemic tobramycin"}, {"drug": "Ursodiol", "dose": "Biliary atresia:10-15 mg/kg q24hr\nTPN induced cholestasis: 10mg/kg q8hr", "remarks": ""}, {"drug": "Valganciclovir", "dose": "16 mg/kg PO q12 hr", "remarks": ""}, {"drug": "Vancomycin", "dose": "", "remarks": "Levels with 5th TOTAL dose\nTherapeutic rage:\nTrough: 10-15 mcg/mL\nPeak: 20-40 mcg/mL"}, {"drug": "Vasopressin", "dose": "0.01-0.6 units/kg/hr", "remarks": "Titrate to effect"}, {"drug": "Vecuronium", "dose": "0.1-0.15 mg/kg/dose every 1-2hr PRN\nContinuous IV infusion: 1.2-3 mcg/kg/min", "remarks": "Must have pain/sedation meds"}, {"drug": "Zidovudine", "dose": "", "remarks": ""}]}], "searchIndex": [{"id": "introduction", "title": "Introduction", "path": "Introduction", "type": "h2"}, {"id": "orientation", "title": "Orientation", "path": "Introduction > Orientation", "type": "h3"}, {"id": "orientation", "title": "Orientation", "path": "Introduction > Orientation", "content": "Short Description of Unit, resident workroom, location of important equipment, tools, etc that residents need to know??", "type": "content"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "type": "h3"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "content": "As soon as you arrive to work, or return after a break, please remember to perform adequate handwashing, including scrub for 3 minutes to elbow", "type": "content"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "content": "Remove watches or jewelry", "type": "content"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "content": "Please keep sleeves at or above your elbows when handling patients", "type": "content"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "content": "Wash hands or use foam before and after entering each patient room", "type": "content"}, {"id": "infection-control", "title": "Infection Control", "path": "Introduction > Infection Control", "content": "FOOD/DRINKS at workstations policy?", "type": "content"}, {"id": "schedule", "title": "Schedule", "path": "Introduction > Schedule", "type": "h3"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "type": "h3"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "Criteria for admission to Well-Baby Nursery", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "No major congenital anomalies (hydrocephalus, UPJ obstruction, bowel obstruction, CHD, fetal HR abnormalities, skeletal dysplasia, maternal myasthenia gravis, syndromic appearance)", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "Infants with mild renal pelviectasis, isolated cleft lip/palate, small CPAM can be admitted to NBN", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "Temperature is stable without the need of an incubator or warmer", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "O2 saturations > 92 on RA if 35 to 35.6 weeks GA, > 90% for other infants", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "No signs of respiratory distress (RR > 70, grunting, severe retractions)  need for continuous electronic cardio-respiratory monitoring", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "No immediate anticipated need for continuous IVF, nasal/oral gastric tubes, or similar interventions", "type": "content"}, {"id": "admissions", "title": "Admissions", "path": "Introduction > Admissions", "content": "All other infants should be admitted to the RNICU.", "type": "content"}, {"id": "rounds", "title": "Rounds", "path": "Introduction > Rounds", "type": "h3"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "type": "h3"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "Criteria for NBN transfer", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "Vitals within normal range (HR: 90-160, RR: 30-60)", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "2 consecutive PO feeds with no distress, especially if RR 60-70", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "4 hr for other infants", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "8 hr if admitted for hypothermia", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "12 hr if < 2000 g (also needs to be > 24 hr old)", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "4 hr if no or < 2 hr of O2 requirement in NICU", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "6 hr if 2 \u2013 12 hr of O2 requirement in NICU", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "12 hr if intubated or > 12 hr of O2 O2 requirement in NICU", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "2 prefeed Glucose checks > 50, 1st prefeed check 3 hours after fluids stopped. If not transferred after second check needs monitoring in the RNICU for", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "12 more hours", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "24 hours if < 37 weeks or 2500 g, SGA, cleft lip or palate", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "If cord blood pH > 7, Base deficit < -15, neuro symptoms at birth, document stable neuro exam for 6 hr before transfer", "type": "content"}, {"id": "transfers", "title": "Transfers", "path": "Introduction > Transfers", "content": "Criteria for CCN transfer", "type": "content"}, {"id": "general-nicu-care", "title": "GENERAL NICU CARE", "path": "GENERAL NICU CARE", "type": "h1"}, {"id": "maternal-disorders-affecting-newborn", "title": "Maternal Disorders Affecting Newborn", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn", "type": "h2"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "type": "h3"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Maternal hyperglycemia \ud83e\udc6a fetal hyperglycemia \ud83e\udc6a increased fetal insulin (hence neonatal hypoglycemia after delivery) \ud83e\udc6a anabolic effects such as accumulation of glycogen and lipid stores \ud83e\udc6a macrosomia, s", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Fetal hyperinsulinism may also increase fetal O2 consumption and cause increased erythropoiesis (leading to polycythemia \ud83e\udc6a RBC breakdown after birth \ud83e\udc6a hyperbilirubinemia) and inhibit surfactant synthe", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Fetal hyperglycemia is considered to increase risk for malformations such as sacral agenesis, NTDs, small left colon syndrome (delayed meconium passage, feeding intolerance), cardiac defects such as T", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Mechanism of hypocalcemia and hypomagnesemia unclear", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Management", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Screen for hypoglycemia within 1-2 hours after birth and follow hypoglycemia protocol", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "Thorough physical exam to screen for anomalies", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "CBC for Hct, bilirubin at 12-24 HOL.  S.Ca and Mg levels may be obtained based on symptoms.", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "CXR if RDS symptoms, respiratory support with OE/CPAP/NIPPV and rarely SIMV, surfactant administration as needed", "type": "content"}, {"id": "infant-of-a-diabetic-mother", "title": "Infant of a diabetic mother", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Infant of a diabetic mother", "content": "ECHO indicated if persistent cyanosis/hypoxemia despite appropriate respiratory support", "type": "content"}, {"id": "hypertension/preeclampsia/eclampsia", "title": "Hypertension/preeclampsia/eclampsia", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Hypertension/preeclampsia/eclampsia", "type": "h3"}, {"id": "hypertension/preeclampsia/eclampsia", "title": "Hypertension/preeclampsia/eclampsia", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Hypertension/preeclampsia/eclampsia", "content": "Uteroplacental insufficiency\ud83e\udc6a fetal growth restriction \ud83e\udc6a need for elective C/S to minimize maternal complications and/or further fetal growth failure \ud83e\udc6a premature birth", "type": "content"}, {"id": "hypertension/preeclampsia/eclampsia", "title": "Hypertension/preeclampsia/eclampsia", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Hypertension/preeclampsia/eclampsia", "content": "Risk of apnea/hypotonia in women given MgSO4 for treatment", "type": "content"}, {"id": "myasthenia-gravis", "title": "Myasthenia gravis", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Myasthenia gravis", "type": "h3"}, {"id": "myasthenia-gravis", "title": "Myasthenia gravis", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Myasthenia gravis", "content": "90% of moms with MG have antibodies that are transplacentally transferred to fetus and cause symptoms in 20% of newborns", "type": "content"}, {"id": "myasthenia-gravis", "title": "Myasthenia gravis", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn > Myasthenia gravis", "content": "Symptoms including weak suck and respiratory distress typically begin by 3 DOL and last up to 1 to 4 weeks", "type": "content"}, {"id": "maternal-disorders-affecting-newborn", "title": "Maternal Disorders Affecting Newborn", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn", "content": "Neonatal lupus due to transplacental ANA (anti-Ro/anti-La) is usually rare, and most often comprises of heart block of varying degrees due to fibrosis and destruction of cardiac conduction system", "type": "content"}, {"id": "maternal-disorders-affecting-newborn", "title": "Maternal Disorders Affecting Newborn", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn", "content": "Newborns with CHB required careful monitoring/EKG/ECHO", "type": "content"}, {"id": "maternal-disorders-affecting-newborn", "title": "Maternal Disorders Affecting Newborn", "path": "GENERAL NICU CARE > Maternal Disorders Affecting Newborn", "content": "Symptomatic/severe bradycardia (<55 bpm) can require pacemaker insertion", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "type": "h2"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "90% of infants require no resuscitation. 10% do, and of these 1% require extensive resuscitation.", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "NRP Algorithm                                          Extensive Resuscitation Indications", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "APGAR score", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Medications used in resuscitation", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Other medications such as Sodium bicarbonate and Calcium gluconate may occasionally be required.", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Techniques for achieving effective ventilation with bag and mask", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Special considerations", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "ELBW infants (see Golden Week section)", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Meconium Aspiration (See MAS section)", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Congenital Diaphragmatic Hernia (see CDH section)", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Congenital Heart Diseases (see CHD section)", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Others", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Pneumothorax", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Can be caused by excessive PPV or be present at birth", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Signs include decreased breath sounds on one side of chest or bulging chest wall", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Transillumination may be quick and helpful. CXR is slow but confirmatory", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "When severely hypoxic/bradycardic in the DR, needle thoracentesis can be both diagnostic and provide immediate relief.", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Fetal hemorrhage", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Can be caused by placenta previa, vasa previa or rarely, placental abruption", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Signs include pallor, poor perfusion, and failure to respond to standard resuscitation", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "AFTER airway establishment/ventilation/oxygenation, consider 20 mL/kg of Rh O negative uncross- matched blood (may need more)", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Upper airway obstruction", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Upper airway obstructions are sometimes not diagnosed antenatally", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Choanal atresia: infant is pink when crying but cyanotic when quiet", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Pierre Robin Sequence: airway obstructed by tongue when supine, so may need an oro-pharyngeal airway", "type": "content"}, {"id": "neonatal-resuscitation", "title": "Neonatal Resuscitation", "path": "GENERAL NICU CARE > Neonatal Resuscitation", "content": "Cranio-facial abnormalities: May require intubation which can be very difficult in such infant; may need to have ENT/Anesthesia available at short notice", "type": "content"}, {"id": "gestational-age-assessment", "title": "Gestational Age Assessment", "path": "GENERAL NICU CARE > Gestational Age Assessment", "type": "h2"}, {"id": "gestational-age-assessment", "title": "Gestational Age Assessment", "path": "GENERAL NICU CARE > Gestational Age Assessment", "content": "When available, ultrasonographic measurements of the fetus in the 1st trimester give the most accurate estimate of gestational age. Gestational age assessments can also be based on  2nd and 3rd trimes", "type": "content"}, {"id": "gestational-age-assessment", "title": "Gestational Age Assessment", "path": "GENERAL NICU CARE > Gestational Age Assessment", "content": "Physical examination of the newborn infant can also be used to estimate GA, with the help of the Ballard Score tool. This is especially useful when other sources of GA estimates are unavailable, for e", "type": "content"}, {"id": "gestational-age-assessment", "title": "Gestational Age Assessment", "path": "GENERAL NICU CARE > Gestational Age Assessment", "content": "Ballard Score examination consists of 2 parts (neuromuscular and physical), can be performed in infants up to 4 days of age (though it is best performed within the first 12 hours) and provides estimat", "type": "content"}, {"id": "late-preterm-infant-care", "title": "Late Preterm Infant Care", "path": "GENERAL NICU CARE > Late Preterm Infant Care", "type": "h2"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "type": "h3"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Late preterm infants are those born at a GA between 34+0 and 36+6 days. Incidence of LPT birth has decreased recently due to the decrease in the incidence of elective planned c-sections done for non-m", "type": "content"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Signs include pale appearance, mottled skin, apnea, bradycardia, hypotonia, weak cry, poor feeding, respiratory distress", "type": "content"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Warm, dry gently after birth, prevent heat loss by keeping warmer closed", "type": "content"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Postpone bath until thermal, cardiorespiratory stability established (1-2 hours after birth)", "type": "content"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Encourage and facilitate skin-to-skin care as possible", "type": "content"}, {"id": "hypothermia", "title": "Hypothermia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypothermia", "content": "Recommended to maintain room temp between 72-75\u00b0F", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypoglycemia", "type": "h3"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypoglycemia", "content": "Risk increased if GDM, obesity, PIH, tocolysis use, difficult/prolonged labor, NRFHM, IUGR, twins, antenatal steroid exposure", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypoglycemia", "content": "Facilitate early and frequent breastfeeding as soon as possible", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hypoglycemia", "content": "Monitor blood glucose 1 hr after feeds and if still low and/or feeding difficulty, initiate IV dextrose (see hypoglycemia section)", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "type": "h3"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "Mostly secondary to RDS (most common), TTN, pneumonia, PPHN, and rarely pneumothorax caused by PPV/CPAP", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "Requires close monitoring for signs of respiratory distress and desaturation", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "Goal O2 saturations for LPT infants are between 91-95% if RDS alone, and > 95% if PPHN suspected (preductal saturations > 10% higher than postductal saturations)  difference.", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "O2 administration through an Oxyhood is superior to Nasal cannula", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "May require CPAP, if FiO2 through O2 hood > 50%, and intubation/surfactant if respiratory distress/FiO2 requirements do not decrease despite CPAP", "type": "content"}, {"id": "respiratory-distress", "title": "Respiratory distress", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Respiratory distress", "content": "Approximately 1% of LPT infants exposed to CPAP for > 12 hours can develop air leak syndromes such as pneumothorax that typically resolve with supportive therapy and needle thoracentesis. Chest tube i", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Apnea", "type": "h3"}, {"id": "apnea", "title": "Apnea", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Apnea", "content": "Typically secondary to RDS and associated respiratory distress", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Apnea", "content": "Can also be caused by hypothermia or sepsis", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Apnea", "content": "Can also indicate respiratory control immaturity and some LPT infants may require caffeine therapy for several days before apnea resolves completely", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Sepsis", "type": "h3"}, {"id": "sepsis", "title": "Sepsis", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Sepsis", "content": "GBS screening results usually not available when infant born < 36 weeks GA", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Sepsis", "content": "LPTs also at increased risk for culture-proven sepsis mostly due to GP organisms", "type": "content"}, {"id": "hyperbilirubinemia", "title": "Hyperbilirubinemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hyperbilirubinemia", "type": "h3"}, {"id": "hyperbilirubinemia", "title": "Hyperbilirubinemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hyperbilirubinemia", "content": "Increased rate of rise is often noted between 48 \u2013 72 hours after birth, peak bilirubin levels around 5 \u2013 7 days of life", "type": "content"}, {"id": "hyperbilirubinemia", "title": "Hyperbilirubinemia", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Hyperbilirubinemia", "content": "Use Bhutani nomograms to evaluate need for phototherapy/exchange transfusion/other measures as needed (see Hyperbilirubinemia section)", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "type": "h3"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "Breastmilk and direct breastfeeding (ad lib, typically Q3H) is preferred", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "However, respiratory distress, premature birth of the infant and other factors often cause difficulties with latching and suck/swallow coordination", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "Order lactation support consult and facilitate access to breast pumps for mothers who wish to exclusively breastfeed. Reassure families that breastfeeding is frequently possible well before EDD in mos", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "Supplementation with formula should be used only when breastfeeding is unsuccessful, as indicated by lack of effective latch, oliguria, excessive weight loss ( > 3% per day), hypoglycemia etc", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "Consider 22 kcal formula for infants who weigh < 2.5 kg, otherwise standard formula (Enfamil 20 Kcal/oz) may be used", "type": "content"}, {"id": "feeding-difficulties", "title": "Feeding difficulties", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Feeding difficulties", "content": "Recommended volumes are 2\u201310 mL per feed (first 24 h), 5\u201315 mL per feed (24\u201348 h), 15\u201330 mL per feed (48\u201372 h) and 30\u201360 mL per feed (72\u201396 h)", "type": "content"}, {"id": "neurologic-morbidity", "title": "Neurologic morbidity", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Neurologic morbidity", "type": "h3"}, {"id": "neurologic-morbidity", "title": "Neurologic morbidity", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Neurologic morbidity", "content": "Fetal brain cortical volume increases by 50% between 34 to 40 weeks", "type": "content"}, {"id": "neurologic-morbidity", "title": "Neurologic morbidity", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Neurologic morbidity", "content": "Immature brain increases risk for complications such as apneas, poor feeding and hypothermia", "type": "content"}, {"id": "neurologic-morbidity", "title": "Neurologic morbidity", "path": "GENERAL NICU CARE > Late Preterm Infant Care > Neurologic morbidity", "content": "If additional morbidities such as severe SGA, asphyxia, in utero drug exposure and genetic syndromes provide referral for neurodevelopmental follow up", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "type": "h2"}, {"id": "introduction", "title": "Introduction", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Introduction", "type": "h3"}, {"id": "introduction", "title": "Introduction", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Introduction", "content": "Global aims: Move to a team centric care model where the patient is the center of focus. Improve outcomes, establish a just culture, eliminate harm, achieve 100% participation of all members of the ca", "type": "content"}, {"id": "introduction", "title": "Introduction", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Introduction", "content": "Interns or NNPs in conjunction with the supervising residents are the Primary Care Provider for these patients in the NICU", "type": "content"}, {"id": "introduction", "title": "Introduction", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Introduction", "content": "Fellows should be fully involved and consulted by NNPs, interns, and residents on day-to-day management decisions during the crucial first week after birth. Fellows should include the NNPs, interns, a", "type": "content"}, {"id": "introduction", "title": "Introduction", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Introduction", "content": "The infant\u2019s care team (NNP/intern, resident, fellow) should make additional rounds (preferably twice) on these patients (with bedside nurse and RT in the patient room) whenever possible between forma", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "type": "h3"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "Fellow and residents discuss with charge nurse about impending delivery to gather resources and supplies.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "Fellow meets with family for prenatal consultation when possible. Residents and interns are encouraged to accompany the fellow for prenatal consults.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "Fellow or residents obtain consents for central lines prior to delivery if able to do so.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "Fellow or resident checks with OB/chart to verify accuracy of dates, antenatal steroid completion status, and other pertinent maternal history.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "Antenatal corticosteroids are indicated for all infants with threatened preterm labor in whom resuscitation is planned.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "RT prepares ventilator, transcutaneous monitor equipment, and surfactant.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "PCT makes preparation for line placement.", "type": "content"}, {"id": "before-impending-delivery", "title": "Before Impending Delivery", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > Before Impending Delivery", "content": "TEAM HUDDLE and ASSIGNMENT of RESUSCITATION ROLES", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "type": "h3"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Note: These are general guidelines, which may change as per attending discretion based on individual patient circumstances.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "In the DR", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Fellow leads the resuscitation assisted by residents/NNPs and DR assigned nurse. Attending physician and RT routinely attend deliveries of these infants", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "0-5 minutes", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Obstetric team are practicing delayed cord clamping at delivery.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Place infant on top of cardiac monitor leads and attach SpO2 monitor.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Thermoregulation- Infant is placed in plastic bag, head is covered by bag and a lined hat, infant placed on a trans warmer mattress.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Oxygen- Start with 60% FiO2 and target oxygen saturations limits as per NRP.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "PPV if HR<100, apneic or gasping. Use ventilation corrective strategies (MRSOPA) if not improving.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Follow NRP recommendations.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "5-15 minutes", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Decision is made to intubate vs. CPAP with long prongs.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Patient should be intubated if persistently apneic, HR<100, or FiO2 >50%.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Before leaving delivery room, allow mother to see her infant.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Delivery nurse obtains cord blood for infant profile.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "In the RNICU", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Admission", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Nurse checks weight, length, axillary temperature, and single non-invasive BP on arrival.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Resident places orders using Golden Week powerplans in the following order\u2013 Neonatology Golden Week Medication; Neonatology Golden Week Lab; Neonatology Golden Week Admission Orders; Neonatology Respi", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Fellow stays with baby from DR to line insertion.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Transcutaneous CO2 monitor to be placed with limits 40-60.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Position head midline neutral position using fluidized positioner.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Thermoregulation", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Trans warmer heating pad to be removed if patient temperature >36.5 degrees.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Keep plastic bag on until after placing umbilical lines, the baby is adequately warm (skin temp > 36.5 degrees), and the incubator reaches 80% humidity.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Surfactant", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Administer surfactant if patient intubated due to any reason.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "If on CPAP, intubate and administer surfactant if FiO2 > 50%, pCO2 > 65 mmHg, or pH < 7.20.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Repeat doses of surfactant if remains intubated with FiO2 > 30%.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Umbilical Lines", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Fellow along with intern or resident places umbilical lines.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "UAC placed in addition to UVC if patient intubated or as per attending discretion.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Avoid flushing or rapid withdrawal to or from central lines.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "If unable to place UVC by 1 hour after birth - consider a double lumen UAC or early PICC.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Leave low lying UVC only until PICC placed and remove low-lying UVC ASAP.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Commence sodium acetate with heparin for UAC fluids and adjust TFI accordingly.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Use UAC for all fluids administration if unable to obtain UVC.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Low lying UAC (L3-L4) can be used.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Prefer PIV or UVC for inotropes and Indocin but use UAC if no PIV or UVC present.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Goal should be to remove UAC/UVC before day 7", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Labs and CXR", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Obtain chest and abdomen (long chest) X-ray after line placement. Fellow should confirm ETT and line placement immediately.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Blood gas and glucose obtained after placement of lines.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Obtain mixed venous blood gas and glucose at 45 minutes if lines not yet started and by 60 minutes if lines get delayed.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Parental Support", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Make every effort to allow mother to see the infant before leaving the delivery room.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Assign a staff member to explain the importance of the Golden Hour and the procedures that will be occurring.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Make contact with the family with an update by 2hrs of life.", "type": "content"}, {"id": "the-golden-hour-(0-60-minutes)", "title": "The Golden Hour (0-60 minutes)", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care > The Golden Hour (0-60 minutes)", "content": "Skin to skin care is encouraged after 72 hours only to minimize sudden changes in infant position during the period of IVH risk.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "On rounds present these babies as \u201chours after birth\u201d until reaches 72 hours/3 days old.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Signs with logos outside door and on incubator identify these infants and have date and time of birth.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Infant Care", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Weigh every 12 hours for first 72 hours and then every 24 hours.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Check urine output every 6 hours with minimal handling diaper changes for first 72 hours.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Follow trends in weight, urine output, lab values, vital signs, and clinical changes carefully.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Ventilator Management", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Low tidal volume strategy to be used aiming for 3-4 ml/kg.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider pressure control strategy if birth weight < 500 grams.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Goals: CO2", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "After 72 hours the residents can intubate the infant under supervision of the fellows. The interns can intubate the infant under supervision of the fellow after the completion of the golden week.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Extubate to NIPPV or bubble CPAP with long prongs and higher PEEP from 7-9 cmH2O.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Metabolic Acidosis", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Use Na bicarbonate judiciously and administer over 30 to 60 minutes (1meq/kg over 30 minutes and to 2meq/kg over 60 minutes) unless in a code or severe metabolic acidosis situation during which it can", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Administered if base deficit > -10 or HCO3 < 15", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Deliver fluid bolus slowly over 30 to 60 minutes also.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Always try to find the cause of metabolic acidosis with careful assessment of perfusion and consideration of Echocardiography.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Labs and CXR", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Use the Golden Week Lab Powerplan order set to order all labs.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "All labs will be clustered to minimize painful sticks or entry into central lines. Any additional labs outside of PowerPlan order set should be given careful consideration.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Avoid flushing or rapid withdrawal to or from central lines.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "IV Fluids", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "TFI goal starting at 70\u201380 ml/kg/day including all meds and drips.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Use only D10 trophamine for the first 72 hours after birth unless higher or lower dextrose needed for hypo/hyperglycemia.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Avoid addition of Na in fluids for at least first 72 hours after birth. Aim for a Na goal of 140-150 and consider hypo or hypernatremia as an indicator of fluid status in combination with weight and u", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Account for medications and arterial line fluids in all TFI calculations.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Order 1/4 normal saline (0.22% sodium chloride) flushes as per Golden Week Powerplan. Can switch back to Normal saline (0.9% sodium chloride) if hyponatremia develops.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "TPN", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider tarting lipids from day 2.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider starting patient specific TPN from 72 hours.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Intern and resident should review each Golden Week patient specific TPN with the fellow on service before finalizing.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Feeds", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Use colostrum in mouth whenever available.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Start trophic feeds with donor breast milk or EBM as early as day 1 if adequate volumes available and increase as tolerated as per attending preference.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Do not include trophic feeds in TFI.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Blood Pressure", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "The interns and residents along with the fellow to decide administration of saline or pressors based on clinical signs of hypoperfusion, metabolic acidosis, bedside assessment of IVC dilation by ultra", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "If diastolic BP < 3rd percentile for gestational age consider a bolus (10/kg x 2 maximum) and/or a dopamine drip.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "If systolic BP alone < 3rd percentile for gestational age consider a bolus (10/kg x 2 maximum) and/or a dobutamine drip.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider hydrocortisone treatment if persistent hypotension or other signs of adrenal insufficiency (hypoglycemia, hyponatremia, and hyperkalemia).", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Ureaplasma/mycoplasma", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Culture to be obtained on day 1 from all intubated babies. Also order if infant becomes intubated in the first week after birth.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Treat if positive.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Drugs", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Surfactant", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Administer 1st dose as soon after birth as possible if intubated \u2013 confirm ETT position clinically for administration \u2013 do not need to wait for x-ray", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "If on CPAP, intubate and administer surfactant if FiO2 > 50%, pCO2 > 65 mmHg, or pH < 7.20 (SUPPORT trial criteria).", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Administer subsequent doses of surfactant if remains intubated and FiO2 > 30%.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "If extubated after receiving 1st dose of surfactant revert back to SUPPORT trial criteria.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Caffeine", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "To be considered on day 1 in all infants, especially those on extubatable settings or not on ventilator.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Use high dose caffeine for loading and for maintenance.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Vitamin A: To be initiated on day 1 for all infants.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Antibiotics", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider starting on all infants on admission.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Antibiotics will automatically be discontinued at 36 hours and should be restarted at Attending\u2019s discretion.", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Consider fluconazole treatment if skin lesions or breakdown, hyperglycemia, and/or thrombocytopenia", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Indomethacin", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "0.1mg/kg q24hr x 1 dose) as soon as possible for ELBW infants with weight < 750g", "type": "content"}, {"id": "extremely-preterm-infant-care", "title": "Extremely Preterm Infant Care", "path": "GENERAL NICU CARE > Extremely Preterm Infant Care", "content": "Contraindications: Absent or reversed end diastolic blood flow, IUGR", "type": "content"}, {"id": "fluid-electrolyte-&-nutrition-problems", "title": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS", "type": "h1"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "type": "h2"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Soon after birth most infants are oliguric for the first 24-48 h. This is followed by a period of diuresis for the next several days that permits contraction of the extracellular fluid compartment, du", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Facilitate early weight loss", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Preterm: 5-7 days, ~5-15% of BW", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Term: 3-5 days, ~5-7% of BW", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Beyond this initial period, promote weight gain with goals of", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "<2 kg = 15-20 g/kg/day, regain BW by 15 days of life", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": ">2 kg = > 30 g/day, regain BW 10 days of life", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Such rates of weight gain are typically achieved with a caloric Intake of", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Preterm: 125-140 kcal/kg/day", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Term: 90-110 kcal/kg/day", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Na and K supplementation is generally required usually only after the first 2 \u2013 4 days of life as S.Na levels generally remain high due to weight loss and extracellular fluid volume contraction  and S", "type": "content"}, {"id": "general-goals-of-fen-management", "title": "General goals of FEN management", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > General goals of FEN management", "content": "Trophamine is a mixture of essential and nonessential amino acids that can be added to standard IVF to maintain positive N2 balance and improve long term neurologic outcomes for infants with BW <1500g", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "type": "h2"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "IVF to be started at birth", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Report daily total fluid intake (TFI) as mL/Kg/day (always prorate to a 24-hour day)", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Include all maintenance IVF, feeds, IV meds, flushes, etc.", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Do not include fluid boluses, blood products (PRBCs, platelets, or FFP) or trophic feeds, but do report them as a separate number.", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Check daily electrolytes while on IVF and/or TPN", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Subsequent daily TFI increases are generally between 10 \u2013 30 mL/kg/day and determined using 3 factors", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Change in weight", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Changes in S.Na", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Urine output", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Report as mL/Kg/hour (if 24 h of output not available, prorate the time)", "type": "content"}, {"id": "intravenous-fluids", "title": "Intravenous fluids", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Intravenous fluids", "content": "Normal UOP is between 1 to 4 mL/kg/hr", "type": "content"}, {"id": "common-electrolyte-disorders", "title": "Common electrolyte disorders", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders", "type": "h2"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "type": "h3"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "S.Na < 130 mEq/L, though up to 125 mEq/L can be tolerated at times", "type": "content"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "Can lead to apnea, seizures", "type": "content"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "If weight remains stable or increases, then hyponatremia is mostly \u201cdilutional\u201d secondary to excessive fluid administration and/or decreased UOP, especially in the first several days of life; rarely c", "type": "content"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "Treatment:  Fluid restriction. If < 120 mEq/L additional Na supplementation is often required", "type": "content"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "If weight decreases, hyponatremia may be due to actual Na deficiency, secondary to renal (renal immaturity in ELBW infants or diuretics) or GI (diarrhea) losses, or osmotic diuresis (hyperglycemia); r", "type": "content"}, {"id": "hyponatremia", "title": "Hyponatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyponatremia", "content": "Treatment: Address cause for excessive Na losses. To correct S.Na directly, calculate Na deficit Desired Na+ (usually 130) \u2013 current Na+ x 0.6 x BW (kg) and administer slowly over 12-24 hours", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "type": "h3"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "S. Na > 150 mEq/L, can cause lethargy, hyperthemia, seizures", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "Commonly due to excessive fluid (and weight) loss either through diuresis or IWL, can sometimes be caused by central diabetes insipidus due to HIE in term infants", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "Treatment: Administer free water in the form of D5-1/2NS or D10-1/2NS (can consider giving NS bolus if severely dehydrated) to increase S.Na by 0.5 mEq/L every hour (faster correction can cause cerebr", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "If excessive UOP (frequently > 6 mL/kg/hr) is considered the cause for hypernatremia a suggested replacement strategy is to replace excess UOP > 6 mL/kg/h over a 6-hour period 1:1 with \u00bd NS over the n", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "Rarely due to excessive Na administration", "type": "content"}, {"id": "hypernatremia", "title": "Hypernatremia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypernatremia", "content": "Treatment: restrict Na intake, consider diuretics if infant is older (caution: administering furosemide can cause worsening of PDA in ELBW infants < 2 weeks old)", "type": "content"}, {"id": "hypokalemia", "title": "Hypokalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypokalemia", "type": "h3"}, {"id": "hypokalemia", "title": "Hypokalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypokalemia", "content": "S.K+ < 3 mEq/L, although up to 2.5 mEq/L is often tolerated as symptoms such as ileus or arrhythmias rarely manifest above that range", "type": "content"}, {"id": "hypokalemia", "title": "Hypokalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypokalemia", "content": "Commonly due to K loss from diuretics,  diarrhea; rarely due to inadequate K intake; hypokalemia can also be caused by metabolic alkalosis (caused by shift of K to the intracellular compartment to com", "type": "content"}, {"id": "hypokalemia", "title": "Hypokalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypokalemia", "content": "Treatment: Increase K in maintenance fluids (normal K need in infants is 2 \u2013 3 mEq/kg/day, can increase by 1-2 mEq/kg/day to correct S.K slowly over 12 -24 hours; rapid correction or pushes is almost ", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "type": "h3"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "S.K > 6 mEq/L, can cause arrhythmias (bradycardia, SVT, VT, rarely V.fib, all of which typically occur only with S.K > 7 mEq/L)", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Commonly due to spurious hemolysis (especially when the result is from a heelstick sample), so if > 7, repeat test using blood sample from venous stick  and get an EKG looking for peaked T waves, prol", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Can also be due to oliguric renal failure, metabolic acidosis, excessive K intake, and rarely CAH", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Treatment:", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Calcium gluconate: 100mg/kg of 10% calcium gluconate over 30 min to stabilize cardiac conduction system, and", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "insulin+glucose (0.05u/kg regular insulin in 2ml/kg of D10 followed by IVF infusion containing glucose) to help shift K into cell;", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Occasionally, sodium bicarbonate (2mEq/kg of sodium bicarb over 20 min) and beta-2 agonist (inhaled albuterol) may also be required", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Furosemide (1mg/kg/dose IV) can help K excretion into urine but will only work if infant is voiding urine", "type": "content"}, {"id": "hyperkalemia", "title": "Hyperkalemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hyperkalemia", "content": "Kayelexate (often used in older children) causes Na load and is rarely, if ever, used in newborns", "type": "content"}, {"id": "hypocalcemia", "title": "Hypocalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypocalcemia", "type": "h3"}, {"id": "hypocalcemia", "title": "Hypocalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypocalcemia", "content": "Total S.Ca < 8 mg/dL or iCa < 1.1 mmol/L, though symptomatic typically only if iCa < 0.9, especially in ELBW infants; symptoms can include jitteriness, agitation, seizures, lethargy, vomiting, decreas", "type": "content"}, {"id": "hypocalcemia", "title": "Hypocalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypocalcemia", "content": "Early-onset hypocalcemia (<1 week after birth) can be due to prematurity/IUGR, IDM, HIE, hypomagnesemia, hypoparathyroidism, maternal hyperparathyroidism; later-onset hypocalcemia is often due to high", "type": "content"}, {"id": "hypocalcemia", "title": "Hypocalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypocalcemia", "content": "Acute treatment: If symptomatic give 100-200 mg/kg of 10% calcium gluconate over 30 min-1 hour (can be given over 5-10 minutes if acutely symptomatic with seizures etc.).", "type": "content"}, {"id": "hypocalcemia", "title": "Hypocalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypocalcemia", "content": "Further management: If hypocalcemia is noted on screening labs and asymptomatic, address causes such as reduction of high phosphate intake, renal failure, hypomagnesemia etc. in addition to increasing", "type": "content"}, {"id": "hypercalcemia", "title": "Hypercalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypercalcemia", "type": "h3"}, {"id": "hypercalcemia", "title": "Hypercalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypercalcemia", "content": "Total S.Ca >12 mg/dL or iCa >1.5 mmol/L; may cause hypotonia and\nencephalopathy", "type": "content"}, {"id": "hypercalcemia", "title": "Hypercalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypercalcemia", "content": "Rare in newborns. Causes include low serum P (usually in preterm infants), subcutaneous fat necrosis (rarely noted in infants with HIE and sepsis), thiazide diuretics; rarely due to hyperparathyroidis", "type": "content"}, {"id": "hypercalcemia", "title": "Hypercalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypercalcemia", "content": "Acute treatment: If symptomatic, normal saline boluses and increase IVF maintenance, and furosemide (increases calcium excretion), steroids (decrease GI absorption), rarely calcitonin", "type": "content"}, {"id": "hypercalcemia", "title": "Hypercalcemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypercalcemia", "content": "Further management: Increase phosphate intake; obtain endocrine consult as needed", "type": "content"}, {"id": "hypomagnesemia", "title": "Hypomagnesemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypomagnesemia", "type": "h3"}, {"id": "hypomagnesemia", "title": "Hypomagnesemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypomagnesemia", "content": "Serum Mg < 1.6 mg/dL; presents like hypocalcemia with jitteriness, apnea, feeding intolerance, and seizures", "type": "content"}, {"id": "hypomagnesemia", "title": "Hypomagnesemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypomagnesemia", "content": "Occasionally seen in preterm infants, can happen in term newborns secondary to IDM, therapeutic hypothermia for HIE, loop diuretics, Gitelman\u2019s syndrome, frequent blood transfusions", "type": "content"}, {"id": "hypomagnesemia", "title": "Hypomagnesemia", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders > Hypomagnesemia", "content": "Treatment: IV MgSO4 25-50 mg/kg/dose over several minutes followed by increased supplementation in IVF/TPN/enteral feeds followed by identification and correction of cause", "type": "content"}, {"id": "common-electrolyte-disorders", "title": "Common electrolyte disorders", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders", "content": "Serum Mg >3 mg/dL; neonatal symptoms include hypotonia, hyporeflexia, hypotension and apnea, as well as vasodilatation with marked flushing", "type": "content"}, {"id": "common-electrolyte-disorders", "title": "Common electrolyte disorders", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders", "content": "Rare in newborns, can be secondary to Mg given to mother for tocolysis/pre-eclampsia.", "type": "content"}, {"id": "common-electrolyte-disorders", "title": "Common electrolyte disorders", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Common electrolyte disorders", "content": "Treatment: Can increase urinary excretion with furosemide, and IV hydration, along with symptomatic management (respiratory/blood pressure support) until magnesium level gradually falls. If severely s", "type": "content"}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations", "type": "h2"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "type": "h3"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "content": "Consider a  2.2 kg infant on 155 ml/kg/day of 24 kcal/oz feeds.", "type": "content"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "content": "Total Volume = 155 ml/kg/day x 2.2 kg = 341 ml", "type": "content"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "content": "Caloric density of feeds he is getting = 24 kcal/oz x 1 oz/30ml = 0.8 kcal/mL", "type": "content"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "content": "Total Calories = 341 ml x 0.8 kcal/ml = 272.8 kcal", "type": "content"}, {"id": "kcal-calculation-example", "title": "Kcal calculation example", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations > Kcal calculation example", "content": "Total kcal/kg/day = 272.8 kcal / wt = 272.8 kcal / 2.2 kg = 124 kcal/kg/day", "type": "content"}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations", "content": "Breakdown of energy", "type": "content"}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations", "content": "Lipids (20%) = 9 kcal/g (40% of cal intake)", "type": "content"}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations", "content": "Glucose = 3.4 kcal/gm (no more than 50-60% of cal intake)", "type": "content"}, {"id": "caloric-intake-calculations", "title": "Caloric intake calculations", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Caloric intake calculations", "content": "Amino acids = 4.0 kcal/g (10-12% of cal intake)", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "type": "h2"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "TPN pointers", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "Just like with TFI, when doing TPN use birth weight until this is surpassed, then use current weight", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "Trophic feeds (< 25 ml/kg/d) do not count into total TFI", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "TPN orders are due to pharmacy by 2pm so should be a priority after rounds", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "Create TPN using excel sheet, then must also enter final orders (including final rate)", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "Always make TPN based on \u201cNPO rate\u201d just in case the feeds are stopped unexpectedly, then you have enough TPN to last until the next day. This is why your final rate may be different than what your ex", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "TPN labs:", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "Daily - electrolytes (Na, K, Cl, HCO3)", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "QMon/Thurs - BMP, Mg, Phos, triglycerides", "type": "content"}, {"id": "parenteral-nutrition", "title": "Parenteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Parenteral Nutrition", "content": "QMon only - add fractionated bilirubin (monitoring for TPN cholestasis)", "type": "content"}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition", "type": "h2"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "type": "h3"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "content": "Start all very preterm babies on human milk from the time of birth (oropharyngeal colostrum on first day)", "type": "content"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "content": "If no EBM available or family chooses to formula feed:", "type": "content"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "content": ">35wga start on 20 kcal/oz", "type": "content"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "content": "if <35wga start on 24 kcal/oz", "type": "content"}, {"id": "type-of-feeds", "title": "Type of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Type of feeds", "content": "Donor Milk policy", "type": "content"}, {"id": "method-of-feeds", "title": "Method of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Method of feeds", "type": "h3"}, {"id": "method-of-feeds", "title": "Method of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Method of feeds", "content": "Coordinated swallowing/swallowing begin to become well-established starting at around 32 weeks GA, so can attempt PO feeds if > 32 weeks", "type": "content"}, {"id": "method-of-feeds", "title": "Method of feeds", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Method of feeds", "content": "Nasogastric tube feedings (given Q3H, 8 times/day) are used for infants < 32 weeks GA as well as those > 32 weeks GA who are unable to achieve adequate feeding volumes with PO intake only", "type": "content"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "type": "h3"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "content": "All preterm infants get started on \u201ctrophic\u201d feeds (defined as feeding volumes provided to promote intestinal maturation and improve tolerance to further feeding advancements). Do not include trophic ", "type": "content"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "content": "If <1000g, start trophics of 25 mL/kg/day of human milk and advance by 25ml/kg/day once past trophic feeds, which should typically be possible by DOL 2-5 (duration of minimal enteral feeding or trophi", "type": "content"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "content": "If >1000g, start trophics of 30 mL/kg/day and advance by 30ml/kg/day once past trophic feeds", "type": "content"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "content": "Continue advancing daily up to a goal of 140 mL/kg/day of enteral feeds (typically by DOL 6 \u2013 8), can then advance to 160-180 if PDA is not a significant concern", "type": "content"}, {"id": "feeding-volumes-and-advancement", "title": "Feeding volumes and advancement", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Feeding volumes and advancement", "content": "Ideal schedule of feeding advancements for preterm infants:", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "type": "h3"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Probiotics should be given to decrease risk of NEC for infants < 32 weeks GA or < 1500 g BW without significant anomalies once they are > 72 hours old and have tolerated feed volumes of at least 20 mL", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Dosage: Ultimate Flora\u2122 probiotic tablet (1/2 tablet crushed into milk, once daily)", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Hold: If infants is made NPO. If diagnosis of NEC, can restart once back on 100 mL/kg/day of feeds", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Discontinue: When > 36 weeks PMA or > 2 months (whichever is earlier), if infants require bowel surgery or at MD/parents request", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Add MVI once on full enteral feeds", "type": "content"}, {"id": "supplements", "title": "Supplements", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Supplements", "content": "Dose etc?", "type": "content"}, {"id": "enteral-feed-fortification", "title": "Enteral feed fortification", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Enteral feed fortification", "type": "h3"}, {"id": "enteral-feed-fortification", "title": "Enteral feed fortification", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Enteral feed fortification", "content": "While optimal for preventing NEC and early growth, breast milk alone provides insufficient nutrients to meet the caloric, protein and mineral (Ca, P, Na etc.) needs of most extremely premature infants", "type": "content"}, {"id": "enteral-feed-fortification", "title": "Enteral feed fortification", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Enteral feed fortification", "content": "Begin fortification of EBM with human milk fortifier when infant is tolerating > 80-100 mL/kg/d (which usually happens by 7-14 days of life)", "type": "content"}, {"id": "enteral-feed-fortification", "title": "Enteral feed fortification", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition > Enteral feed fortification", "content": "Can begin with a caloric density of 24 kcal/oz, and increase up to 30 kcal/oz if necessary, to optimize growth, using HMF (can also fortify with MCT oil if considered necessary)", "type": "content"}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition", "content": "Growth is monitored by plotting out serial measurements of weight, length, and head circumference using standard growth charts (Z-scores?)", "type": "content"}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition", "content": "Weight is assessed daily", "type": "content"}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition", "content": "Length and HC are assessed weekly", "type": "content"}, {"id": "enteral-nutrition", "title": "Enteral Nutrition", "path": "FLUID, ELECTROLYTE & NUTRITION PROBLEMS > Enteral Nutrition", "content": "Wednesdays are \u201cgrowth chart\u201d days for infants on the resident service", "type": "content"}, {"id": "respiratory-problems", "title": "RESPIRATORY PROBLEMS", "path": "RESPIRATORY PROBLEMS", "type": "h1"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "type": "h2"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "type": "h3"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "The basic objectives of any kind of respiratory support are to achieve ventilation and oxygenation adequate to support metabolic demands", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Ventilation (elimination of CO2, measured with pCO2/transcutaneous CO2) is determined by minute ventilation = Rate x Vt \u2013Vd (tidal volume minus dead space)", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Increasing PEEP often decreases Vt by decreasing pulmonary compliance and therefore could increase pCO2", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Oxygenation (adequate oxygenated Hb, measured using pO2 and O2 saturations), is determined largely by the MAP & FiO2", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "However, increased MAP can cause over-distention of the lungs, which impairs cardiac output and can lead to decreased tissue oxygenation.", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Acceptable ranges of blood gas values for ELBW infants are different than those for older, more mature infants", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "pH: 7.2 \u2013 7.4 (> 7.15 is often tolerated and weaning SIMV/HFOV strongly recommended for values > 7.35)", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "pCO2: 40 \u2013 60 (hypocarbia can increase risk of white matter injury and hypercarbia worsens risk for severe IVH)", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "pO2: Important in infants with PPHN or CHD, otherwise since most blood gases in the NICU are capillary samples, O2 saturations are a better determinant of oxygenation status", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "BE: -4 to + 4 (values < -5 should prompt evaluation for possible causes of metabolic acidosis)", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Lactic acid: Often elevated in most infants soon after birth; indicates adequacy of perfusion and needs to be closely monitored in infants at risk for hypotension/shock and in those with cardiac disea", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "To interpret a BG, start by determining whether the pH is acidotic or alkalotic", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Next consider the CO2. Remember that for every 10 mm Hg change in pCO2, the pH will change by 0.08 in the OPPOSITE direction. Does this relationship between CO2 and pH fully account for the observed p", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "What does this mean? If the CO2 accounts for the change in pH, then you have a primary respiratory process. If not, then you have an additional metabolic process going on.", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Example 1: 7.24/60/78/24/-3 = acidotic pH, respiratory acidosis, pCO2 accounts for change in pH (2 x 0.08 = 0.16 => 7.40 \u2013 0.16 = expected pH 7.24), so primary respiratory process", "type": "content"}, {"id": "blood-gases", "title": "Blood gases", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation > Blood gases", "content": "Example 2: 7.02/72/43/18/-9 = acidotic pH, respiratory acidosis, pCO2 does not fully account for change in pH.  (3 x 0.08 = 0.24 => 7.40 - 0.24 = expected pH 7.16) primary respiratory plus primary met", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TcCO2 (along with continuous O2 saturation monitoring) provides continuous and noninvasive monitoring of adequacy of ventilation, which helps with ventilator changes and reduces need for frequent bloo", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TcCO2 values correlate with capillary (as well as arterial) blood gas values in most ELBW infants (usually within a \u00b1 5 range), and TcCo2 trends over time are very useful for assessing changes in vent", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TcCO2 values higher than blood gas pCO2 can often be an indicator of poor perfusion, hypotension etc and", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TcCO2 values much lower than blood gas CO2 typically indicate loss of contact between probe and the skin that may require RT intervention to re-site it", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TcCO2 lower than the set limit, in addition to indicating that weaning the ventilator rate and/or pressures is likely needed to avoid overventilation and decrease risk for later BPD, can also lead to ", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "TCCO2 limits", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "For most infants initial TcCO2 limits of 40 to 60 are considered acceptable", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "As renal function and the ELBW infant\u2019s ability to reabsorb bicarbonate to provide metabolic compensation for respiratory acidemia improves over the first few weeks of life, TcCO2 limits can be increa", "type": "content"}, {"id": "adequacy-of-ventilation", "title": "Adequacy of Ventilation", "path": "RESPIRATORY PROBLEMS > Adequacy of Ventilation", "content": "Example: Blood gas on DOL3 for an ELBW infant is 7.20/60/55/18/-6. The infant has respiratory acidosis without adequate metabolic compensation due to the relatively low levels of HCO3. Therefore this ", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "type": "h2"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "type": "h3"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "Provides continuous pressure to maintain functional residual capacity (FRC) in infants and can be used as our primary mode of support in ELBW infants or as a weaning mode in infants being extubated", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "NCPAP requires these settings:", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "Positive End Expiratory Pressure (PEEP)", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "Starting settings: in a baby with RDS, start with CPAP of 5-7 cm H2O (you may increase to EEP as high as 8), consider rate of 20", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "CPAP causes infants to swallow a lot of air, so will likely need NG or OG to decompress the abdomen", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "The unit currently uses two CPAP interfaces:", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "Mask/Prong: These are placed over or on the infant\u2019s nose to create a seal", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "RAM Cannula: which looks like a green nasal cannula", "type": "content"}, {"id": "nasal-continuous-positive-airway-pressure-(ncpap)", "title": "Nasal Continuous Positive Airway Pressure (NCPAP)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Continuous Positive Airway Pressure (NCPAP)", "content": "Most small neonates are started on Mask/Prongs. Watch for complications with nasal or septal breakdown.", "type": "content"}, {"id": "nasal-intermittent-positive-pressure-ventilation-(nippv)", "title": "Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "type": "h3"}, {"id": "nasal-intermittent-positive-pressure-ventilation-(nippv)", "title": "Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "content": "Similar to CPAP except that a rate (and therefore peak inspiratory pressure) is also provided in addition to a PEEP. Both NIPPV and CPAP appear equivalent at this time.", "type": "content"}, {"id": "nasal-intermittent-positive-pressure-ventilation-(nippv)", "title": "Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Nasal Intermittent Positive Pressure Ventilation (NIPPV)", "content": "Can only be provided via a ventilator (NCPAP can be provided by both a \u201cbubble\u201d setup as well as ventilator. Rate will sometimes be added for extra support. This is considered", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "type": "h3"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "Heated and humidified air that is given at flow rates > 2L/min.", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "It can be blended and provides O2 for oxygenation, reduces airway resistance, and may flush dead space.", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "Unlike CPAP, HFNC provides variable pressure but a continuous flow", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "HFNC appears to be inferior to NCPAP for infants with RDS < 32 weeks", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "It (along with NC) does not provide precise FIO2 delivery, so it should not be used when that is needed (e.g. in PPHN).", "type": "content"}, {"id": "high-flow-nasal-cannula", "title": "High Flow Nasal Cannula", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > High Flow Nasal Cannula", "content": "It may be beneficial in infants who have had prolonged SIMV or CPAP support and need to be weaned.", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "type": "h3"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "Currently, the RNICU utilizes 2 modes of conventional ventilation:", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "Pressure control SIMV - Inspiratory pressures are adjusted to affect tidal volume. Pressure support is usually \u00bd - 2/3 inspiratory pressure. Most preterm infants will receive pressure control ventilat", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "Volume control SIMV - Tidal volume is set (4-6 ml/kg) and the ventilator determines the inspiratory pressure necessary. Pressure support still functions as a weaning mechanism and is adjusted in terms", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "Conventional Ventilator Cheat Sheet", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "-What settings should I start on pressure-control SIMV?", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "How do I know my settings are good? In Golden Week and stable babies target a Vt of 3-5 ml/kg (keep Vt low); on Drager vents the deadspace is always ~1ml in the neonatal mode. In all infants, follow t", "type": "content"}, {"id": "conventional-ventilator", "title": "Conventional Ventilator", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support > Conventional Ventilator", "content": "What should I wean first? Wean the most noxious variable first\u2014PIP then Rate. FiO2 can be weaned based on saturations", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Pulses or oscillates gases at a rate of 300-1500 breaths/minute.", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Two modes available - High Frequency Oscillatory Ventilation (HFOV) or Jet Ventilation (HFJV)", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Tidal volumes are equal to or smaller than the anatomic dead space, so HFOV/HFJV can maintain adequate lung volumes (avoiding swings in lung volume associated with barotrauma/volutrauma).", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "CO2 elimination is proportional to rate x Vt2; so you get more bang for your Vt buck.", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Expiration is passive with HFJV, and active with HFOV. Use these vents when the infant is failing conventional ventilation.", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "HFOV settings", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Amplitude", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Set at the PIP on the conventional settings and adjust until you see \u2018chest wiggle.\u2019", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Frequency", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "breaths per minute (1 Hz=60 breaths per minute)", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Ranges from 7 \u2013 15 Hz", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Higher frequencies lead to lower alveolar ventilation and CO2 retention", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "If it is a preterm infant, start at a higher frequency (i.e. 10 \u2013 12) and in a term infant, a lower frequency (i.e. 8-10)", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "MAP", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Good starting setting: initial MAP should be 1-2cm H2O higher than that being used on conventional vent", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "I-time", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "set at 33%; almost never changed except if infant develops intractable air leak syndrome", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "HFJV settings", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "PIP", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "start at PIP of approximately 20% lower than those being used with conventional ventilation", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Rate", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Usually set at 420 breaths/minute with inspiratory jet valve i-time of 0.02 second", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "\u201cSigh\u201d breath rate", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "A conventional vent is used in conjunction with HFJV to provide \u201csigh\u201d breaths, during which alveolar recruitment may occur", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "PEEP", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Is also provided by the conventional ventilator and is the main driver of MAP in HFJV", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Generally, start with the same PEEP as on previous conventional vent.", "type": "content"}, {"id": "modes-of-respiratory-support", "title": "Modes of Respiratory Support", "path": "RESPIRATORY PROBLEMS > Modes of Respiratory Support", "content": "Note the servo pressure for an infant before and after PEEP adjustments (this is an indirect measure of tidal volume delivered); for instance, if you decrease the PEEP and see the servo pressure go fr", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "type": "h2"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Causes: Inadequate pulmonary surfactant, which leads to diffuse atelectasis, edema, & cell injury", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Diagnosis", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Characteristic \u201cground-glass\u201d appearance of CXR", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Increasing O2 requirement in at-risk infant", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Management", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "General goals: Preventing hypoxia, optimizing fluid status, reducing metabolic demands, preventing worsening atelectasis & edema, & minimizing barotraumas & oxygen damage", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Small preterm infants are generally started on NCPAP, with intubation and surfactant if FiO2>0.50 needed or hypercapnia occurs.", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Surfactant (Curosurf aka Poractant at 2.5 ml/kg then 1.25 ml/kg) may be administered by the RTs. Repeat doses may be required every 12 hours for up to 3 doses if the baby\u2019s oxygen requirement increase", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Failure of paying attending to sudden increase in lung compliance may result in pulmonary hemorrhage in infants receiving surfactant*", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "In larger babies, start with a trial of oxyhood. This can be followed by NCPAP & intubation if needed", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Pearls", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "One should target oxygen saturation between 91-95% to both minimize the risk of ROP and recognize the risk for higher lower mortality at lower saturations", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "The PCO2 may be allowed to increase as long as the infant compensates with normal pH", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "May allow permissive hypercapnea and pH of 7.2-7.35", "type": "content"}, {"id": "rds", "title": "RDS", "path": "RESPIRATORY PROBLEMS > RDS", "content": "Vitamin A injections are given to ELBW infants 3x/week x 12 doses if they need oxygen during the first 96 hours to decrease the incidence of BPD", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "type": "h2"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Sustained elevation of pulmonary vascular resistance (PVR) after birth, which leads to right\ud83e\udc6a left shunting across a PFO or PDA, which then results in an inability to oxygenate blood", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Causes:", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Idiopathic", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "MAS", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Sepsis/pneumonia", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Asphyxia", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "CDH", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "CHD", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Pulmonary parenchymal disease", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Diagnosis", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "If mild PPHN is present, a hyperoxia challenge may be useful:", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Check PaO2", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Place baby in 100% O2 environment for 30 minutes - 1 hr", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "If arterial pO2 >150, PPHN is unlikely", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "If PaO2 does not change, PPHN or congenital cyanotic heart disease (CHD) may be present  echocardiogram is indicated.", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Management", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Achieving oxygen saturations above 92%, dilates pulmonary vascular beds", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Consider surfactant early in the disease process if infant has impending need for ECMO", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "iNO after adequate recruitment can also cause pulmonary vasodilation", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Correction of acidosis", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Mechanical ventilation or High Frequency Ventilation", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Maintenance of good systemic blood pressures (may require volume replacement)", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Maintenance of cardiac output to try to overcome PVR (may require fluid boluses, pressors, inotropes, paralysis & sedation)", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "ECMO if OI >40 or PaO2<40-50 on maximal support for > 4-6 hrs", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Pearls", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "OI=oxygenation index: (FiO2*MAP)/PaO2", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Low numbers are better. If OI >40, indication for ECMO!", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "Consider an echo in all infants with suspected PPHN as it can present similarly to congenital heart disease!", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "PPHN is a different entity than pulmonary hypertension experienced by infants with BPD", "type": "content"}, {"id": "pphn", "title": "PPHN", "path": "RESPIRATORY PROBLEMS > PPHN", "content": "PPHN is often associated with infection, so consider antibiotics on any infant diagnosed with PPHN until sepsis is ruled out", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "type": "h2"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Cause: Acute or chronic hypoxemia due to meconium aspirated before or during birth", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Diagnosis", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Meconium history", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "CXR abnormalities", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Hypoxemia", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Management", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Ventilatory support starting with increasing FiO2 & progressing to mechanical ventilation (and ECMO if needed)", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Pulmonary hypertension (PPHN) may develop", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "These infants are at risk for pneumothorax & pneumomediastinum", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "Pearls", "type": "content"}, {"id": "mas", "title": "MAS", "path": "RESPIRATORY PROBLEMS > MAS", "content": "If called to a delivery for meconium, we previously intubated and suctioned below the cords if a baby was non-vigorous; however, this was not found effective in studies and is no longer routine care", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "type": "h2"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Cause", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Transient pulmonary edema due to delayed reabsorption of fetal lung fluid by lymphatics", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Infants most at risk are those born precipitously, with macrosomia, via C/S, or maternal narcotic administration", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Diagnosis", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "PE findings of cyanosis, grunting/flaring/retracting in term or near-term infants that develops within 6h of delivery", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "CXR reveals prominent perihilar streaking, coarse, fluffy densities, & air-trapping", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Diff Dx includes pneumonia/ sepsis, RDS, congenital malformation (such as congenital diaphragmatic hernia), CNS insults causing central hypoventilation", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Management", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Supplemental oxygen if needed", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Other basic supportive measures such as IVF or OG feedings if the baby is too tachypneic to be fed PO (>60 to 80 breaths/min)", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Restricting fluids in the first few days of life", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Pearls", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Babies should not have an O2 requirement >40% or require mechanical ventilation (this is probably not TTN)", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "Can this be treated in WBN? Usually not. If requiring O2, will need transfer to RNICU.", "type": "content"}, {"id": "ttn", "title": "TTN", "path": "RESPIRATORY PROBLEMS > TTN", "content": "If simply tachypneic, may do CBC, blood cx, possibly LP & watch in WBN", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "type": "h2"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Causes", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Volutrauma from mechanical ventilation", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Airway and vascular tone may be altered", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Can develop emphysematous changes", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Diagnosis", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Traditional definition: O2 requirement for the first 28 days of life.", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Physiologic definition: In babies <32 wga, classified by oxygen requirement when baby reaches 36 wga", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "mild BPD: no supplemental O2 requirement", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "moderate BPD: supplemental O2 <30%", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Management", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Supplemental oxygen and/or respiratory support as needed", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Minimize further barotrauma if possible", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Treat hemodynamically significant PDA\u2019s in infants unable to be weaned from vent", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Restrict fluids (maybe 120-140 mL/kg/day rather than 160-180)", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Diuretics if having pulmonary fluid retention (furosemide, chlorothiazide)", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Albuterol or ipratropium", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Courses of steroids if increased respiratory distress", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Pearls", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Watch electrolytes on babies who are on diuretics\u2014hyponatremia, hypokalemia, and hypochloremia are common", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Periodically get an ECHO on these babies (usually monthly) to monitor for pulmonary hypertension as well as trending BNPs (usually every Monday)", "type": "content"}, {"id": "bpd", "title": "BPD", "path": "RESPIRATORY PROBLEMS > BPD", "content": "Perform an oxygen reduction challenge at 36 wga (corrected) for any infant born at <32 weeks, who remains on O2 via NC or OE (not CPAP or higher support)", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "type": "h2"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Cause: Vascular remodeling due to prolonged lung disease and chronic hypoxic events", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Diagnosis:", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Clinical findings: infant with BPD with inability to oxygenate despite adequate ventilation and lung recruitment.", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Elevated BNP", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Echocardiographic findings (e.g. flattened intraventricular septum, septal bulging into RA, significant triscupid regurgitation, etc)", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Management", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Supplemental oxygen and/or respiratory support as needed (prevent further hypoxemia)", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Improve lung recruitment through ventilator maneuvers", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Consider a trial of iNO AFTER the infant is adequately recruited", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Sedatives and paralytics may be beneficial", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Systemic vasodilators (sildenafil or milrinone) may decrease vascular resistance", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Maintain adequate perfusion with potential use of vasopressors", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Pearls:", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "iNO can help improve sats even when the cause for hypoxemia is not PHTN. i.e. iNO can make your sats increase if you simply have V/Q mismatch. This is why it is important to recruit prior to starting ", "type": "content"}, {"id": "bpd/phtn", "title": "BPD/PHTN", "path": "RESPIRATORY PROBLEMS > BPD/PHTN", "content": "Infection (viral or bacterial) often push BPD infants \u201cover the edge\u201d into a pulmonary hypertensive crisis. Look for a source if this suddenly occurs!", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "type": "h2"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "In the NICU apnea is defined as no breathing effort for > 20 sec, or for shorter durations that is associated with significant bradycardia and desaturations", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Should be differentiated from periodic breathing (pauses of up to 10 seconds with desaturations/bradycardias that do not need intervention", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Apnea of prematurity", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Caused by immature respiratory control in infants born preterm (<37 weeks)", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Occurs in almost all infants < 28 weeks GA", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Mostly central or mixed. Can also be obstructive.", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Central \u2013 no respiratory effort detected", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Obstructive \u2013 ineffective respiration", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Mixed \u2013 Central followed by obstructive (or) obstructive followed by central apnea. Longer apneic episodes are often mixed.", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Usually clinically evident between 24-72 hours of life", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Apnea of prematurity is a diagnosis of exclusion and other causes should be always considered, especially in infants > 28 weeks GA", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Other causes that should be considered, especially in infants > 28 weeks include", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Maternal MgSO4, opioid, general anesthesia exposure", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Sepsis: screening labs such as CBC, UA, CRP; may require blood/urine/CSF cultures and antibiotics", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Hypoglycemia: check POC glucose", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Hypothermia (link to Temperature management chapter)", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "NEC: clinical signs of feeding intolerance, KUB showing signs of NEC", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "IVH: may require HUS", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "HIE, seizures", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Anemia: in preterm infants > 1 month of age, Hct < 25 associated with increased apneic events", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Airway anomalies: if noted to be predominantly obstructive may need airway evaluation and ENT consult", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "PGE1 use in infants with CHD", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Inborn errors of metabolism", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Congenital hypoventilation syndrome", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Management of apnea of prematurity", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Methylxanthines: Caffeine stimulates respiratory output by inhibiting adenosine receptors.", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Consider starting and continuing caffeine (loading followed by maintenance) on all ELBW infants admitted to the NICU irrespective of respiratory support", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Sinus tachycardia and SVT are complications of caffeine therapy. that usually occur only with caffeine dosing > 15-20 mg/kg/day", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Discontinuing caffeine can be attempted beginning around 32-34 weeks once infant has had at least 5 days without apneas that required intervention and is off respiratory support", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "CPAP/NIPPV: can be useful for decreasing obstructive/mixed apneas in infants who are not on SIMV and continue to remain apneic despite maximal therapy", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Transfusion: Consider maintaining Hct > 25-30 in infants with persistent apneic episodes that require intervention despite maximal caffeine therapy", "type": "content"}, {"id": "apnea", "title": "Apnea", "path": "RESPIRATORY PROBLEMS > Apnea", "content": "Though caffeine can offer symptomatic relief, management of apneas due to other etiologies requires careful evaluation and treatment of underlying causes.", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "type": "h2"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Caused by developmental failure of the posterolateral diaphragm and persistence of the foramen of Bochdalek (less commonly anterior diaphragm and foramen of Morgagni) which allows abdominal contents t", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "A weakness in the diaphragm rather than failed closure leads to diaphragmatic eventration which is typically not associated with lung hypoplasia", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "CDH is typically diagnosed on prenatal US (around 16-20 weeks GA)", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Rarely may go undiagnosed, especially when mom has not received adequate prenatal care", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Symptoms include severe respiratory distress, cyanosis, scaphoid abdomen, decreased breath sounds in the left chest, heart sounds displaced to the right", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "CXR typically shows bowel loops in the chest, decreased pulmonary markings and lung expansion", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Prognosis is worse with", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Presence of associated anomalies and cardiac dysfunction", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Severe lung hypoplasia: lung head ratio (LHR) < 0.6 has an almost 0% chance of survival; LHR > 1.35 has an almost 100% of survival", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Presence/absence of liver herniation", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Pre/Perinatal management", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Antenatal: Prenatal closure of CDH hasn\u2019t been shown to improve survival", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Delivery room: Avoid BMV, but otherwise follow NRP,; majority will need endotracheal intubation, target saturations > 90% by 10 minutes of life;  insert an OG/NG for bowel decompression", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "In the NICU", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Inform CoA Neonatal Fellow/Attending and transfer to the CoA NICU as soon as possible", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Monitor both pre and post ductal saturations; typical target saturations 92-97%", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Place UAC/UVC or PICC; consider obtaining a radial arterial line if UAC fails", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "Both SIMV and HFOV offer similar benefits for infants with CDH; HFOV is typically used as a rescue mode if SIMV fails to provide adequate oxygenation/ventilation", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "May require pressors such as dopamine/dobutamine/vasopressin/epinephrine for hemodynamic support", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "If > 10% difference between preductal and postductal saturations noted, begin iNO @ 20 ppm. May require milrinone as well.", "type": "content"}, {"id": "cdh", "title": "CDH", "path": "RESPIRATORY PROBLEMS > CDH", "content": "ECMO: Required when unable to maintain O2 saturations > 90%, pH > 7.15 despite optimal ventilation strategies and/or metabolic acidosis, hypotension resistant to optimal management with pressors. Can ", "type": "content"}, {"id": "infectious-disease-problems", "title": "INFECTIOUS DISEASE PROBLEMS", "path": "INFECTIOUS DISEASE PROBLEMS", "type": "h1"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "type": "h2"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "type": "h3"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Infections are an important cause for poor outcomes in newborn infants. Prematurely born infants have defective mucosal/cutaneous barriers against invading pathogens as well as poor cellular and humor", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Maternal factors - such as preterm labor, PROM >18hr, chorioamnionitis (indicated by intrapartum fever, maternal or fetal tachycardia, uterine tenderness, foul-smelling discolored amniotic fluid and h", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Typically presents as blood stream infection (rarely as UTI or CNS infection)", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Organisms that cause EOS are usually vertically transmitted from mom", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "GBS in term infants (less frequent these days due to increased maternal screening and treatment for GBS)", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "E.coli in preterm infants (has become more significant in recent years)", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Streptococcus viridans", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Staphyococcus aureus", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Enterococcus fecalis", "type": "content"}, {"id": "early-onset-sepsis", "title": "Early Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Early Onset Sepsis", "content": "Listeria monocytogenes", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "type": "h3"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Risk factors include BW <750g, presence of presence of central catheters, delayed enteral feeding, prolonged TPN, mechanical ventilation, complications of prematurity (BPD, NEC)", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Mostly blood stream infections, though meningitis and UTI risk is higher with LOS than with EOS", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Organisms that cause LOS are usually", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Coagulase negative staphylococci such as S. epidermidis and S. hemolyticus (should not be considered contaminants in the NICU)", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "E.coli", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "S.aureus including MRSA", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Enterococci including VRE", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Klebsiella", "type": "content"}, {"id": "late-onset-sepsis", "title": "Late Onset Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Late Onset Sepsis", "content": "Pseudomonas", "type": "content"}, {"id": "clinical-presentation", "title": "Clinical presentation", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Clinical presentation", "type": "h3"}, {"id": "clinical-presentation", "title": "Clinical presentation", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Clinical presentation", "content": "Sepsis (like most other neonatal illnesses) presents mostly with a constellation of non-specific signs such as tachycardia/bradycardia, tachypnea/intermittent apnea, increased respiratory distress or ", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "type": "h3"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "A high index of clinical suspicion based on maternal/infant history, reports of clinical providers such as bedside nurses regarding changes in infant\u2019s clinical condition and physical examination find", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "HERO scores should be reported at rounds routinely for all ELBW/preterm infants (and term infants at risk for sepsis) and any abnormal trends should prompt careful consideration and further evaluation", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "CRP \u2018at birth\u2019 is unhelpful (as CRP may be normal at onset of infection and may rise and peak around 24-36 hrs after onset), but serial values can be useful to monitor trend as a marker of inflammatio", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "Appropriately performed blood culture (1 mL is advised; a minimum of 0.5 mL of blood should be collected to significantly improve ability to detect true bacterial sepsis) remains the gold standard for", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "Urinalysis, urine culture, CSF cell count/glucose/protein, CSF culture (usually not required for EOS evaluation in preterm infants)", "type": "content"}, {"id": "screening/labs", "title": "Screening/labs", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis > Screening/labs", "content": "CXR/KUB if pneumonia/NEC or other concurrent pulmonary/GI causes are suspected based on clinical status of infant", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "Empiric antibiotic choice", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "EOS: Ampicillin & Gentamicin to cover GBS, E.Coli, & Listeria", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "LOS: Nafcillin + Tobramycin is the first choice unless MRSA risk is high in which case vancomycin + Tobramycin can be used \u00b1 ceftazidime (for double coverage of GNR and meningeal penetration)", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "After culture results are available", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "Median time to culture positivity is for most pathogenic bacteria is 9-36 hours", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "Therefore, empiric antibiotics should be continued for 36 hr and further antibiotic choice should be guided by sensitivity reports", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "If cultures are negative, and infant is clinically well-appearing with stable vitals, antibiotics can be discontinued after discussion with Fellow/Attending", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "Culture-negative sepsis \u2013 rarely, antibiotic therapy may be considered necessary though culture results are  negative, especially for infants who remain critically ill (significant ventilator needs, p", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "If bacteremia is confirmed by positive cultures, a repeat culture should be obtained by the next calendar day", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "Persistently positive blood cultures: Catheter removal, PIV placement for continued antibiotics and placement of a new catheter 24 hours after first negative culture may be required but not always pos", "type": "content"}, {"id": "sepsis", "title": "Sepsis", "path": "INFECTIOUS DISEASE PROBLEMS > Sepsis", "content": "LP if BCX +ve?", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "type": "h2"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "GBS, E.coli, other GPs like enterococcus, CONS, other GN such as Neisseria meningitidis.", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "CSF WBCs > 15 cells/\u00b5L should prompt consideration for meningitis dosing of antibiotics (correction for blood in CSF due to traumatic taps is typically not needed).", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "Other CSF indices: Protein:  > 150 in preterm and > 100 in term is abnormal CSF glucose < 30 is considered indicative of bacterial meningitis", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "Management:", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "Early onset: Ampicillin+Gentamycin+ceftazidime is a common choice", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "Late onset: Vancomycin + tobramycin + ceftazidime (if listeria/GBS/enterococci suspected can add ampicillin as well)", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "If cultures positive, antibiotics should be continued for a minimum of 3 weeks", "type": "content"}, {"id": "meningitis", "title": "Meningitis", "path": "INFECTIOUS DISEASE PROBLEMS > Meningitis", "content": "Get ID consult and order HUS/CT/MRI near the end of antibiotic course to assess degree of brain injury and complications such as abscesses that may require longer courses.", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "type": "h2"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "E.coli, Klebsiella, Proteus and CONS, Enterococcus in term infants, CONS, Klebsiella, E.coli and Candida in preterm infants are common causes", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "UA/Urine Culture is best obtained from suprapubic aspiration (though rarely performed in our NICU), next best is I&O catheterization and prior to initiation of antibiotics", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Bacterial growth: any species >50,000 CFU/mL in samples collected through catherization", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Management:", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Ampicillin / Gentamicin x 10-14 days", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Can use Vancomycin for later onset (>7d) in some hospitalized infants", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Target antibiotics when known previous UTI with identified organism", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Renal Ultrasound (RUS) should be performed when infection is detected. VCUG should be considered on infants with UTI. VCUG should not be performed until a negative urine culture has been documented", "type": "content"}, {"id": "uti", "title": "UTI", "path": "INFECTIOUS DISEASE PROBLEMS > UTI", "content": "Infants should not be placed on antibiotic prophylaxis unless indicated. If desired, obtain consultation from Pediatric Infectious Disease subspecialist and urologic surgery services", "type": "content"}, {"id": "focal-bacterial-infections", "title": "Focal bacterial infections", "path": "INFECTIOUS DISEASE PROBLEMS > Focal bacterial infections", "type": "h2"}, {"id": "gbs-algorithm", "title": "GBS algorithm", "path": "INFECTIOUS DISEASE PROBLEMS > GBS algorithm", "type": "h2"}, {"id": "viral-infections", "title": "Viral Infections", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections", "type": "h2"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "type": "h3"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Transmission", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Intrapartum exposure via maternal genital tract", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Postnatal exposure to infected breast milk", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Infected blood/blood products", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Nosocomial via saliva or urine", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Clinical Presentation", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Congenital early: acute fulminant (petechiae/purpura, HSM, prematurity, IUGR, \u201cblueberry muffin\u201d spots, transaminitis, hyperbilirubinemia, anemia, thrombocytopenia) vs symptomatic without life-threate", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Asymptomatic congenital: later presentation with dev abnormalities, hearing loss,chorioretinitis, acquired microcephaly", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "CMV pneumonitis: PT infants <4mo", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Diagnosis", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "PCR of saliva or urine (if baby has eaten, highest sensitivity), considered congenital if found within first 2 wks of life vs perinatal if negative in first 2 wks but positive after 4wk of life", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Congenital CMV workup: CBC, LFTs, eye exam, abdominal US, monitor head circumference", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Treatment", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Ganciclovir, Valganciclovir", "type": "content"}, {"id": "cmv-(cytomegalovirus)", "title": "CMV (Cytomegalovirus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > CMV (Cytomegalovirus)", "content": "Will need ID consult for outpt FU & close audiology FU", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "type": "h3"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Transmission", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Most Mothers of infants with neonatal HSV do not have a history of HSV", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Intrapartum transmission increases with ROM >4hr, direct fetal monitoring (ie scalp probes)", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Antenatal transmission is uncommon", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Postal transmission from oropharyngeal shedding, maternal breast lesions", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Clinical Presentation", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Skin, eye, and/or mouth: vesicular presentation, can develop neurologic impairment & keratoconjuncitivis therefore need opthalmology and neuro follow up", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Encephalitis +/- mucocutaneous disease: symptomatic at 10-14 d of life with lethargy, seizures, temp instability, & hypotonia, high mortality with late or absent treatment", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Disseminated: most severe form, presents within 1st week of life with seizures, respiratory distress/failure, shock, DIC reflecting involvement of liver, adrenals, and other visceral organs, 20% may b", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Strongly consider HSV in any neonate admitted for concerns of sepsis, hypothermia, seizures etc in the first 2 weeks of life, even if there is no maternal history \u2013 as most neonatal infections are fro", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Diagnosis", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Blood & CSF HSV PCR", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Viral culture of eye/nose/mouth/anus", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Treatment", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Acyclovir x14d (21+ days with evidence of CNS/disseminated dz, longer of CSF PCR positivity persists)", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "-Women with known clinical/serologic evidence of HSV-2 are offered acyclovir near term until delivery", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "-refer to RedBook recommendations & Kimberlin, et al Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions PMID: 23378604", "type": "content"}, {"id": "hsv-(herpes-simplex-virus):-see-algorithm-below", "title": "HSV (Herpes Simplex Virus): See algorithm below", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HSV (Herpes Simplex Virus): See algorithm below", "content": "Kimberlin et al, Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions. Pediatrics. February 2013, Vol 131, Issue 2", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "type": "h3"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Transmission", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Antenatally (maternal sx asymptomatic vs arthralgias, rash), worse when contracted in 2nd/3rd trimester", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Clinical Presentation", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Children, Adults, & Immunosuppressed patient presentation not described here", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Fetal: implicated in 10% non-immune hydrops (maternal primary infection \ud83e\udc6atransplacental transfer of virus\ud83e\udc6aRBC precursor infection\ud83e\udc6aarrested RBC production \ud83e\udc6asevere anemia\ud83e\udc6acongestive heart failure\ud83e\udc6aedema,", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Diagnosis", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Blood PCR (OB may obtain PCR or IgM via PUBS, percutaneous umbilical blood sampling if hydrops detected)", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Treatment", "type": "content"}, {"id": "parvovirus", "title": "Parvovirus", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Parvovirus", "content": "Supportive (OB may opt to perform intrauterine blood transfusion for severe hydrops fetalis)", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "type": "h3"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Transmission", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Congenital & Perinatal transmission: as early as 14-20wga but most commonly during 3rd trimester/delivery", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Sexual and parenteral transmission not described here", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Clinical Presentation", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Infants: usually asymptomatic at birth with sx presenting >2wk of life (lymphadenopathy, HSM, poor weight gain, occasionally encephalopathy), initially high viral lode that declines over first 5yr of ", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "HIV in pregnancy not discussed here", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Children: un-diagnosed symptoms occur in first yr of life (medium age 9mo)", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Diagnosis", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Mother known HIV-infected: HIV DNA PCR if mother known HIV-infected, RNA PCR if mother not treated, positive within 3d of life are considered infected in utero vs those test negative in 1st 3d of life", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Mother unknown HIV status: immediately obtain rapid HIV testing on mother unless mother refuses. If positive, zidovudine and nevirapine should be started on infant immediately if baby is less than 48 ", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "HIV workup: CBC, AST/ALT, HIV DNA PCR for 0600 on DOL #1 for all HIV-exposed newborns", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Treatment", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "ALL infants born to HIV positive women must begin Zidovudine (AZT) after delivery with 1st dose given given before 6 hours of life. Neviripine should also be given in certain high-risk situations (see", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Use Newborn HIV Exposed Infants power plan to order labs and pharmacy consult. Use Newborn Medications power plan to order meds.", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Breastfeeding contraindicated in all HIV positive women in US", "type": "content"}, {"id": "hiv-(human-immunodeficiency-virus)", "title": "HIV (Human Immunodeficiency Virus)", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > HIV (Human Immunodeficiency Virus)", "content": "Must obtain pharmacy discharge consult for AZT supply and teaching & order >24 hours prior to anticipated discharge. Notify Family Clinic 939-9400, HIV study nurse at 996-6418 or 996-7831, and Jeffers", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "type": "h3"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Transmission", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Congenital: highest rate of fetal infection during first 12-16wk and last 10wk of gestation, with early-gestation infection resulting in multiple organ anomalies (most commonly cardiac defect & deafne", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Clinical Presentation", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Infants: cataracts, sensorineural hearing loss, and CHD (PDA, pulmonary artery stenosis) with common early sx (IUGR, microphthalmia, meningocencephalitis, hypotonia, HSM, thrombocytopenia purpura, rad", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Maternal history: if present, malaise, low-grade fever, headache, mild corzya, and conjunctivitis 1-5d prior to salmon-pink macular rash that spreads downward", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Diagnosis", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Isolation of rubella virus (oropharynx or urine, latter has highest sensitivity), Rubella-specific IgM (cord or neonatal blood), persistent rubella-specific titers", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "Treatment", "type": "content"}, {"id": "rubella", "title": "Rubella", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Rubella", "content": "None. If infection known to have occurred >20thwk of gestation, unlikely any abnormalities however close audiology FU should occur.", "type": "content"}, {"id": "hepatitis-b", "title": "Hepatitis B", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Hepatitis B", "type": "h3"}, {"id": "hepatitis-b", "title": "Hepatitis B", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Hepatitis B", "content": "Refer to Manual of Neonatal Care for more detail regarding all types of Hepatitis viruses", "type": "content"}, {"id": "hepatitis-b", "title": "Hepatitis B", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Hepatitis B", "content": "Diagnosis: Check maternal HbsAg status", "type": "content"}, {"id": "hepatitis-b", "title": "Hepatitis B", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Hepatitis B", "content": "Treatment\ta.\t See Table below", "type": "content"}, {"id": "varicella-zoster", "title": "Varicella-Zoster", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Varicella-Zoster", "type": "h3"}, {"id": "varicella-zoster", "title": "Varicella-Zoster", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Varicella-Zoster", "content": "Greatest risk for severe disease occurs when primary maternal infection occurs 5 days prior to or 2 days after delivery", "type": "content"}, {"id": "varicella-zoster", "title": "Varicella-Zoster", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Varicella-Zoster", "content": "infected infants should be isolated in separate room,", "type": "content"}, {"id": "varicella-zoster", "title": "Varicella-Zoster", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections > Varicella-Zoster", "content": "all neonates <28wga should be given VariZIG or IVIG postexposure regardless of maternal status", "type": "content"}, {"id": "viral-infections", "title": "Viral Infections", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections", "content": "Synagis (Palivizumab) prophylaxis per 2014 AAP Policy Statement", "type": "content"}, {"id": "viral-infections", "title": "Viral Infections", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections", "content": "Infants <12mo at start of RSV season who were born <29wk may receive up to 5 doses given monthly", "type": "content"}, {"id": "viral-infections", "title": "Viral Infections", "path": "INFECTIOUS DISEASE PROBLEMS > Viral Infections", "content": "Infants <12mo at start of RSV season with chronic lung disease (CLD) as defined as GA <32 & O2 requirement >21% for at least first 28d after birth may receive up to 5 doses given monthly (see policy s", "type": "content"}, {"id": "syphilis", "title": "Syphilis", "path": "INFECTIOUS DISEASE PROBLEMS > Syphilis", "type": "h2"}, {"id": "cardiovascular-problems", "title": "CARDIOVASCULAR PROBLEMS", "path": "CARDIOVASCULAR PROBLEMS", "type": "h1"}, {"id": "prenatal-and-postnatal-circulation", "title": "Prenatal And Postnatal Circulation", "path": "CARDIOVASCULAR PROBLEMS > Prenatal And Postnatal Circulation", "type": "h2"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "type": "h2"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Timing and symptoms depend on", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "nature and severity of the anatomic defect", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "PDA closure", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "fall in pulmonary vascular resistance", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Cyanosis:", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Decreased pulmonary blood flow with intracardiac R to L shunt", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Normal pulmonary blood flow with intracardiac mixing of systemic and pulmonary venous return.", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "CHF:", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Tachycardia, tachypnea, crackles, hepatomegaly, delayed cap refill, diaphoresis, growth failure, feeding difficulty.", "type": "content"}, {"id": "chd-patterns-of-clinical-presentations", "title": "CHD Patterns of Clinical Presentations", "path": "CARDIOVASCULAR PROBLEMS > CHD Patterns of Clinical Presentations", "content": "Heart murmur, Arrhythmias, Cardiogenic shock", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "type": "h2"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Required to keep PDA open for CHDs in which ductal flow is required to maintain adequate  pulmonary or systemic (sometimes both) circulation", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "List of infants with CHDs who might be born during the month is circulated via email to Fellow/Attending. As soon as you are aware of impending delivery of an infant with CHD", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Always check with Fellow if PGE2 is required", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "If required, pre-order PGE2 (can begin at 0.05 mcg/kg/min and titrate later)", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Response: expect a clinical response in 15-30 minutes for cyanotic CHD (smooth muscle of ductus is particularly sensitive) and 1-3 hrs for non-cyanotic CHD (relaxation of pulmonary vasculature not as ", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "If decompensation is noted after starting, a lesion with impaired left-heart return may exist; stop infusion immediately.", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Contraindications to PGE are processes obstructing left heart return (because keeping the PDA open may lead to more shunting away from systemic circulation): Obstructive TAPVR (infradiaphragmatic), co", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Complications include apnea, hypotension, fever, tachycardia/bradycardia, seizure", "type": "content"}, {"id": "prostaglandin-infusion", "title": "Prostaglandin infusion", "path": "CARDIOVASCULAR PROBLEMS > Prostaglandin infusion", "content": "Monitor carefully for apnea; may require caffeine therapy", "type": "content"}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD", "type": "h2"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "type": "h3"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Closed in 50% of full-term infants by 24h, 90% by 48h, >99% by 96h; in contrast spontaneous closure occurs only in 38%-85% of babies <1500g and in 25-34% of those <1000g", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Other risk factors: No exposure to antenatal steroids, excessive fluid intake (especially in the first 2 weeks for ELBW infants), critical illness due to other causes in ELBW infants", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "When to suspect a PDA", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Harsh systolic ejection murmur over entire chest", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Widened pulse pressure (palmar pulses)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "No consensus exists regarding what is considered a hemodynamically significant PDA; however, the possibility should be explored when a PDA is associated with", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Worsening respiratory status and/or inability to wean from high SIMV settings (especially in ELBW/VLBW infants)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Pulmonary \u201csteal\u201d which can lead to", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Pulmonary hypertension, edema", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Renal failure", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "NEC", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Metabolic acidosis", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "IVH, PVL", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Obtain an ECHO for ELBW infants who are suspected to have a HS-PDA. Findings", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Large PDA (> 2 mm in size)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "LA enlargement (LA:Ao ratio > 1.4)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Significant L\ud83e\udc6aR flow across PDA", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "HS-PDA incidence and complications can be prevented or minimized over the first 2 weeks of life by", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Careful attention to fluid intake/output in all ELBW infants (continued transition to enteral feeds can help limit parenteral fluid intake from IVF/TPN)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Avoid loop diuretics such as furosemide (increases prostaglandin production which can cause ductus to remain patent)", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Medical closure:", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Indomethacin is most commonly used", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Contraindications \u2013 active clinical bleeding, on steroids, Cr>1.8, UOP < 0.6 ml/kg/hr, platelets <60,000, NEC, worsening IVH", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Ibuprofen", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Relative contraindications \u2013 oliguria, steroid use", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Acetaminophen", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Relative contraindications \u2013 elevated liver enzymes", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Continue trophic feeds during medical management and increase feeds after treatment complete", "type": "content"}, {"id": "patent-ductus-arteriosus-(pda)", "title": "Patent Ductus Arteriosus (PDA)", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Patent Ductus Arteriosus (PDA)", "content": "Surgical/transcatheter closure may be considered in older infants (> 1 month of age) if medical closure does not succeed and if PDA closure is considered necessary", "type": "content"}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Persistent fetal circulation", "type": "h3"}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Persistent fetal circulation", "content": "Pulmonary vascular resistance fails to decrease causing PVR to continue to remain supra-systemic, resulting in R to L shunting of blood", "type": "content"}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Persistent fetal circulation", "content": "Most often noted in term infants with perinatal hypoxia/difficult resuscitation/meconium aspiration", "type": "content"}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Persistent fetal circulation", "content": "Can progress to persistent pulmonary hypertension (PPHN)", "type": "content"}, {"id": "persistent-fetal-circulation", "title": "Persistent fetal circulation", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Persistent fetal circulation", "content": "Can present with respiratory distress shortly after delivery, post-ductal sat< pre-ductal sat (desaturated blood reaching descending aorta)", "type": "content"}, {"id": "coarctation-of-the-aorta", "title": "Coarctation of the aorta", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Coarctation of the aorta", "type": "h3"}, {"id": "coarctation-of-the-aorta", "title": "Coarctation of the aorta", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD > Coarctation of the aorta", "content": "Findings: decreased perfusion/pulses/BP in lower extremities, signs of congestive heart failure, metabolic acidosis, lethargy", "type": "content"}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD", "content": "Resulting from the underdevelopment of the L side of the heart (LV, aortic valve and aorta)", "type": "content"}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD", "content": "Therefore, systemic perfusion with oxygenated blood depends on the presence of a ASD which permits a LA\ud83e\udc6aRA shunt followed by a R\ud83e\udc6aL shunt through the PDA.", "type": "content"}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD", "content": "Management (both coarc and HLHS)", "type": "content"}, {"id": "non-cyanotic-chd", "title": "Non-Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Non-Cyanotic CHD", "content": "Maintain PDA with prostaglandin drip to keep blood flow to the descending aorta. Surgical correction.", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "type": "h2"}, {"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Truncus Arteriosus", "type": "h3"}, {"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Truncus Arteriosus", "content": "Usually presents with symptoms of CHF (treated with digoxin/diuretics) as well as cyanosis (typical O2 saturations between 80-90)", "type": "content"}, {"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Truncus Arteriosus", "content": "Avoid supplemental O2 because this will only further dilate pulmonary vasculature and lead to pulmonary overcirculation/hypertension", "type": "content"}, {"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Truncus Arteriosus", "content": "Always screen for DiGeorge (and Ca levels)", "type": "content"}, {"id": "truncus-arteriosus", "title": "Truncus Arteriosus", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Truncus Arteriosus", "content": "No real role for PGE here as not ductal dependent", "type": "content"}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Transposition of the Great Arteries", "type": "h3"}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Transposition of the Great Arteries", "content": "Aorta arises from desaturated RV, and pulmonary artery arises  from oxygenated LV.  So get parallel circuits of flow that is dependent on mixing for survival", "type": "content"}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Transposition of the Great Arteries", "content": "Blood mixing must occur either through the foramen ovale or PDA (so DO start PGE here)", "type": "content"}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Transposition of the Great Arteries", "content": "Findings: tachypnea, loud and single 2nd heart sound (bc anterior position of aorta coming off RV) , CXR shows EGG shape heart with increased pulmonary vascularity (opposite to TOF), generally has NO ", "type": "content"}, {"id": "transposition-of-the-great-arteries", "title": "Transposition of the Great Arteries", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Transposition of the Great Arteries", "content": "Most common cyanotic heart defect identified in 1st week of life*", "type": "content"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "type": "h3"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "content": "No communication btw RA and RV, so pulmonary circulation compromised.", "type": "content"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "content": "Blood from systemic circulation goes RA\ud83e\udc6acrosses ASD (must have this for survival)\ud83e\udc6amixes in LA with oxygenated blood\ud83e\udc6a pulmonary blood flow through PDA and/or a VSD", "type": "content"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "content": "Presents early on with cyanosis", "type": "content"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "content": "Do start PGE here as PDA allows for improved pulmonary blood flow", "type": "content"}, {"id": "tricuspid-atresia", "title": "Tricuspid Atresia", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tricuspid Atresia", "content": "Pulmonary atresia and Ebsteins anomaly are similar", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "type": "h3"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "Most common cyanotic heart condition overall.  Hypoxia related to degree of RV outflow obstruction.", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "Components: Pulmonary stenosis, RVH, VS  D, overriding aorta", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "DO start PGE here to help augment pulmonary blood flow", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "Can be asymptomatic early on and not present until 3-5 months of age", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "Findings: single 2nd heart sound, BOOT-shaped heart with decreased pulmonary vascularity on CXR.", "type": "content"}, {"id": "tetralogy-of-fallot", "title": "Tetralogy of Fallot", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD > Tetralogy of Fallot", "content": "Tet spell: hypercyanotic hypoxic episodes resulted from increased R to L shunting during an acute episode", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "content": "\u201cAnomalous\u201d drainage of oxygenated pulmonary venous blood back into the RA instead of the LA", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "content": "Systemic blood flow dependent on shunting from RA  to LA across PFO/ASD (essential for survival)", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "content": "Range of mild to severe hypoxia based on any obstruction of pulmonary venous return (depends on where the veins are draining.  If infracardiac- may pass through diaphragm which puts at risk for severe", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "content": "Findings: fixed split S2, short systolic murmur, CXR with SNOWMAN (heart bc dilated mediastinal veins), and PULMONARY EDEMA (bc pulmonary vein obstruction)", "type": "content"}, {"id": "cyanotic-chd", "title": "Cyanotic CHD", "path": "CARDIOVASCULAR PROBLEMS > Cyanotic CHD", "content": "So PGE doesn\u2019t really have a role here bc not ductal dependent", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "type": "h2"}, {"id": "general-pointers-to-tachycardia-or-bradycardia", "title": "General Pointers to tachycardia or bradycardia", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > General Pointers to tachycardia or bradycardia", "type": "h3"}, {"id": "general-pointers-to-tachycardia-or-bradycardia", "title": "General Pointers to tachycardia or bradycardia", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > General Pointers to tachycardia or bradycardia", "content": "Gradual onset: Repetitive firing from a single focus such as the sinus node", "type": "content"}, {"id": "general-pointers-to-tachycardia-or-bradycardia", "title": "General Pointers to tachycardia or bradycardia", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > General Pointers to tachycardia or bradycardia", "content": "Abrupt and frequent: Bursts of activity from a single pathologic focus", "type": "content"}, {"id": "general-pointers-to-tachycardia-or-bradycardia", "title": "General Pointers to tachycardia or bradycardia", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > General Pointers to tachycardia or bradycardia", "content": "Abrupt onset, sustained rate, and abrupt termination: Usually due to reentrant mechanisms", "type": "content"}, {"id": "premature-complexes", "title": "Premature Complexes", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Premature Complexes", "type": "h3"}, {"id": "premature-complexes", "title": "Premature Complexes", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Premature Complexes", "content": "Atrial - P wave that begins before the T wave ends, PVC \u2013 QRS complex without a preceding P wave that is different in shape/height vs. other QRS complexes", "type": "content"}, {"id": "premature-complexes", "title": "Premature Complexes", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Premature Complexes", "content": "Occasional PACs and PVCs are frequently noted in preterm newborns and to a lesser extent in term newborns", "type": "content"}, {"id": "premature-complexes", "title": "Premature Complexes", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Premature Complexes", "content": "If frequent, perform 12-lead EKG/echocardiogram, ensure that infant has normal S.electrolytes, central catheter positioning, and consult cardiology", "type": "content"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "type": "h3"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "content": "Sinus bradycardia: Most commonly due to non-cardiac causes such as hypothyroidism, cardio-respiratory failure, acidosis etc.; treating underlying cause", "type": "content"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "content": "Heart block", "type": "content"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "content": "Due to AV conduction disturbances caused by infections, metabolic or congenital abnormalities", "type": "content"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "content": "1st degree block due to PR interval prolongation; 2nd degree block due to intermittent transmission of atrial impulses to the ventricles, 3rd  degree (complete) heart block occurs due to complete fail", "type": "content"}, {"id": "common-bradycardias", "title": "Common Bradycardias", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders > Common Bradycardias", "content": "Complete block is usually due to maternal autoimmune disorders (such as SLE) and often requires pacemaker placement when HR persistently < 55 bpm, or when the EKG shows complex ventricular ectopy or d", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "content": "If the QRS complex during the tachycardia episode is narrow and similar in shape to the QRS complex before the onset of tachycardia, then the pathology is almost always supraventricular in origin", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "content": "If the QRS complex is wide then the pathology is usually ventricular, but may also be supraventricular", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "content": "SVT vs. Sinus Tachycardia", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "content": "Long QT syndrome", "type": "content"}, {"id": "cardiac-rhythm-disorders", "title": "Cardiac Rhythm Disorders", "path": "CARDIOVASCULAR PROBLEMS > Cardiac Rhythm Disorders", "content": "Defective K+ channel function which delays cardiac repolarization and can cause VT with varying QRS morphology. Can be treated with \u03b2-blockers.", "type": "content"}, {"id": "gastrointestinal-problems", "title": "GASTROINTESTINAL PROBLEMS", "path": "GASTROINTESTINAL PROBLEMS", "type": "h1"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "type": "h2"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "Gastric residuals and what they mean", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "There is paucity of evidence to support utility of checking gastric residuals in the diagnosis of NEC or feeding intolerance", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "In the absence of other symptoms, there is no evidence to support the discontinuation of feeds based ONLY on gastric residuals.", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "Residuals are checked selectively in the RNI now (no longer performed as a routine practice!)", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "Although new-onset and large amounts of gastric residuals or changes from previous patterns have been proposed as a diagnostic tool for NEC, gastric residuals are poor clinical predictors of NEC.", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "Checking gastric residuals delays time to full feeding without decreasing the risk of NEC.", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "It is hard to define the accuracy of measurements because the technique is not standardized", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "Because acid production in the stomach limits bacterial overgrowth and facilitates protein digestion, it is advisable not to aspirate the stomach content of preterm infants.", "type": "content"}, {"id": "ileus/feeding-intolerance", "title": "Ileus/Feeding Intolerance", "path": "GASTROINTESTINAL PROBLEMS > Ileus/Feeding Intolerance", "content": "If clinical picture and diagnostics/imaging show low risk for NEC or other abdominal emergencies, consider ileus/feeding intolerance. May need NPO for bowel rest, start TPN/IVF, monitor response. If i", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "type": "h2"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Definition: Acute intestinal necrosis of unknown etiology. It has been suggested that altered patterns of intestinal colonization initiate an unbalanced pro-inflammatory cascade resulting in intestina", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Epidemiology:", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Clinical: Early attention to clinical symptoms of feeding intolerance including abdominal distension, bloody stools and emesis is essential.", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Systemic sx: Similar to sepsis; respiratory distress, A/Bs, lethargy, temp instability, irritability, poor feeding, hypotension, poor perfusion, acidosis, oliguria", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Abdominal sx: distention, tenderness, vomiting (esp blood/bile), ileus (BS), abdominal wall erythema/discoloration, ascites, blood-tinged stool", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Differentials: Ileus, meconium peritonitis, surgical abdominal catastrophe (malrotation with obstruction/malrotation, gastric perforation, mesenteric vessel thrombosis), spontaneous intestinal perfora", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Diagnosis: The clear presence of pneumatosis intestinalis is diagnostic in the presence of other clinical symptoms.", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Management:", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Risk Assessment: If NEC is suspected, perform risk assessment.", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Other important considerations to assess risk:", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Presence of emesis", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Presence of frank blood in stools (guaiac + stools are common in NG fed infants and therefore not a useful indicator of NEC)", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Presence of the triad of metabolic acidosis, thrombocytopenia, and hyponatremia", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Presence of increased gastric residuals*", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Labs: CBC with diff, blood gas with lytes and lactic acid, BUN, creatinine, serial CRP for dx & assess response to therapy, blood cultures (positive in 30%), consider urine/CSF cx if suspicious for or", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Imaging: If there is a high risk for NEC, order STAT abdominal XRAY AP to look for pneumatosis intestinalis. If concerned for pneumoperitoneum, order left lateral decubitus or cross-table. Serial abdo", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Modified Bell\u2019s Staging & Management:", "type": "content"}, {"id": "necrotizing-enterocolitis-(nec)", "title": "Necrotizing Enterocolitis (NEC)", "path": "GASTROINTESTINAL PROBLEMS > Necrotizing Enterocolitis (NEC)", "content": "Treatment: For suspected or proven cases of NEC, enteral feeding is discontinued and IVF or TPN is initiated. A Replogle tube, with low intermittent suction, is placed in the stomach. Empiric antibiot", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "type": "h2"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "SIP is a single intestinal perforation that is typically found at the terminal ileum. It occurs primarily in VLBW and ELBW preterm infants. SIP is a separate clinical entity and must be differentiated", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Epidemiology: Occurs in 2-5% of VLBW and ELBW", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Risk Factors: Prematurity, postnatal exposure to steroids and indomethacin", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Clinical Presentation:", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Although there can be overlap, the following common findings of SIP typically distinguish it from NEC:", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Lab Findings: WBC may be elevated. Drop in platelets or hct may be observed.", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Imaging: Abdominal films AP and left-lateral decubitus or cross-table lateral to look for pneumoperitoneum. If film shows gasless abdomen, US may be helpful to look for echogenic free fluid (sign of p", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Management:", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "Directed toward stabilization and includes the following", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "- NPO and start IVF/TPN", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "- Abdominal decompression with replogle under LIWS", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "- Fluid resuscitation and inotropic support for hypotension", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "- IV antibiotics (Vanc, tobra, flagyl)", "type": "content"}, {"id": "spontaneous-intestinal-perforation-(sip)", "title": "Spontaneous Intestinal Perforation (SIP)", "path": "GASTROINTESTINAL PROBLEMS > Spontaneous Intestinal Perforation (SIP)", "content": "- Transfer to CoA for surgery (peritoneal drain or ex lap with bowel resection and primary anastomosis or ostomy)", "type": "content"}, {"id": "conjugated-hyperbilirubinemia", "title": "Conjugated Hyperbilirubinemia", "path": "GASTROINTESTINAL PROBLEMS > Conjugated Hyperbilirubinemia", "type": "h2"}, {"id": "conjugated-hyperbilirubinemia", "title": "Conjugated Hyperbilirubinemia", "path": "GASTROINTESTINAL PROBLEMS > Conjugated Hyperbilirubinemia", "content": "Diagnosed when direct bilirubin > 2 mg/dL or is > 20% of total bilirubin", "type": "content"}, {"id": "conjugated-hyperbilirubinemia", "title": "Conjugated Hyperbilirubinemia", "path": "GASTROINTESTINAL PROBLEMS > Conjugated Hyperbilirubinemia", "content": "Management", "type": "content"}, {"id": "conjugated-hyperbilirubinemia", "title": "Conjugated Hyperbilirubinemia", "path": "GASTROINTESTINAL PROBLEMS > Conjugated Hyperbilirubinemia", "content": "UDCA (a choleretic that increases bile flow) can be used to decrease conjugated bilirubin. Vit.  A/D/E/K supplements", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "type": "h2"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "An omphalocele is a midline abdominal wall defect of variable size, covered by a membrane of amnion and peritoneum with Wharton\u2019s jelly between the two layers, and containing abdominal contents. Sac m", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Gastroschisis is a full thickness, paraumbilical abdominal wall defect usually associated with evisceration of bowel. 8-16% of infants with gastroschisis will have other gastrointestinal anomalies", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Diagnosis", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Prenatal ultrasonography, elevated maternal alpha fetal protein and physical exam", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Management", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Management at birth", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Use latex free products including gloves", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Maintain thermoneutral environment", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Use transparent bowel bag to cover the sac to prevent heat and water loss", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Minimize handling of the bowel to prevent vascular compromise", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Place nasogastric tube to decompress the stomach", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Obtain immediate IV access and start IVF (Usually require 2-3 times of the normal maintenance IVF)", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Begin broad spectrum antibiotics prophylactically (Covering vaginal flora)", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Monitor temperature and PH", "type": "content"}, {"id": "omphalocele-and-gastroschisis:", "title": "Omphalocele and Gastroschisis:", "path": "GASTROINTESTINAL PROBLEMS > Omphalocele and Gastroschisis:", "content": "Obtain urgent surgical consultation", "type": "content"}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "path": "GASTROINTESTINAL PROBLEMS > Duodenal atresia", "type": "h2"}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "path": "GASTROINTESTINAL PROBLEMS > Duodenal atresia", "content": "Clinical: May have a history of polyhydramnios and is commonly diagnosed prenatally by ultrasound. Bile stained vomiting usually occurs within few hours of birth", "type": "content"}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "path": "GASTROINTESTINAL PROBLEMS > Duodenal atresia", "content": "Diagnosis: Plain radiograph of non-decompressed abdomen will show \u2018\u2019double bubble\u201d", "type": "content"}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "path": "GASTROINTESTINAL PROBLEMS > Duodenal atresia", "content": "Management: NPO, gastric decompression with nasogastric suction and surgical consultation", "type": "content"}, {"id": "duodenal-atresia", "title": "Duodenal atresia", "path": "GASTROINTESTINAL PROBLEMS > Duodenal atresia", "content": "70% of cases have other associated malformations, including Down syndrome, cardiovascular anomalies and GI anomalies.", "type": "content"}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "path": "GASTROINTESTINAL PROBLEMS > Malrotation with or without Midgut Volvulus", "type": "h2"}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "path": "GASTROINTESTINAL PROBLEMS > Malrotation with or without Midgut Volvulus", "content": "An emergency because bowel viability is at stake!", "type": "content"}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "path": "GASTROINTESTINAL PROBLEMS > Malrotation with or without Midgut Volvulus", "content": "Clinical: Presents with sudden onset of bilious vomiting in an infant who has passed stool. Bilious emesis equals malrotation until proved otherwise. Signs of sepsis and shock are often present", "type": "content"}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "path": "GASTROINTESTINAL PROBLEMS > Malrotation with or without Midgut Volvulus", "content": "Diagnosis: Upper GI series, specifically looking for an absent or abnormal position of the ligament of treitz is the gold standard. Ultrasonography can be used to determine the position of the superio", "type": "content"}, {"id": "malrotation-with-or-without-midgut-volvulus", "title": "Malrotation with or without Midgut Volvulus", "path": "GASTROINTESTINAL PROBLEMS > Malrotation with or without Midgut Volvulus", "content": "Management: An acutely ill child with the presumed diagnosis of volvulus requires urgent operative intervention even at the expense of full resuscitation. In malrotation without volvulus, urgency of s", "type": "content"}, {"id": "nephrology-problems", "title": "NEPHROLOGY PROBLEMS", "path": "NEPHROLOGY PROBLEMS", "type": "h1"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "type": "h2"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "At birth, the kidney replaces the placenta as the major homeostatic organ", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "GFR improves over the first weeks of life (dependent on gestational age) and continues to improve until 18-24 months of age", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "Serum Anion Gap: Na \u2013 (Cl + HCO3-) is used to determine if there are excessive non-measured anion in the blood", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "Urine Anion Gap: (Na + K) - Cl is used to determine if urine is handling acid well in context of a non-anion gap metabolic acidosis. If kidneys are working appropriately, the urine anion gap should be", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "FeNa: 100 x (uNa x sCr) / (sNa x uCr); is used in context of a rising creatinine to determine if the tubules are able to avidly conserve sodium", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "While the above values are useful for older children and adults, the FENa\u00a0must be interpreted more cautiously in younger pediatric patients due to the limited ability of immature tubules to reabsorb s", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "4. Insensible Losses: 400cc/m2", "type": "content"}, {"id": "common-labs", "title": "Common Labs", "path": "NEPHROLOGY PROBLEMS > Common Labs", "content": "Normal Serum Creatinine Values in Term & Preterm Infants (\u00b1 SD)", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "type": "h2"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Prerenal azotemia occurs when there is low perfusion to the kidneys: loss of effective blood volume, low oncotic pressure, leaky capillaries, poor cardiac output, medications (ACE), intra-abdominal co", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Intrinsic AKI (ATN): prolonged/severe ischemia, nephrotoxins, sepsis, infants on cooling protocol", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Evaluation: Renal failure indices in the oliguric neonate table (Manual of Neonatal Care)", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Management:", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Hyperkalemia: eliminate/limit K (Similac PM 60/40), CIGAR acronym", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Fluid Mgmt: unless dehydration, limit volume to replacement of insensible losses + UOP. If unable to prevent fluid overload, consult nephrology", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Sodium: restrict (check IVF, TPN, & any Na in medications)", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Phosphorous: restrict (Sim 60/40), oral calcium carbonate can be used as phosphate-binder", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Calcium: give based on ionized calcium or if symptomatic", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Metabolic acidosis: NaHCO3 only if severe", "type": "content"}, {"id": "acute-kidney-injury-(aki)", "title": "Acute Kidney Injury (AKI)", "path": "NEPHROLOGY PROBLEMS > Acute Kidney Injury (AKI)", "content": "Dialysis: need to reduce fluid overload, severe hyperkalemia, acidosis, and/or uremia \ud83e\udc6a Consult Nephrology!", "type": "content"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "type": "h2"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "content": "These include hydronephrosis, hypoplasia, dysplastic kidneys, & duplications.", "type": "content"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "content": "No matter the etiology, its important to assure that fluid balance occurs. Depending on the degree of dysplasia, some newborns may have excessive fluid losses and require up to 240 mL/kg/day to mainta", "type": "content"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "content": "Hydronephrosis", "type": "content"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "content": "Unilateral: more common, if mild in-utero hydronephrosis, don\u2019t perform US in first few days of life when hydronephrosis may not be detected b/c of physiologic dehydration", "type": "content"}, {"id": "congenital-renal-anomalies", "title": "Congenital Renal Anomalies", "path": "NEPHROLOGY PROBLEMS > Congenital Renal Anomalies", "content": "Bilateral: more worrisome esp if oligohydramnio or pulmonary disease is present, males should have VCUG performed within first few days to r/o posterior urethral valves (PUV), ureterpelvic junction ob", "type": "content"}, {"id": "hypertension", "title": "Hypertension", "path": "NEPHROLOGY PROBLEMS > Hypertension", "type": "h2"}, {"id": "neurological-problems", "title": "NEUROLOGICAL PROBLEMS", "path": "NEUROLOGICAL PROBLEMS", "type": "h1"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "type": "h2"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": ": Vasculature of germinal matrix in ELBW infants has little support & its blood flow is poorly autoregulated. Risk factors for IVH include chorioamnionitis, hypotension, hypoxia, hypercarbia, hypernat", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": ": Inversely proportional to gestational age. 90% of bleeds occur in first 72h.", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": ": Mostly insidious in onset. Can also be \u201ccatastrophic\u201d, with signs such as full/bulging anterior fontanel, increased head circumference, fall in Hct, DIC, hyperglycemia, metabolic acidosis, thrombocy", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": "Screening: Ultrasound is best study. Order one if high clinical suspicion & order one on admission orders at 7 days of life as screening if <1500 grams or 31 weeks. Pleaseinclude  mastoid view as part", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": ":", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": "Management: Treatment is supportive - give PRBCs as necessary, treat seizures with phenobarb. Assess for signs of post-hemorrhagic hydrocephalus: rapidly enlarging head circumference (> 2 cm in < 7 da", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": "Prevention: Antenatal steroid exposure reduces IVH incidence. Low dose indomethacin (0.1mg/kg q24hr x 1 dose) as soon as possible for ELBW infants with weight < 750g to stabilize the autoregulation of", "type": "content"}, {"id": "intraventricular-hemorrhage-(ivh)", "title": "Intraventricular Hemorrhage (IVH)", "path": "NEUROLOGICAL PROBLEMS > Intraventricular Hemorrhage (IVH)", "content": "Contraindications for Indomethacin: Absent or reversed end diastolic blood flow (hypoperfusion to gut), IUGR presumably caused by", "type": "content"}, {"id": "seizures", "title": "Seizures", "path": "NEUROLOGICAL PROBLEMS > Seizures", "type": "h2"}, {"id": "seizures", "title": "Seizures", "path": "NEUROLOGICAL PROBLEMS > Seizures", "content": ": Encephalopathy (most common from hypoxia), cerebral contusion, intracranial hemorrhage (IVH, SAH, SDH), bacterial or viral meningitis, TORCH infections, narcotic withdrawal, electrolyte disturbances", "type": "content"}, {"id": "seizures", "title": "Seizures", "path": "NEUROLOGICAL PROBLEMS > Seizures", "content": ": Varied in the neonatal period; can be \u201cSubtle Seizures\"-- only blinking/altered gaze/oral movements/apnea as clinical manifestations. Clonus & jitteriness (NOT assoc with VS changes; movements start", "type": "content"}, {"id": "seizures", "title": "Seizures", "path": "NEUROLOGICAL PROBLEMS > Seizures", "content": ": Load with phenobarb 20mg/kg over 10 min. If no effect in an hour, repeat phenobarb load. If patient is INTUBATED, can again repeat a load of Phenobarbital 10-20mg/kg. Check level if still not effect", "type": "content"}, {"id": "seizures", "title": "Seizures", "path": "NEUROLOGICAL PROBLEMS > Seizures", "content": ": 55% normal, 30% with neuro changes. Dependent on cause: 1. Electrolyte disturbances - once corrected, are usually benign and resolves. 2. Meningitis - about 1/3 with abnormal outcome. 3. HIE - poor ", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "type": "h2"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Associated with perinatal asphyxia (lack of oxygen &/or lack of perfusion). Diagnosis established only in infants with compatible perinatal history and abnormal neurological exam. Therefore, diagnosis", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": ": 90% of asphyxia occurs in antepartum/intrapartum period due to placental insufficiency. Risk factors include maternal HTN, vascular disease, diabetes, substance abuse, hypoxia, infection, cord probl", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Genetic/structural defects, drugs, toxins, infection, metabolic disease, trauma, intracranial hemorrhage, electrolyte derangements; HIE is reasonable diagnosis if cord or first pH < 7.0, base deficit ", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Obtain baseline LFT/BMP/RFT on DOL1. Continue to monitor as required based on clinical status.", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Assessment: If severe (cord pH <7.0, encephalopathy) determine if therapeutic hypothermia is warranted (see criteria below). Consult RNICU fellow about turning infant warmer off during this period to ", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Resp: Keep saturation levels between 92-98% (to minimize PPHN risk, alsoto prevent hyperoxia that could decrease CBF & increase free radical damage). Keep CO2 ranges within normal (hyperventilation le", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "CV: May require pressor agents due to bradycardia, hypotension or poor perfusion", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Metabolic/FEN: Since renal function is often temporarily impaired in HIE, start with a TFI of 50-60 mL/kg/d and adjust daily based on weight changes, urine output and labs. Withhold enteral feedings u", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Neuro: If cooling protocol initiated, load with single dose of phenobarbital (range of 20-40 mg/kg single dose, depending on clinical preference). Consider sedation/analgesia with prn versed/morphine ", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Load with phenobarbital (20mg/kg x 1 dose), then continue maintenance dose of 5 mg/kg/d (start maintenance 24 hrs AFTER loading dose).", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "If refractory, start phenytoin @ 20 mg/kg load & maintenance of 5 g/kg/d (start maintenance 24 hrs AFTER loading dose).", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "May need 3rd anti-epileptic agent if still refractory such as lorazepam @ 0.05 mg/kg-0.1 mg/kg", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Consider other underlying causes for seizures", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Consider neurology consult for refractory seizures!", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Cooling protocol (within 6 hrs after birth) for moderate to severe encephalopathy", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Criteria", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "EITHER:", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Cord pH or any postnatal blood gas pH <7.0 at <1hr of life", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "OR", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Base deficit on cord gas or any postnatal blood gas >16 mEq/L at <1hr of life", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "History of an acute perinatal event (abruptio placenta, cord prolapse, severe fetal distress, prolonged resuscitation variable or late decels).", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "AND", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "An Apgar score <5 at 10 minutes.", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "OR", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Continued requirement for ventilation initiated at birth and continued for at least 10 minutes.", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "Once infant meets criteria, proceed to .", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "The presence of moderate/severe encephalopathy defined as seizures OR presence of one or more signs in 3/6 of the categories below.", "type": "content"}, {"id": "hypoxic-ischemic-encephalopathy-(hie)", "title": "Hypoxic-Ischemic Encephalopathy (HIE)", "path": "NEUROLOGICAL PROBLEMS > Hypoxic-Ischemic Encephalopathy (HIE)", "content": "***If patient meets criteria for cooling, refer to cooling protocol attached to cooling machine or ask RT***", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "type": "h2"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Retinal disease noted in prematurely born infants, caused by cessation of blood vessel growth during the first month of postnatal life and later-onset abnormal proliferative neovascularization which c", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Screening by ophthalmology ROP team is usually initiated at 31 weeks\u2019 postmenstrual age or 4 weeks after birth, whichever is later", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Description of ROP", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Zones: Retinal vascularization proceeds from the posterior pole and the retinal area around this contains the macula which is responsible for posterior vision (Zone 1); therefore Zone 1 ROP has a much", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Stages: Based on degree of abnormal neovascularization. ROP > stage 3 is considered threshold ROP that requires closer monitoring of disease progression", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Extent: Number of clock hours of retinal area affected by ROP", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Plus disease \u2013 posterior pole venous dilation is considered severe ROP regardless of other findings", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Prevention of ROP is best achieved by maintaining O2 saturations within target ranges to prevent hyperoxia and by optimizing nutrition and weight gain", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Treatment strategies include laser ablation of abnormal blood vessels or intravitreal injection of antibodies against vascular growth factors such as VEGF (bevacizumab), typically done for", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Zone II: Plus disease with stage 2 or 3 ROP", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Zone I: Plus disease with stage 1 or 2 RO", "type": "content"}, {"id": "retinopathy-of-prematurity", "title": "Retinopathy of prematurity", "path": "NEUROLOGICAL PROBLEMS > Retinopathy of prematurity", "content": "Zone I: Stage 3 ROP", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "type": "h2"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Clavicle fracture: Most commonly injured bone during delivery, +/- crepitus on clavicle exam. Risk factors: shoulder dystocia, macrosomia, breech delivery with arms extended. DDx: Humerus fx or brachi", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Diagnosis: CXR", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "If arm movement decreased, cervical spine, brachial plexus and humerus should be assessed", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Management: Supportive, infants sleeve should be pinned to shirt at 90-degree angle to limit movement until callus forms.", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Prognosis: Complete healing is expected", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Brachial Plexus Injuries: Caused by excessive traction on the head, neck and arm during birth. Risk factors: macrosomia, shoulder dystocia, malpresentation and instrumented deliveries.", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Erb\u2019s Palsy (C5, C6, C7 injury): Extension and pronation at the elbow and flexion of wrist and fingers, \u201cwaiter\u2019s tip\u201d posture. Grasp reflex intact. Moro, biceps and radial reflexes absent. Diaphragm ", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Klumpke Palsy (C7/C8, T1 injury): Rarest, \u201cclaw hands,\u201d absent grasp reflex, but biceps and radial reflexes present. T1 injury \ud83e\udc6a ipsilateral Horner\u2019s syndrome", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Total brachial plexus injury (C5-T1 injury): Entire arm is flaccid, all reflexes (grasp and sensation) absent. Can also have Horner\u2019s syndrome (ptosis, miosis, anhydrosis).", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Radiographs of shoulder and upper arm should be performed to r/o bony injuries, evaluate for diaphragm paralysis.", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "supportive, PT, passive ROM exercises to prevent contractures at DOL 7-10.", "type": "content"}, {"id": "birth-trauma", "title": "Birth Trauma", "path": "NEUROLOGICAL PROBLEMS > Birth Trauma", "content": "Full recovery depends on extent of injury. If nerve roots stretched and intact, not avulsed, >90% full recovery expected. EMG and nerve conduction studies can differentiate avulsion from stretch injur", "type": "content"}, {"id": "hematologic-problems", "title": "HEMATOLOGIC PROBLEMS", "path": "HEMATOLOGIC PROBLEMS", "type": "h1"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "type": "h2"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Maximum rate of bilirubin increase for normal infants with nonhemolytic hyperbilirubinemia: 5mg/dL/24hr or 0.2mg/dl/hr", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Consider pathologic cause: visible jaundice or total bilirubin concentrations >5mg/dL on first day of life", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Risk factors: Birth weight <2500g, breast feeding, prematurity", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Evaluation:", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Maternal prenatal testing: ABO and Rh (D) typing and serum screen for isoimmune antibodies", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Infant or cord blood: blood smear, direct Coombs test, blood and Rh typing, Hct, retic count", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Management:", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Phototherapy (PTx): traditionally treated based on the \u201clight level\u201d &/or AAP recommendations (see graphs below).", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Initiate PTx earlier if evidence of ABO/other incompatibility or concerns for hemolysis", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "PTx is contraindicated if baby has direct hyperbilirubinemia", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Check TB at least q24 while baby is on PTx (more if concerns for exchange Tx or hemolysis)", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Should produce a decrease in total bili level of 1-2mg/dL within 4-6 hrs", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Phototherapy (By weight)", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "AAP Guidelines for phototherapy in infants of 35 or more weeks\u2019 gestation (PEDIATRICS Vol. 114 No. 1 July 2004, pp. 297-316)", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "PHOTOTHERAPY (>35WKS)", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "Neonatology: Management, procedures, on-call problems, diseases, and drugs 5th Ed. Gomella et al.", "type": "content"}, {"id": "unconjugated-hyperbilirubinemia", "title": "Unconjugated Hyperbilirubinemia", "path": "HEMATOLOGIC PROBLEMS > Unconjugated Hyperbilirubinemia", "content": "AAP Guidelines for exchange transfusion in infants of 35 or more weeks\u2019 gestation (PEDIATRICS Vol. 114 No. 1 July 2004, pp. 297-316", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "type": "h2"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "Typically defined as Hct < 35 in term infants during the first week of life, < 30 for all other infants; lower levels of Hb are often tolerated especially in former ELBW infants without significant re", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "Anemia of prematurity", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "In the NICU this is typically noted in infants < 1000 g BW as a gradual decline in Hct to a low of around 22-24 at around 4-8 weeks of life", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "Caused by excessive EPO deficiency, shorter RBC lifespan. However routine EPO administration is not currently recommended due to lack of significant impact on long-term outcomes", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "Risk increased by and decreased by 30 -60 s of delayed umbilical cord clamping at birth (can also significantly decrease NEC, IVH risk)", "type": "content"}, {"id": "anemia", "title": "Anemia", "path": "HEMATOLOGIC PROBLEMS > Anemia", "content": "Other causes of anemia in newborns and infants", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "type": "h2"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Defined as venous hct > 60, though typically no treatment is required unless Hct > 65 and symptomatic, or > 70.", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Samples should be from free-flowing venous blood; capillary values should be confirmed with venous testing", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Causes of polycythemia include TTTS, uteroplacental insufficiency and SGA, IDM, hyperthyroidism, CAH, and syndromes such as Down\u2019s, Beckwith-Wiedemann syndrome", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Symptoms due to polycythemia are caused by hyperviscosity of the blood", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Lethargy, poor feeding", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Hypoglycemia", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Seizures (venous sinus thrombosis)", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "PPHN", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Hematuria (RVT)", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Hyperbilirubinemia", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Management", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Supportive, hydration with saline boluses as needed", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Rarely partial exchange transfusion", "type": "content"}, {"id": "polycythemia", "title": "Polycythemia", "path": "HEMATOLOGIC PROBLEMS > Polycythemia", "content": "Volume required = Hct (obs) \u2013 Hct (des) / Hct (obs)  x wt (kg) x 80 mL/kg", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "type": "h2"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Defined as PLT < 150,000/\u00b5L, though often considered severe and requiring PLT transfusions only when <50,000 and signs of bleeding diathesis or < 30,000 without symptoms", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Early onset (< 72 hours)", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Ill-appearing: Sepsis, TORCH, DIC associated with HIE", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Well-appearing: Placental insufficiency (usually due to maternal preeclampsia/PIH-induced hypoxia, PLT generally expected to rise to normal by 7-10 days after birth), autoimmune or neonatal alloimmune", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Late onset (>72 hours)", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Ill-appearing: Sepsis (consumption increased disproportionately compared to PLT production), NEC, IEM", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Well-appearing: drug-induced, Fanconi\u2019s anemia, thrombosis", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "PLT < 50,000 are typically associated with causes such as DIC, sepsis and immune-mediated thrombocytopenia", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Note: Lab errors/PLT clumping is a frequent cause for low PLT in the NICU; consider repeating PLT if this is considered likely", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Autoimmune thrombocytopenia is caused by maternal antibodies against her own PLT antigens (from ITP or other immune processes) that are acquired transplacentally by the infant; should improve over tim", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Alloimmune thrombocytopenia (NAIT) is caused by transplacentally acquired of maternal antibodies against paternal antigens on fetal platelets (most commonly HPA 1a)", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Normal maternal PLT", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Increased risk for parenchymal as well as intracranial hemorrhage", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Diagnosis: MPV (generally small PLT indicate failure of production, large PLT indicates consumptive causes, though some genetic syndromes can be associated with large PLT). Follow PLT frequently and p", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Sepsis w/u", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "TORCH labs", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "LFTs and other w/u for DIC", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "PLT antigen screening for infant, mother (and father if NAIT is suspected)", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "based on cause(s) considered likely", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Head US should be obtained to look for signs of hemorrhage irrespective of the neurological status, if severe thrombocytopenia and/or NAIT suspected", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Management of neonate with suspected NAIT in an unknown pregnancy", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Random donor platelet transfusions (with platelet count <30k if baby stable and <100k if evidence of IVH), IVIG x 2days", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "Management of neonate with known NAIT", "type": "content"}, {"id": "neonatal-thrombocytopenia", "title": "Neonatal Thrombocytopenia", "path": "HEMATOLOGIC PROBLEMS > Neonatal Thrombocytopenia", "content": "neonate born to a mother with previous pregnancy affected by confirmed NAIT, genotypically matched platelets (e.g. HPA-1b1b) should be arranged with blood bank.", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "type": "h2"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Can present as", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Early: < 24 h; due to maternal use of anticonvulsants, warfarin etc.; typically scalp, subdural, intraventricular, intra-abdominal bleeding", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Classical: 1-7 days; idiopathic; GI, umbilical, skin (ecchymosis), circumcision sites", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Late: >7 days, due to exclusive breastfeeding without supplemental Vit K, prolonged antibiotic therapy, malabsorption syndromes; intracranial, GI, skin bleeds", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Prolonged PT/aPTT; otherwise normal coagulation studies", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Prevention: IM Vit K at birth; oral doses not effective over the long-term", "type": "content"}, {"id": "vit-k-deficiency", "title": "Vit K deficiency", "path": "HEMATOLOGIC PROBLEMS > Vit K deficiency", "content": "Management: FFP for active bleeding, Vit K (slow IV infusion)", "type": "content"}, {"id": "hemophilia", "title": "Hemophilia", "path": "HEMATOLOGIC PROBLEMS > Hemophilia", "type": "h2"}, {"id": "hemophilia", "title": "Hemophilia", "path": "HEMATOLOGIC PROBLEMS > Hemophilia", "content": "Iatrogenic bleeding from circumcision, intracranial hemorrhage, subgaleal bleeds", "type": "content"}, {"id": "hemophilia", "title": "Hemophilia", "path": "HEMATOLOGIC PROBLEMS > Hemophilia", "content": "Prolonged aPTT", "type": "content"}, {"id": "hemophilia", "title": "Hemophilia", "path": "HEMATOLOGIC PROBLEMS > Hemophilia", "content": "Rx \u2013 FFP, recombinant F VIII after confirmation of diagnosis", "type": "content"}, {"id": "disseminated-intravascular-coagulation", "title": "Disseminated intravascular coagulation", "path": "HEMATOLOGIC PROBLEMS > Disseminated intravascular coagulation", "type": "h2"}, {"id": "disseminated-intravascular-coagulation", "title": "Disseminated intravascular coagulation", "path": "HEMATOLOGIC PROBLEMS > Disseminated intravascular coagulation", "content": "Systemic activation of coagulation/fibrinolysis, platelet consumption, generation of fibrin clots \ud83e\udc6a ischemia \ud83e\udc6a organ failure", "type": "content"}, {"id": "disseminated-intravascular-coagulation", "title": "Disseminated intravascular coagulation", "path": "HEMATOLOGIC PROBLEMS > Disseminated intravascular coagulation", "content": "Diagnosis is based on compatible clinical signs and labs such as prolonged PT/aPTT/TT; elevated d-dimers, decreased fibrinogen as well as PLT", "type": "content"}, {"id": "disseminated-intravascular-coagulation", "title": "Disseminated intravascular coagulation", "path": "HEMATOLOGIC PROBLEMS > Disseminated intravascular coagulation", "content": "Management: FFP, Cryoprecipitate, PLT transfusions; supportive management; correction of underlying cause", "type": "content"}, {"id": "thrombosis", "title": "Thrombosis", "path": "HEMATOLOGIC PROBLEMS > Thrombosis", "type": "h2"}, {"id": "thrombosis", "title": "Thrombosis", "path": "HEMATOLOGIC PROBLEMS > Thrombosis", "content": "Most commonly secondary to an indwelling vascular catheter", "type": "content"}, {"id": "thrombosis", "title": "Thrombosis", "path": "HEMATOLOGIC PROBLEMS > Thrombosis", "content": "Diagnosis: clinical signs + doppler US of affected areas", "type": "content"}, {"id": "thrombosis", "title": "Thrombosis", "path": "HEMATOLOGIC PROBLEMS > Thrombosis", "content": "Management: Careful consideration should be given to initiation of anticoagulants (typically unfractionated heparin) especially in preterm infants.", "type": "content"}, {"id": "endocrine-and-metabolic-problems", "title": "ENDOCRINE AND METABOLIC PROBLEMS", "path": "ENDOCRINE AND METABOLIC PROBLEMS", "type": "h1"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "type": "h2"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Usually defined as plasma glucose < 60 mg/dL in POC plasma glucose measurements in term infants though preterm and ELBW infants typically are asymptomatic with BG values > 45 mg/dL", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Common causes of transient hypoglycemia in newborns include SGA/IUGR and LGA including IDM, sepsis, maternal use of \u03b2-blockers", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Persistent hypoglycemia (especially after treatment measures such as glucagon, steroids etc.) is mostly due to genetic causes of hyperinsulinism, endocrine causes such as CAH, GH deficiency etc. or IE", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Common symptoms and signs are nonspecific -  abnormal cry, decreased feeding, jitteriness, irritability, pallor, cyanosis, hypothermia, lethargy, tachypnea, hemodynamic instability, apnea, seizures, o", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Prevention", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "If on IVF/TPN, maintaining a GIR  between 3-6 mg/kg/min can prevent hypoglycemia in most infants", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "If on enteral feeds of breast milk, consider starting/increasing fortification of feeds. If on formula feeds consider increasing caloric density", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Management", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Acute hypoglycemic episode: 2 mL/kg of 10% dextrose, followed by continuous dextrose infusion to achieve euglycemia", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "If  a GIR > 8-10 mg/kg/min has been required to achieve euglycemia for more than 24-48 hours, consider obtaining an endocrine consult (hyperinsulinemia typically requires GIR > 15 mg/kg/min)", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Administering IV fluids with dextrose concentration > 12.5% requires a central venous catheter", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Pharmacologic management: Glucocorticoids such as dexamethasone or hydrocortisone, glucagon (typically as a continuous infusion),  GH, diazoxide \u00b1 chlorothiazide, octreotide (risk of NEC in preterm in", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Further laboratory evaluation may include", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "\u201cCritical labs\u201d for persistent hypoglycemia: S.electrolytes, insulin, plasma ketones and FFAs, S. cortisol, GH and lactate measurements", "type": "content"}, {"id": "hypoglycemia", "title": "Hypoglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hypoglycemia", "content": "Evaluation for IEMs: S. amino acids, Urine OAs, NH3 levels", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "type": "h2"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Generally defined as PG > 125 mg/dL in term infants and as PG > 200 mg/dL in preterm, though ELBW infants typically do not need management unless PG > 200 mg/dL consistently for > 2 checks 1-3 hours a", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Term infants develop hyperglycemia less frequently compared to preterm infants", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Causes of hyperglycemia include", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Critical illness", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Infection", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Excessive parenteral glucose administration", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Inadequate insulin release, typically due to lack of enteral feeds", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Neonatal Diabetes mellitus: typically noted in severely SGA babies (Insulin is the major growth factor during in-utero life", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Most infants with hyperglycemia do not develop polyuria even in the presence of glycosuria, therefore symptoms such as dehydration, weight loss, poor perfusion, are not frequently noticed", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "However, these infants frequently develop electrolyte disturbances such as hyponatremia, hypokalemia, metabolic acidosis", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Long-term implications also include ROP, white matter injury, PVL etc.", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Management/Prevention", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Limit GIR in TPN/IVF: Can go as low as 2-3 mg/kg/min if needed", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Limiting IV lipid infusions", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Early and increased amino acids in TPN/IVF", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "Early initiation and continued progression of enteral feeds", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "If all such measures fail to control hyperglycemia then can initiate insulin infusion", "type": "content"}, {"id": "hyperglycemia", "title": "Hyperglycemia", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Hyperglycemia", "content": "If hyperglycemia remains persistent for > 5 \u2013 7 days, initiate an endocrine consult for possible neonatal DM", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "type": "h2"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Reduction of bone mineral content, also known as metabolic bone disease (MBD) of prematurity", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Premature birth interrupting accretion of Ca and P by the fetus during the 3rd trimester is the most important cause of MBD", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Both parenteral and enteral nutrition with unfortified breast milk are unable to meet the Ca and P demands of the growing premature infant", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Additional causes include poor absorption of nutrients due to NEC/immature bowel function as well as use of medications such as caffeine, diuretics and steroids which can induce osteolysis", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Screening for MBD should be carried out around 4 \u2013 6 weeks of age for all VLBW infants, especially those with prolonged/frequent interruptions of enteral feedings and in those with incidental findings", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Biomarkers such as decreased serum P levels (< 5 mg/dL)  and elevated serum ALP levels (> 800 IU/L) should prompt", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "X-rays of the wrist and/or knee", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Other imaging modalities such as CT/DEXA can provide better visualization but are typically not required to make the diagnosis", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Management of established MBD", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Supplemental Ca as calcium gluconate or glubionate supplements (20 \u2013 30 mg/kg/day in addition to Ca supplied through enteral nutrition)", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Supplemental P (20 to 40 mg/kg/day of elemental P, as KPhos)", "type": "content"}, {"id": "osteopenia-of-prematurity", "title": "Osteopenia of Prematurity", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Osteopenia of Prematurity", "content": "Vitamin D (up to 800 IU/day)", "type": "content"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "type": "h2"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "content": "The most common DSD presenting in the neonatal period is a 46,XX infant with CAH.", "type": "content"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "content": "Most common form of CAH (>90%) is caused by deficiency of 21-hydroxylase (all state newborn screening programs include screening for 21-OHase deficiency).", "type": "content"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "content": "Rare forms of CAH are caused by 11-OHase deficiency, 3B-HSD deficiency", "type": "content"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "content": "In an infant suspected of 21-OHase deficiency, treatment (Hydrocortisone and Fludrocortisone) should be started as soon as the laboratory tests mentioned have been obtained.", "type": "content"}, {"id": "cah", "title": "CAH", "path": "ENDOCRINE AND METABOLIC PROBLEMS > CAH", "content": "Consult the endocrinology team to guide you for hormone replacement therapy.", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "type": "h2"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Bilateral cryptorchidism at birth occurs in 3:1,000 infants, most of whom are premature.", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Ultrasonography or MRI (look for inguinal or intra-abdominal testes). If testicular tissue cannot be found on exam/imaging, levels of serum FHS, LH, testosterone, and anti-mullerian hormone (AMH) shou", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Urologist should be consulted. If surgery is indicated, orchiopexy should be performed by 1 year of age. If the intra-abdominal testes cannot be brought into the scrotum, removal should be considered ", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Endocrinology consult (hormone replacement therapy).", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Evaluation for disorder of sex development should be done if any of the following:", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Unilateral cryptorchidism with hypospadias (perineo-scrotal or penile hypospadias)", "type": "content"}, {"id": "bilateral-cryptorchidism", "title": "Bilateral Cryptorchidism", "path": "ENDOCRINE AND METABOLIC PROBLEMS > Bilateral Cryptorchidism", "content": "Unilateral cryptorchidism with microphallus", "type": "content"}, {"id": "nas-iem-and-genetic-problems", "title": "NAS, IEM and GENETIC PROBLEMS", "path": "NAS, IEM and GENETIC PROBLEMS", "type": "h1"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "type": "h2"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Neonates with IEMs are usually healthy at birth with symptoms typically developing in hours to days after birth. The symptoms are usually nonspecific: decreased activity, lethargy, poor feeding, vomit", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "When a newborn presents with this clinical picture, think about: SEPSIS, SEPSIS \u2014> Duct dependent congenital heart disease \u2014> IEMs.", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Maintaining a high index of suspicion is important for early diagnosis and the institution of appropriate therapy, which is mandatory to prevent death and ameliorate complications from many IEMs.", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Initial evaluation", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Family history:  miscarriages, stillborn, neonatal deaths (vast majority of IEMs are autosomal recessive, OCT deficiency is X-linked),", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Careful physical examination", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Laboratory studies (CBC with differential, serum glucose, electrolytes, blood gas, LFTs, coagulation profile, plasma ammonia, plasma lactate, plasma amino acids, plasma carnitine and acylcarnitine pro", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Management", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Decrease production of the toxic intermediate (hold enteral feeds for 24-48 hours, IV glucose, provide adequate caloric intake to promote anabolism, provide adequate hydration, correct hypoglycemia)", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Elimination of toxic metabolites (IV hydration, use medications to create alternate pathways such as carnitine for organic acidemias, sodium benzoate for glycine encephalopathy and urea cycle defects,", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Correction of metabolic acidosis", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Correction of hypoglycemia", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Cofactor supplementation (vitamin-responsive enzyme deficiencies)", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "Contact the metabolic team any time the clinical and lab findings suggest an IEMs.", "type": "content"}, {"id": "inborn-errors-of-metabolism", "title": "Inborn Errors of Metabolism", "path": "NAS, IEM and GENETIC PROBLEMS > Inborn Errors of Metabolism", "content": "blue diaper syndrome (abnormal tryptophan transport ).", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "type": "h2"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Trisomy 21: AV canal defect, VSD", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Trisomy 13, 18: VSD", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Turner: Bicuspid aortic valve (most common), coarctation of aorta", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Noonan: Pulmonary stenosis (vulvar), ASD, hypertrophic CM", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Holt-Oram: ASD or VSD", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Alagille: Peripheral pulmonic stenosis", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "DiGeorge: Conotruncal malformations (Truncus, TOF)", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "Williams: Supravalvar aortic stenosis", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "VACTERL: VSD", "type": "content"}, {"id": "chds-associated-with-common-syndromes", "title": "CHDs associated with common syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > CHDs associated with common syndromes", "content": "CHARGE: Conotruncal malformations (Truncus, TOF, DORV)", "type": "content"}, {"id": "congenital-renal-syndromes", "title": "Congenital Renal Syndromes", "path": "NAS, IEM and GENETIC PROBLEMS > Congenital Renal Syndromes", "type": "h2"}, {"id": "nonimmune-hydrops", "title": "Nonimmune hydrops", "path": "NAS, IEM and GENETIC PROBLEMS > Nonimmune hydrops", "type": "h2"}, {"id": "procedures", "title": "PROCEDURES", "path": "PROCEDURES", "type": "h1"}, {"id": "umbilical-lines", "title": "Umbilical Lines", "path": "PROCEDURES > Umbilical Lines", "type": "h2"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "type": "h3"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "For any procedure, always obtain consent from mother. The father may give consent only if parents are legally married. For emergency situations or if the mother is unavailable (e.g. under general anes", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Nurses or CNAs will help set up tray for you with all equipment necessary.", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Need full sterile attire\u2014hat, mask, gloves, and gown.", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Sizes: \tSingle lumen 3.5 Fr for preemies < 2kg", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Single lumen 5.0 Fr for larger babies", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "UAC length (cm) = [weight(kg) x 3] + 9", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Order long chest film to check placement.", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Normal UAC T7-T10 (above Celiac trunk).", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Low Lying L3-L5.", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Fluids: Heparin to run at 0.5 mL/hr. Best to order with admit orders.", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "(for golden week preemies use \u00bc sodium acetate with heparin rather than \u00bc NaCl for art line fluids)", "type": "content"}, {"id": "uac-placement", "title": "UAC Placement", "path": "PROCEDURES > Umbilical Lines > UAC Placement", "content": "Never advance your catheter once sterile field has been broken. Be sure to wash off betadine after procedure to prevent burns and hypothyroidism.", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "type": "h3"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Sizes: Double lumen 3.5 Fr for premies < 1.5kg, Double lumen 5.0 Fr for larger babies, UVC length (cm) = 1/2 UAC insertion + 1cm", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Tip: If resistance is encountered or the catheter is \u201cbouncing\u201d, or there is no blood return from both ports, the catheter may be in the liver. If unable to advance fully after several attempts:", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Leave that catheter in place & introduce another catheter of same size from the patient\u2019s left side of previous catheter & attempt to pass it to desired length.", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Attempt to flush the catheter as you advance with gentle twisting motion.", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Apply gentle pressure to the liver directed medial-cephalad while advancing", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Order long chest film to check placement.", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "Position: Junction of IVC and RA above Liver", "type": "content"}, {"id": "uvc-placement", "title": "UVC Placement", "path": "PROCEDURES > Umbilical Lines > UVC Placement", "content": "If unable to position here, pull back so tip is proximal or well below liver (low UVC) \u2013 use only as temporary access! Get PICC placed.", "type": "content"}, {"id": "umbilical-lines", "title": "Umbilical Lines", "path": "PROCEDURES > Umbilical Lines", "content": "Removing Umbilical Catheters", "type": "content"}, {"id": "umbilical-lines", "title": "Umbilical Lines", "path": "PROCEDURES > Umbilical Lines", "content": "Keep fluids running. Use 18-gauge needle to cautiously cut the anchor from the umbilical stump. Remove the catheter slowly, a few centimeters at a time to allow the vessel to spasm and prevent bleedin", "type": "content"}, {"id": "umbilical-lines", "title": "Umbilical Lines", "path": "PROCEDURES > Umbilical Lines", "content": "continuous pressure for several minutes with gauze. Interns may remove lines under supervision from residents.", "type": "content"}, {"id": "umbilical-lines", "title": "Umbilical Lines", "path": "PROCEDURES > Umbilical Lines", "content": "**Catheters are to be removed during the day when help is available. If they are to be removed at night, the fellow needs to be present at the bedside during procedure.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "type": "h2"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Tips: Proper preparation prevents poor performance. Master bag-and-mask ventilation first before attempting to intubate. YouTube videos are a helpful resource. Make sure you are comfortable with the p", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Equipment Necessary: laryngoscopes, ET tubes of various sizes, end tidal CO2 detector, suction, tape, scissors, meconium aspirator, stethoscope, bag/mask", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "ETT sizes", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Place in sniffing position, do not hyperextend -- will place cords too anterior", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Stop attempt after 20-30 seconds if bradycardia or hypoxia develops & return to bag/mask ventilation.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Hold scope in left hand, pass into right side of pt\u2019s mouth, sweep towards midline moving tongue out of way.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Advance to vallecula & lift upward with scope (DO NOT USE ROCKING MOTION).", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Once you visualize cords, take ETT in right hand while continuing to visualize the cords", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Insert until black marks on ETT rest at the cords.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "May want to ask for cricoid pressure to help with visualization. Assistant may feel tube slide underneath fingers.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Signs that you are in the trachea: improving HR and oxygen saturations; change in color of end tidal CO2 detector from purple to yellow, misting in the ETT; equal breath sounds on auscultation.", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Note: If a patient is asystolic or severely bradycardic, the end tidal CO2 detector might not change color since there\u2019s no effective cardiac output to allow exhalation of CO2. If decreased breath sou", "type": "content"}, {"id": "intubation", "title": "Intubation", "path": "PROCEDURES > Intubation", "content": "Confirm placement with a CXR (ideal position is mid trachea at T1-T2).", "type": "content"}, {"id": "suprapubic-bladder-aspiration-(spu)", "title": "Suprapubic Bladder Aspiration (SPU)", "path": "PROCEDURES > Suprapubic Bladder Aspiration (SPU)", "type": "h2"}, {"id": "suprapubic-bladder-aspiration-(spu)", "title": "Suprapubic Bladder Aspiration (SPU)", "path": "PROCEDURES > Suprapubic Bladder Aspiration (SPU)", "content": "Consider using bedside ultrasound to check for urine in bladder first.", "type": "content"}, {"id": "suprapubic-bladder-aspiration-(spu)", "title": "Suprapubic Bladder Aspiration (SPU)", "path": "PROCEDURES > Suprapubic Bladder Aspiration (SPU)", "content": "Ask nurse when was most recent wet diaper; must have been over one hour to have enough volume.", "type": "content"}, {"id": "suprapubic-bladder-aspiration-(spu)", "title": "Suprapubic Bladder Aspiration (SPU)", "path": "PROCEDURES > Suprapubic Bladder Aspiration (SPU)", "content": "Prep with betadine. Wear sterile gloves. Use 3 or 5 mL syringe attached to 22 or 23 gauge needle, palpate pubic bone, start in midline about 1.5cm above bone. Advance perpendicular to skin (with confi", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "type": "h2"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "Consent!", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "Ask RN/CNA to set up tray (if unavailable, get tray, betadine, sterile water, entire bottle of alcohol, extra 22G 1 \u00bd\u201d myelinated needles, & sterile gloves).", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "May choose either lateral decubitus position or sitting upright with straight legs.", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "Prep with betadine, drape under pt & around site, instruct assistant to hold pt firmly over shoulders & buttocks & get lower spine as curved as possible.", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "With pt\u2019s spine as parallel to table as possible, introduce needle midline between 4th & 5th lumbar processes (locate by palpating the iliac crests \u2013 can use level at iliac crests or below/inferior). ", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "Obtain 1 mL per tube & consider necessity of extra fluid for HSV PCR. May obtain less fluid for preemies (6-10 drops per bottle).", "type": "content"}, {"id": "lumbar-puncture-(lp)", "title": "Lumbar Puncture (LP)", "path": "PROCEDURES > Lumbar Puncture (LP)", "content": "Remember to clean away excess betadine post procedure.", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "type": "h2"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "If emergent, may forego consent.", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Diagnosis- respiratory distress, falling HR, decreasing BP, cyanosis, chest asymmetry (expansion of affected side), increasing frequency of A/B\u2019s, decreased breath sounds on affected side.", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Evaluation - Transillumination- may be hard to tell if baby is edematous or has severe PIE. CXR with hyperlucent hemithorax, flat diaphragm, mediastinal shift;", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Materials: 22-gauge needle or butterfly, 3-way stopcock, 20 mL syringe", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Treatment - Immediate needle aspiration is needed if signs of tension pneumothorax. While the patient is supine, use a gauge 22 needle and insert perpendicularly into the 2nd intercostal space, mid-cl", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Fellow will perform needle decompression or CT placement.", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Chest tube placement is typically in the 4th or 5th intercostal space, anterior axillary line.", "type": "content"}, {"id": "needle-thoracentesis-for-pneumothorax", "title": "Needle Thoracentesis for Pneumothorax", "path": "PROCEDURES > Needle Thoracentesis for Pneumothorax", "content": "Note: If a pneumothorax is not in tension and baby is asymptomatic, observation may be done with close monitoring of oxygen requirement and transcutaneous CO2.", "type": "content"}, {"id": "medications", "title": "MEDICATIONS", "path": "MEDICATIONS", "type": "h1"}, {"id": "medications", "title": "Acetaminophen", "path": "MEDICATIONS > Acetaminophen", "content": "10-15 mg/kg  q4-6hr prn (max 5 doses/day)\n15 mg/kg q6hr x 3-7 days", "type": "medication"}, {"id": "medications", "title": "Acyclovir", "path": "MEDICATIONS > Acyclovir", "content": "20 mg/kg IV q8hr", "type": "medication"}, {"id": "medications", "title": "Adenosine", "path": "MEDICATIONS > Adenosine", "content": "0.1-0.2 mg/kg/dose IV PUSH", "type": "medication"}, {"id": "medications", "title": "Albumin", "path": "MEDICATIONS > Albumin", "content": "0.5-1 gram/kg/dose", "type": "medication"}, {"id": "medications", "title": "Alprostadil (PGEs)", "path": "MEDICATIONS > Alprostadil (PGEs)", "content": "0.025-0.2 mcg/kg/min", "type": "medication"}, {"id": "medications", "title": "Amoxicillin", "path": "MEDICATIONS > Amoxicillin", "content": "10-25 mg/kg q24hr", "type": "medication"}, {"id": "medications", "title": "Amphotericin B", "path": "MEDICATIONS > Amphotericin B", "content": "1 mg/kg/dose IV q24hr", "type": "medication"}, {"id": "medications", "title": "Ampicillin", "path": "MEDICATIONS > Ampicillin", "content": "", "type": "medication"}, {"id": "medications", "title": "Azithromycin", "path": "MEDICATIONS > Azithromycin", "content": "20 mg/kg q24hr x3 day or 10mg/kg q24hr x10 day IV/PO", "type": "medication"}, {"id": "medications", "title": "Baclofen", "path": "MEDICATIONS > Baclofen", "content": "10 \u2013 40 mg/DAY div. q8hr", "type": "medication"}, {"id": "medications", "title": "Bosentan", "path": "MEDICATIONS > Bosentan", "content": "0.5-1 mg/kg q12hr x 4wks\n1-2 mg/kg q12", "type": "medication"}, {"id": "medications", "title": "Ca Carbonate", "path": "MEDICATIONS > Ca Carbonate", "content": "50-150 mg(elemental)/kg/DAY div in 3-4 doses", "type": "medication"}, {"id": "medications", "title": "Ca Gluconate", "path": "MEDICATIONS > Ca Gluconate", "content": "100-200 mg/kg IV \u2013 repeat every 6hr as needed", "type": "medication"}, {"id": "medications", "title": "Caffeine citrate", "path": "MEDICATIONS > Caffeine citrate", "content": "LD: 20-80 mg/kg x 1 dose\nMD: 5-25 mg/kg PO/IV q24hr", "type": "medication"}, {"id": "medications", "title": "Cefdinir", "path": "MEDICATIONS > Cefdinir", "content": "14 mg/kg/day divided q12hr or q24", "type": "medication"}, {"id": "medications", "title": "Cefepime", "path": "MEDICATIONS > Cefepime", "content": "", "type": "medication"}, {"id": "medications", "title": "Ceftazidime", "path": "MEDICATIONS > Ceftazidime", "content": "", "type": "medication"}, {"id": "medications", "title": "Chlorothiazide", "path": "MEDICATIONS > Chlorothiazide", "content": "PO: 10-20 mg/kg q12hr\nIV: 1-4 mg/kg q12hr", "type": "medication"}, {"id": "medications", "title": "Clindamycin", "path": "MEDICATIONS > Clindamycin", "content": "", "type": "medication"}, {"id": "medications", "title": "Cromolyn", "path": "MEDICATIONS > Cromolyn", "content": "20mg neb q12hr-q6hr", "type": "medication"}, {"id": "medications", "title": "Dexamethasone", "path": "MEDICATIONS > Dexamethasone", "content": "Extubation: 0.25-0.5 mg/kg IV/PO q8hr x 3", "type": "medication"}, {"id": "medications", "title": "Diazepam", "path": "MEDICATIONS > Diazepam", "content": "0.12-0.8 mg/kg/DAY PO div q6-8hr", "type": "medication"}, {"id": "medications", "title": "Dobutamine / Dopamine", "path": "MEDICATIONS > Dobutamine / Dopamine", "content": "2-20 mcg/kg/min IV", "type": "medication"}, {"id": "medications", "title": "Doxapram", "path": "MEDICATIONS > Doxapram", "content": "LD: 2.5-3 mg/kg IV over 30 min\nMD: 1-2.5 mg/kg/hr IV", "type": "medication"}, {"id": "medications", "title": "Enalapril", "path": "MEDICATIONS > Enalapril", "content": "0.04-0.1 mg/kg q24hr (titrate to effect)", "type": "medication"}, {"id": "medications", "title": "Enoxaparin", "path": "MEDICATIONS > Enoxaparin", "content": "Prophylaxis: 0.75 mg/kg q12\nPreemie treatment: 2 mg/kg12q\nTerm treatment: 1.7 mg/kg q12hr", "type": "medication"}, {"id": "medications", "title": "Epinephrine", "path": "MEDICATIONS > Epinephrine", "content": "IV: 0.01-0.03 mg/kg q3-5 min\nETT: 0.05-0.1 mg/kg q3-5 min\nContinuous: 0.1-1 mcg/kg/min", "type": "medication"}, {"id": "medications", "title": "Erythromycin", "path": "MEDICATIONS > Erythromycin", "content": "Low: 1.5-2.5 mg/kg PO q6hr \nHigh: 10-12.5 mg/kg PO q6-8hr", "type": "medication"}, {"id": "medications", "title": "Famotidine", "path": "MEDICATIONS > Famotidine", "content": "<3 months: 0.5-1 mg/kg daily\n>3 months: 0.5-1 mg/kg BID", "type": "medication"}, {"id": "medications", "title": "Fentanyl", "path": "MEDICATIONS > Fentanyl", "content": "Interval: 1-4 mcg/kg IV q2-4hr\nContinuous: 0.5-3 mcg/kg/hr\nAnesthesia: 0.1-1 mcg/kg/min", "type": "medication"}, {"id": "medications", "title": "Fluconazole", "path": "MEDICATIONS > Fluconazole", "content": "Treatment: 12 mg/kg IV/PO q24hr\nProphylaxis: 3 mg/kg IV/PO qM/Th x 6 wks", "type": "medication"}, {"id": "medications", "title": "Furosemide", "path": "MEDICATIONS > Furosemide", "content": "1-2 mg/kg IV or 1-6 mg/kg PO", "type": "medication"}, {"id": "medications", "title": "Gabapentin", "path": "MEDICATIONS > Gabapentin", "content": "10-15 mg/kg/DAY divided TID", "type": "medication"}, {"id": "medications", "title": "Ganciclovir", "path": "MEDICATIONS > Ganciclovir", "content": "6 mg/kg IV q12 hr", "type": "medication"}, {"id": "medications", "title": "Gentamicin / Tobramycin", "path": "MEDICATIONS > Gentamicin / Tobramycin", "content": "", "type": "medication"}, {"id": "medications", "title": "Glycopyrrolate", "path": "MEDICATIONS > Glycopyrrolate", "content": "IV: 4-10 mcg/kg q3-4hr\nPO: 20-100 mcg/kg 3-4 times per day", "type": "medication"}, {"id": "medications", "title": "Heparin", "path": "MEDICATIONS > Heparin", "content": "LD: 75 units/kg over 10 minutes\nInitial MD: 28 units/kg/hr", "type": "medication"}, {"id": "medications", "title": "Hydrocortisone", "path": "MEDICATIONS > Hydrocortisone", "content": "Refractory hypotension: 1mg/kg IV q8hr\n BPD:2.5-10 mg/kg/DAY IV/PO div  q6-8hr", "type": "medication"}, {"id": "medications", "title": "Ibuprofen", "path": "MEDICATIONS > Ibuprofen", "content": "", "type": "medication"}, {"id": "medications", "title": "(IVIG)", "path": "MEDICATIONS > (IVIG)", "content": "400-1000 mg/kg IV q24hr for 2-5 days", "type": "medication"}, {"id": "medications", "title": "DRUG", "path": "MEDICATIONS > DRUG", "content": "DOSE", "type": "medication"}, {"id": "medications", "title": "Indomethacin", "path": "MEDICATIONS > Indomethacin", "content": "IVH: 0.1 mg/kg once\nPDA:0.2 mg/kg x 1 dose followed by:", "type": "medication"}, {"id": "medications", "title": "Insulin, Regular", "path": "MEDICATIONS > Insulin, Regular", "content": "Intermittent: 0.1-0.2 units/kg SQ q6-12hr\nContinuous: 0.01-0.1 units/kg/hr", "type": "medication"}, {"id": "medications", "title": "Ketamine", "path": "MEDICATIONS > Ketamine", "content": "IV: 0.5 \u2013 2 mg/kg x 1 dose\nIM: 3-7mg/kg x 1 dose", "type": "medication"}, {"id": "medications", "title": "KCl", "path": "MEDICATIONS > KCl", "content": "1-2 mEq/kg IV/PO up to q4hr\n2-6 mEq/kg/day continuous infusion", "type": "medication"}, {"id": "medications", "title": "Lactobacillus", "path": "MEDICATIONS > Lactobacillus", "content": "0.5 pack q8-24hr", "type": "medication"}, {"id": "medications", "title": "Levetiracetam", "path": "MEDICATIONS > Levetiracetam", "content": "5-15 mg/kg BID", "type": "medication"}, {"id": "medications", "title": "Levothyroxine", "path": "MEDICATIONS > Levothyroxine", "content": "<3 months: 10-15 mcg/kg daily\n4-6 months: 8-10 mcg/kg daily\n7-12 months: 6-8 mcg/kg daily", "type": "medication"}, {"id": "medications", "title": "Lorazepam", "path": "MEDICATIONS > Lorazepam", "content": "", "type": "medication"}, {"id": "medications", "title": "Meropenem", "path": "MEDICATIONS > Meropenem", "content": "", "type": "medication"}, {"id": "medications", "title": "Methadone", "path": "MEDICATIONS > Methadone", "content": "0.05-0.2 mg/kg q12-24hr\n0.5 mg/kg/DAY div q8hr", "type": "medication"}, {"id": "medications", "title": "Methylpred", "path": "MEDICATIONS > Methylpred", "content": "1 mg/kg IV q6-12hr", "type": "medication"}, {"id": "medications", "title": "Metronidazole", "path": "MEDICATIONS > Metronidazole", "content": "", "type": "medication"}, {"id": "medications", "title": "Midazolam", "path": "MEDICATIONS > Midazolam", "content": "0.1-0.2 mg/kg IV/IM q1-2hr\n0.06-0.36 mg/kg/hr IV cont infusion", "type": "medication"}, {"id": "medications", "title": "Milrinone", "path": "MEDICATIONS > Milrinone", "content": "0.25-0.75 mcg/kg/min; titrate to effect", "type": "medication"}, {"id": "medications", "title": "Morphine sulfate", "path": "MEDICATIONS > Morphine sulfate", "content": "0.05-0.2 mg/kg IV/IM q2-4hr\n0.025-0.05 mg/kg/hr IV cont infusion", "type": "medication"}, {"id": "medications", "title": "NaCl", "path": "MEDICATIONS > NaCl", "content": "2-8 mEq/kg/DAY\nBOLUS 10-20 mL/kg", "type": "medication"}, {"id": "medications", "title": "NaHCO3", "path": "MEDICATIONS > NaHCO3", "content": "1-2 mEq/kg/dose IV", "type": "medication"}, {"id": "medications", "title": "Nafcillin", "path": "MEDICATIONS > Nafcillin", "content": "", "type": "medication"}, {"id": "medications", "title": "Nevirapine", "path": "MEDICATIONS > Nevirapine", "content": "", "type": "medication"}, {"id": "medications", "title": "Nystatin", "path": "MEDICATIONS > Nystatin", "content": "100000-200000 units PO q6hr", "type": "medication"}, {"id": "medications", "title": "Omeprazole", "path": "MEDICATIONS > Omeprazole", "content": "0.7-1.5 mg/kg q24hr (1 mg/kg q24hr)", "type": "medication"}, {"id": "medications", "title": "Pantoprazole", "path": "MEDICATIONS > Pantoprazole", "content": "0.5-1 mg/kg q 24hr", "type": "medication"}, {"id": "medications", "title": "Penicillin G Na", "path": "MEDICATIONS > Penicillin G Na", "content": "", "type": "medication"}, {"id": "medications", "title": "Piperacillin / Tazobactam", "path": "MEDICATIONS > Piperacillin / Tazobactam", "content": "", "type": "medication"}, {"id": "medications", "title": "Phenobarbital", "path": "MEDICATIONS > Phenobarbital", "content": "MD: 2.5 mg/kg IV/PO q12hr", "type": "medication"}, {"id": "medications", "title": "Polyethylene Glycol", "path": "MEDICATIONS > Polyethylene Glycol", "content": "0.5-1.5 grams/kg q24hr", "type": "medication"}, {"id": "medications", "title": "Poractant", "path": "MEDICATIONS > Poractant", "content": "2.5ml/kg then 1.25ml/kg at 12hr intervals x2 if needed", "type": "medication"}, {"id": "medications", "title": "Prednisolone", "path": "MEDICATIONS > Prednisolone", "content": "0.05-2 mg/kg/DAY div q6-24hr", "type": "medication"}, {"id": "medications", "title": "Propranolol", "path": "MEDICATIONS > Propranolol", "content": "0.01-0.15 mg/kg IV q6hr (MAX 1 mg/dose)\n0.5-5 mg/kg/DAY div q6hr (MAX 16 mg/kg/DAY)", "type": "medication"}, {"id": "medications", "title": "Rocuronium", "path": "MEDICATIONS > Rocuronium", "content": "Initial: 0.45-0.6 mg/kg\nMD surgical relaxation: 0.075-0.15 mg/kg \nContinuous IV infusion: 7-10 mcg/kg/min", "type": "medication"}, {"id": "medications", "title": "Sildenafil", "path": "MEDICATIONS > Sildenafil", "content": "0.5-2mg/kg/dose every 8hr MAX 10mg every 8hr PO", "type": "medication"}, {"id": "medications", "title": "Sulfamethoxazole / Trimethorpim", "path": "MEDICATIONS > Sulfamethoxazole / Trimethorpim", "content": "PCP prophylaxis: 75 mg/m2 PO q12hr or MWF\nStenotrophomonas:5 mg/kg q6-8hr (IV or PO)", "type": "medication"}, {"id": "medications", "title": "Tobramycin Inhaled", "path": "MEDICATIONS > Tobramycin Inhaled", "content": "< 4 kg: 20 mg neb q12hr\n> 4 kg: 40mg neb q12hr", "type": "medication"}, {"id": "medications", "title": "Ursodiol", "path": "MEDICATIONS > Ursodiol", "content": "Biliary atresia:10-15 mg/kg q24hr\nTPN induced cholestasis: 10mg/kg q8hr", "type": "medication"}, {"id": "medications", "title": "Valganciclovir", "path": "MEDICATIONS > Valganciclovir", "content": "16 mg/kg PO q12 hr", "type": "medication"}, {"id": "medications", "title": "Vancomycin", "path": "MEDICATIONS > Vancomycin", "content": "", "type": "medication"}, {"id": "medications", "title": "Vasopressin", "path": "MEDICATIONS > Vasopressin", "content": "0.01-0.6 units/kg/hr", "type": "medication"}, {"id": "medications", "title": "Vecuronium", "path": "MEDICATIONS > Vecuronium", "content": "0.1-0.15 mg/kg/dose every 1-2hr PRN\nContinuous IV infusion: 1.2-3 mcg/kg/min", "type": "medication"}, {"id": "medications", "title": "Zidovudine", "path": "MEDICATIONS > Zidovudine", "content": "", "type": "medication"}], "medications": [{"drug": "Acetaminophen", "dose": "10-15 mg/kg  q4-6hr prn (max 5 doses/day)\n15 mg/kg q6hr x 3-7 days", "remarks": "32 mg/mL liquid\nPDA Closure"}, {"drug": "Acyclovir", "dose": "20 mg/kg IV q8hr", "remarks": ""}, {"drug": "Adenosine", "dose": "0.1-0.2 mg/kg/dose IV PUSH", "remarks": "May increase by 0.05 mg/kg q2min (up to 5x) until SVT converts to sinus rhythm"}, {"drug": "Albumin", "dose": "0.5-1 gram/kg/dose", "remarks": "MAX 4 gram/kg/dose"}, {"drug": "Alprostadil (PGEs)", "dose": "0.025-0.2 mcg/kg/min", "remarks": "MAX conc. 2 mg/100 mL\nWatch for apnea; Compatible with heparin"}, {"drug": "Amoxicillin", "dose": "10-25 mg/kg q24hr", "remarks": "UTI prophylaxis"}, {"drug": "Amphotericin B", "dose": "1 mg/kg/dose IV q24hr", "remarks": "Precipitates in NS; USE D5W & flush\nMonitor UOP, CBC, SCr"}, {"drug": "Ampicillin", "dose": "", "remarks": "Use higher end of dose for GBS and meningitis dosing"}, {"drug": "Azithromycin", "dose": "20 mg/kg q24hr x3 day or 10mg/kg q24hr x10 day IV/PO", "remarks": "For Ureaplasma"}, {"drug": "Baclofen", "dose": "10 \u2013 40 mg/DAY div. q8hr", "remarks": "MAX 40mg/day"}, {"drug": "Bosentan", "dose": "0.5-1 mg/kg q12hr x 4wks\n1-2 mg/kg q12", "remarks": ""}, {"drug": "Ca Carbonate", "dose": "50-150 mg(elemental)/kg/DAY div in 3-4 doses", "remarks": "MAX 1000 mg/24hr"}, {"drug": "Ca Gluconate", "dose": "100-200 mg/kg IV \u2013 repeat every 6hr as needed", "remarks": "VERY Caustic; do NOT give arterially\nWatch extravasation & bradycardia"}, {"drug": "Caffeine citrate", "dose": "LD: 20-80 mg/kg x 1 dose\nMD: 5-25 mg/kg PO/IV q24hr", "remarks": "MAX 25 mg/kg/24hr MD \nIV infuse over 30 min"}, {"drug": "Cefdinir", "dose": "14 mg/kg/day divided q12hr or q24", "remarks": ""}, {"drug": "Cefepime", "dose": "", "remarks": "RENAL adjustments needed"}, {"drug": "Ceftazidime", "dose": "", "remarks": "RENAL adjustments needed"}, {"drug": "Chlorothiazide", "dose": "PO: 10-20 mg/kg q12hr\nIV: 1-4 mg/kg q12hr", "remarks": "Caution \u2013 renal/liver dys fxn\nMAX 10 mg/kg"}, {"drug": "Clindamycin", "dose": "", "remarks": "For Mycoplasma x 10 days\n\nAnaerobic coverage for GI perforation"}, {"drug": "Cromolyn", "dose": "20mg neb q12hr-q6hr", "remarks": ""}, {"drug": "Dexamethasone", "dose": "Extubation: 0.25-0.5 mg/kg IV/PO q8hr x 3", "remarks": "MAX 1.5 mg/kg/24hr\n\n\u201cNeonatology Steriods\u201d Power Plan pre-built IV vs PO doses & days"}, {"drug": "Diazepam", "dose": "0.12-0.8 mg/kg/DAY PO div q6-8hr", "remarks": "FOR sedation"}, {"drug": "Dobutamine / Dopamine", "dose": "2-20 mcg/kg/min IV", "remarks": "DOPAmine 400 mg/250 mL D5W in OmniCell"}, {"drug": "Doxapram", "dose": "LD: 2.5-3 mg/kg IV over 30 min\nMD: 1-2.5 mg/kg/hr IV", "remarks": "Make infusion [C] 1 OR 2 mg/mL"}, {"drug": "Enalapril", "dose": "0.04-0.1 mg/kg q24hr (titrate to effect)", "remarks": "MAX 0.94 mg/kg/24hr"}, {"drug": "Enoxaparin", "dose": "Prophylaxis: 0.75 mg/kg q12\nPreemie treatment: 2 mg/kg12q\nTerm treatment: 1.7 mg/kg q12hr", "remarks": "Titrate based on anti-Xa drawn 4 hours after dose"}, {"drug": "Epinephrine", "dose": "IV: 0.01-0.03 mg/kg q3-5 min\nETT: 0.05-0.1 mg/kg q3-5 min\nContinuous: 0.1-1 mcg/kg/min", "remarks": "For HR < 60bpm"}, {"drug": "Erythromycin", "dose": "Low: 1.5-2.5 mg/kg PO q6hr \nHigh: 10-12.5 mg/kg PO q6-8hr", "remarks": "Prokinetic dosing\nHigh dose for PNA >14d"}, {"drug": "Famotidine", "dose": "<3 months: 0.5-1 mg/kg daily\n>3 months: 0.5-1 mg/kg BID", "remarks": "Max 40 mg/dose"}, {"drug": "Fentanyl", "dose": "Interval: 1-4 mcg/kg IV q2-4hr\nContinuous: 0.5-3 mcg/kg/hr\nAnesthesia: 0.1-1 mcg/kg/min", "remarks": "Tolerance builds quickly\nTitrate to effect"}, {"drug": "Fluconazole", "dose": "Treatment: 12 mg/kg IV/PO q24hr\nProphylaxis: 3 mg/kg IV/PO qM/Th x 6 wks", "remarks": "Infuse over 2 hrs\nInfuse over 1 hr"}, {"drug": "Furosemide", "dose": "1-2 mg/kg IV or 1-6 mg/kg PO", "remarks": "Long term= renal calcifications"}, {"drug": "Gabapentin", "dose": "10-15 mg/kg/DAY divided TID", "remarks": "Up to 50 mg/kg/DAY"}, {"drug": "Ganciclovir", "dose": "6 mg/kg IV q12 hr", "remarks": ""}, {"drug": "Gentamicin / Tobramycin", "dose": "", "remarks": "Levels with 4th TOTAL dose\n\nTherapeutic range:\nPeak 4-8 mcg/mL\nTrough: 0.5-1.2 mcg/mL\n\nCorrect GA up to 25 wks (ie 24.2 DOL8 = 25 wks for LD/MD)"}, {"drug": "Glycopyrrolate", "dose": "IV: 4-10 mcg/kg q3-4hr\nPO: 20-100 mcg/kg 3-4 times per day", "remarks": ""}, {"drug": "Heparin", "dose": "LD: 75 units/kg over 10 minutes\nInitial MD: 28 units/kg/hr", "remarks": "Titrate dose based on Anti-Xa\nBolus doses out of bag"}, {"drug": "Hydrocortisone", "dose": "Refractory hypotension: 1mg/kg IV q8hr\n BPD:2.5-10 mg/kg/DAY IV/PO div  q6-8hr", "remarks": ""}, {"drug": "Ibuprofen", "dose": "", "remarks": ""}, {"drug": "(IVIG)", "dose": "400-1000 mg/kg IV q24hr for 2-5 days", "remarks": ""}, {"drug": "DRUG", "dose": "DOSE", "remarks": "REMARKS"}, {"drug": "Indomethacin", "dose": "IVH: 0.1 mg/kg once\nPDA:0.2 mg/kg x 1 dose followed by:", "remarks": "PDA: interval ext to q24hr for\nUOP 0.6-1 mL/kg/hr\nUOP < 0.6 mL/kg/hr NOT used"}, {"drug": "Insulin, Regular", "dose": "Intermittent: 0.1-0.2 units/kg SQ q6-12hr\nContinuous: 0.01-0.1 units/kg/hr", "remarks": "[C] #units / 100 mL D5W or \u00bdNS"}, {"drug": "Ketamine", "dose": "IV: 0.5 \u2013 2 mg/kg x 1 dose\nIM: 3-7mg/kg x 1 dose", "remarks": "Anesthesia for procedure"}, {"drug": "KCl", "dose": "1-2 mEq/kg IV/PO up to q4hr\n2-6 mEq/kg/day continuous infusion", "remarks": "1-4 mEq PO loaded in ADC"}, {"drug": "Lactobacillus", "dose": "0.5 pack q8-24hr", "remarks": ""}, {"drug": "Levetiracetam", "dose": "5-15 mg/kg BID", "remarks": "Up to 60 mg/kg/DAY IV or PO"}, {"drug": "Levothyroxine", "dose": "<3 months: 10-15 mcg/kg daily\n4-6 months: 8-10 mcg/kg daily\n7-12 months: 6-8 mcg/kg daily", "remarks": "Round dose to nearest 6.25 mcg"}, {"drug": "Lorazepam", "dose": "", "remarks": ""}, {"drug": "Meropenem", "dose": "", "remarks": "Requires a UAB Infectious Disease MD approval for use"}, {"drug": "Methadone", "dose": "0.05-0.2 mg/kg q12-24hr\n0.5 mg/kg/DAY div q8hr", "remarks": "Titrate to control withdrawal symptoms"}, {"drug": "Methylpred", "dose": "1 mg/kg IV q6-12hr", "remarks": ""}, {"drug": "Metronidazole", "dose": "", "remarks": ""}, {"drug": "Midazolam", "dose": "0.1-0.2 mg/kg IV/IM q1-2hr\n0.06-0.36 mg/kg/hr IV cont infusion", "remarks": "For conscious sedation"}, {"drug": "Milrinone", "dose": "0.25-0.75 mcg/kg/min; titrate to effect", "remarks": ""}, {"drug": "Morphine sulfate", "dose": "0.05-0.2 mg/kg IV/IM q2-4hr\n0.025-0.05 mg/kg/hr IV cont infusion", "remarks": ""}, {"drug": "NaCl", "dose": "2-8 mEq/kg/DAY\nBOLUS 10-20 mL/kg", "remarks": "1-4 mEq PO soln in ADC"}, {"drug": "NaHCO3", "dose": "1-2 mEq/kg/dose IV", "remarks": "Give over 20-30 minutes"}, {"drug": "Nafcillin", "dose": "", "remarks": "Meningitis 14 \u2013 21 days treatment"}, {"drug": "Nevirapine", "dose": "", "remarks": "1st dose within 48hr, 2nd dose 48hrs after 1st & 3rd dose 96hr after 2nd"}, {"drug": "Nystatin", "dose": "100000-200000 units PO q6hr", "remarks": "Swab each cheek for thrush"}, {"drug": "Omeprazole", "dose": "0.7-1.5 mg/kg q24hr (1 mg/kg q24hr)", "remarks": "ORAL or NG tube"}, {"drug": "Pantoprazole", "dose": "0.5-1 mg/kg q 24hr", "remarks": "INJECTION"}, {"drug": "Penicillin G Na", "dose": "", "remarks": "Penicillin G (Benzathine) syphilis IM 50000 units/kg x 1 dose\nAvoid Penicillin G Potassium in newborns"}, {"drug": "Piperacillin / Tazobactam", "dose": "", "remarks": "Dosed on piperacillin component"}, {"drug": "Phenobarbital", "dose": "MD: 2.5 mg/kg IV/PO q12hr", "remarks": "Order TROUGH prior to dose"}, {"drug": "Polyethylene Glycol", "dose": "0.5-1.5 grams/kg q24hr", "remarks": ""}, {"drug": "Poractant", "dose": "2.5ml/kg then 1.25ml/kg at 12hr intervals x2 if needed", "remarks": "MAX 5ml/kg"}, {"drug": "Prednisolone", "dose": "0.05-2 mg/kg/DAY div q6-24hr", "remarks": "PO"}, {"drug": "Propranolol", "dose": "0.01-0.15 mg/kg IV q6hr (MAX 1 mg/dose)\n0.5-5 mg/kg/DAY div q6hr (MAX 16 mg/kg/DAY)", "remarks": "Tet spells: double the dose\nArrhythmias: low dose IVP"}, {"drug": "Rocuronium", "dose": "Initial: 0.45-0.6 mg/kg\nMD surgical relaxation: 0.075-0.15 mg/kg \nContinuous IV infusion: 7-10 mcg/kg/min", "remarks": "Cont. surgical relaxation dose interval as determined by monitoring"}, {"drug": "Sildenafil", "dose": "0.5-2mg/kg/dose every 8hr MAX 10mg every 8hr PO", "remarks": "IV product \u2013 call store room"}, {"drug": "Sulfamethoxazole / Trimethorpim", "dose": "PCP prophylaxis: 75 mg/m2 PO q12hr or MWF\nStenotrophomonas:5 mg/kg q6-8hr (IV or PO)", "remarks": "Dose based on trimethoprim product"}, {"drug": "Tobramycin Inhaled", "dose": "< 4 kg: 20 mg neb q12hr\n> 4 kg: 40mg neb q12hr", "remarks": "Should not be administered with systemic tobramycin"}, {"drug": "Ursodiol", "dose": "Biliary atresia:10-15 mg/kg q24hr\nTPN induced cholestasis: 10mg/kg q8hr", "remarks": ""}, {"drug": "Valganciclovir", "dose": "16 mg/kg PO q12 hr", "remarks": ""}, {"drug": "Vancomycin", "dose": "", "remarks": "Levels with 5th TOTAL dose\nTherapeutic rage:\nTrough: 10-15 mcg/mL\nPeak: 20-40 mcg/mL"}, {"drug": "Vasopressin", "dose": "0.01-0.6 units/kg/hr", "remarks": "Titrate to effect"}, {"drug": "Vecuronium", "dose": "0.1-0.15 mg/kg/dose every 1-2hr PRN\nContinuous IV infusion: 1.2-3 mcg/kg/min", "remarks": "Must have pain/sedation meds"}, {"drug": "Zidovudine", "dose": "", "remarks": ""}], "quickReference": {"medications": {"caffeine": {"indication": "Apnea of prematurity", "dosing": ["Loading: 20 mg/kg IV/PO (give over 30 min if IV)", "Maintenance: 5 mg/kg/day IV/PO (start 24h after load)"], "monitoring": ["HR (watch for tachycardia >180-200)", "Feeding tolerance", "Trough level if apnea persists (goal: 8-20 mcg/mL)"], "notes": ["Can give via NG/OG tube", "Decrease if persistent tachycardia or feeding issues"]}, "ampicillin": {"indication": "Bacterial infections, sepsis, meningitis", "dosing": ["See full dosing table by age and indication", "Higher doses for GBS and meningitis"], "monitoring": ["Renal function", "CBC if prolonged use"], "notes": ["Combine with gentamicin for empiric coverage", "Adjust for renal impairment"]}, "gentamicin": {"indication": "Gram-negative coverage, sepsis", "dosing": ["See dosing by gestational age and postnatal age", "Extended interval dosing preferred"], "monitoring": ["Trough levels (goal <2 mcg/mL)", "Renal function", "Hearing screen before discharge"], "notes": ["Nephrotoxic and ototoxic", "Synergistic with ampicillin"]}}, "procedures": {"lumbar-puncture": {"positioning": "Lateral decubitus (preferred) or sitting", "landmarks": "L3-L4 or L4-L5 (at level of iliac crest)", "needle": "22-gauge, 1.5 inch", "steps": ["Prep with chlorhexidine, full sterile technique", "Local anesthetic (optional): 0.1-0.2 mL lidocaine 1%", "Insert needle with bevel UP", "Advance slowly, remove stylet when 'pop' felt", "Collect 1 mL in each of 3 tubes"], "tubes": {"tube1": "Gram stain, culture", "tube2": "Glucose, protein", "tube3": "Cell count"}, "normalValues": {"wbc": "<30 (preterm: <50)", "protein": "<150 mg/dL (preterm: <170)", "glucose": ">50% of serum glucose"}, "complications": ["Apnea/bradycardia during procedure", "Bloody tap (send tube 1 and 3 for comparison)"]}, "intubation": {"preparation": ["Suction available", "Appropriate ETT size ready (see table)", "Stylet in place", "Tape prepared", "Monitoring in place"], "ettSize": ["<1000g or <28 wks: 2.5mm", "1000-2000g or 28-34 wks: 3.0mm", ">2000g or >34 wks: 3.5mm"], "depth": ["Rule: Weight(kg) + 6 = depth at lip in cm", "Verify with CXR (tip at T1-T2)"], "medications": ["Atropine: 0.02 mg/kg (if not emergent)", "Fentanyl: 1-3 mcg/kg (if hemodynamically stable)", "Rocuronium: 1 mg/kg (if needed)"], "postIntubation": ["Confirm placement: CO2 detector, breath sounds", "Secure tube well", "CXR for position", "ABG in 15-30 minutes"]}}, "protocols": {"transfer-to-nbn": {"vitalSigns": ["HR: 90-160 bpm", "RR: 30-60 bpm"], "feeding": ["2 consecutive PO feeds without distress", "Especially important if RR 60-70"], "timing": ["4 hr for most infants", "8 hr if admitted for hypothermia", "12 hr if <2000g (must also be >24hr old)"], "oxygenHistory": ["4 hr if no O2 or <2 hr of O2 in NICU", "6 hr if 2-12 hr of O2 in NICU", "12 hr if intubated or >12 hr O2 in NICU"], "glucose": ["2 prefeed checks >50", "First check 3h after IVF stopped", "If not transferred after 2 checks \u2192 wait 12 more hours"], "special": ["24 hr if <37 wks or <2500g, SGA, cleft lip/palate", "If HIE concern: document stable neuro exam 6 hrs"]}, "admission-criteria": {"nbnCriteria": ["No major congenital anomalies", "Temperature stable without incubator/warmer", "O2 sats >92% on RA if 35-35.6 wks GA, >90% for others", "No respiratory distress (RR <70, no grunting/retractions)", "No need for continuous IVF, NG/OG tubes"], "rnicuCriteria": ["All other infants should be admitted to RNICU"], "notes": ["Mild renal pelviectasis, isolated cleft lip/palate, small CPAM can go to NBN"]}}, "conditions": {"rds": {"initialManagement": ["Give surfactant if intubated", "Try CPAP first if not intubated (5-6 cm H\u2082O)", "Intubate if FiO\u2082 >40-50% or severe distress"], "surfactant": {"dose": "4 mL/kg (Survanta/Curosurf)", "repeat": "Can repeat q12h \u00d7 2 more doses if needed"}, "targetSats": "90-95% for preterm", "ventilatorSettings": {"rate": "40-60", "pip": "Start 18-22 (adjust for chest rise)", "peep": "5-6", "iTime": "0.3-0.35 sec"}, "cxr": ["After intubation", "If not improving as expected", "Before each additional surfactant dose"], "additional": ["Antibiotics (until cultures negative)", "Minimal handling first 48-72h", "Keep warm (avoid cold stress)"]}, "hypoglycemia": {"definition": ["Blood glucose <50 mg/dL in first 24h", "Blood glucose <60 mg/dL after 24h"], "immediateAction": ["If symptomatic or <25 mg/dL: Give D10W 2 mL/kg IV push", "If asymptomatic 25-50: Feed if able, recheck in 1 hour", "Start IV dextrose if persistent"], "ivDextrose": {"gir": "Start at 6-8 mg/kg/min", "increase": "Increase by 1-2 mg/kg/min if still low", "max": "Up to 12-15 mg/kg/min usually"}, "monitoring": ["Check glucose q30-60 min until stable >50-60", "Once stable, check q3-4h before feeds"], "workup": ["If persistent or requiring high GIR: Check insulin, cortisol, GH", "Consider sepsis workup", "Endocrine consult if not responding"]}, "seizures": {"immediateActions": ["Ensure airway/breathing/circulation", "Check glucose immediately (treat if <50)", "Get IV access"], "firstLine": {"drug": "Phenobarbital", "dose": "20 mg/kg IV loading dose (may repeat 10-20 mg/kg \u00d7 2)", "rate": "Give over 10-15 minutes"}, "secondLine": ["Levetiracetam 40-60 mg/kg IV", "Or Fosphenytoin 20 mg PE/kg IV"], "workup": ["Glucose, calcium, magnesium, electrolytes", "Blood gas (check for acidosis)", "Consider LP if concerned for meningitis", "EEG", "Head ultrasound or MRI"], "maintenance": "Continue phenobarbital 3-5 mg/kg/day divided q12-24h"}}}};

        function App() {
            const [isAuthenticated, setIsAuthenticated] = useState(false);
            const [password, setPassword] = useState('');
            const [passwordError, setPasswordError] = useState('');

            const handleLogin = (e) => {
                e.preventDefault();
                if (password === CORRECT_PASSWORD) {
                    setIsAuthenticated(true);
                    setPasswordError('');
                } else {
                    setPasswordError('Incorrect password. Please try again.');
                }
            };

            if (!isAuthenticated) {
                return (
                    <div className="min-h-screen gradient-bg flex items-center justify-center p-4">
                        <div className="bg-white rounded-lg shadow-2xl p-8 max-w-md w-full">
                            <div className="text-center mb-6">
                                <i className="fas fa-baby text-6xl text-indigo-600 mb-4"></i>
                                <h1 className="text-3xl font-bold text-gray-800 mb-2">RNICU Resident Guide</h1>
                                <p className="text-gray-600">Interactive Clinical Protocol Resource</p>
                            </div>
                            <form onSubmit={handleLogin}>
                                <div className="mb-4">
                                    <label className="block text-gray-700 text-sm font-semibold mb-2">
                                        Access Password
                                    </label>
                                    <input
                                        type="password"
                                        value={password}
                                        onChange={(e) => setPassword(e.target.value)}
                                        className="w-full px-4 py-3 border border-gray-300 rounded-lg focus:outline-none focus:ring-2 focus:ring-indigo-500"
                                        placeholder="Enter password"
                                        autoFocus
                                    />
                                    {passwordError && (
                                        <p className="text-red-500 text-sm mt-2">{passwordError}</p>
                                    )}
                                </div>
                                <button
                                    type="submit"
                                    className="w-full bg-indigo-600 text-white py-3 rounded-lg font-semibold hover:bg-indigo-700 transition duration-200"
                                >
                                    Access Guide
                                </button>
                            </form>
                            <div className="mt-6 text-center text-sm text-gray-500">
                                <i className="fas fa-lock mr-1"></i>
                                For authorized personnel only
                            </div>
                        </div>
                    </div>
                );
            }

            return <MainApp />;
        }

        function MainApp() {
            const [view, setView] = useState('home');
            const [selectedSection, setSelectedSection] = useState(null);
            const [searchQuery, setSearchQuery] = useState('');
            const [searchResults, setSearchResults] = useState([]);
            const [showQuickRef, setShowQuickRef] = useState(false);
            const [quickRefMode, setQuickRefMode] = useState(false); // Toggle for content view

            const handleSearch = (query) => {
                setSearchQuery(query);
                if (!query.trim()) {
                    setSearchResults([]);
                    return;
                }

                const results = APP_DATA.searchIndex.filter(item => {
                    const searchText = (item.title + ' ' + (item.content || '') + ' ' + item.path).toLowerCase();
                    return searchText.includes(query.toLowerCase());
                }).slice(0, 20);

                setSearchResults(results);
                if (results.length > 0) {
                    setView('search');
                }
            };

            const navigateToSection = (sectionId) => {
                const section = findSectionById(APP_DATA.sections, sectionId);
                setSelectedSection(section);
                setView('content');
                setSearchQuery('');
                setSearchResults([]);
                setQuickRefMode(false);
            };

            const findSectionById = (sections, id) => {
                for (const section of sections) {
                    if (section.id === id) return section;
                    if (section.children) {
                        const found = findSectionById(section.children, id);
                        if (found) return found;
                    }
                }
                return null;
            };

            return (
                <div className="min-h-screen bg-gray-50">
                    <header className="sticky-header border-b border-gray-200 shadow-sm">
                        <div className="max-w-7xl mx-auto px-4 py-4">
                            <div className="flex items-center justify-between mb-3">
                                <button
                                    onClick={() => {
                                        setView('home');
                                        setSearchQuery('');
                                        setSearchResults([]);
                                        setSelectedSection(null);
                                        setShowQuickRef(false);
                                    }}
                                    className="flex items-center space-x-2 text-indigo-600"
                                >
                                    <i className="fas fa-baby text-2xl"></i>
                                    <div>
                                        <h1 className="text-xl font-bold">RNICU Guide</h1>
                                        <p className="text-xs text-gray-500">Clinical Protocols</p>
                                    </div>
                                </button>
                                <div className="flex space-x-2">
                                    <button
                                        onClick={() => {
                                            setView('quickref');
                                            setShowQuickRef(false);
                                        }}
                                        className={`flex items-center space-x-2 px-4 py-2 rounded-lg font-semibold transition ${
                                            view === 'quickref'
                                                ? 'bg-orange-500 text-white quick-ref-badge'
                                                : 'bg-white text-orange-600 border border-orange-600'
                                        }`}
                                    >
                                        <i className="fas fa-bolt"></i>
                                        <span className="hidden sm:inline">Quick Ref</span>
                                    </button>
                                </div>
                            </div>
                            
                            <div className="relative">
                                <i className="fas fa-search absolute left-3 top-1/2 transform -translate-y-1/2 text-gray-400"></i>
                                <input
                                    type="text"
                                    value={searchQuery}
                                    onChange={(e) => handleSearch(e.target.value)}
                                    placeholder="Search protocols, medications, procedures..."
                                    className="w-full pl-10 pr-4 py-3 border border-gray-300 rounded-lg focus:outline-none focus:ring-2 focus:ring-indigo-500"
                                />
                            </div>
                        </div>
                    </header>

                    <main className="max-w-7xl mx-auto px-4 py-6">
                        {view === 'home' ? (
                            <HomeView onNavigate={() => setView('browse')} onSectionClick={navigateToSection} />
                        ) : view === 'browse' ? (
                            <BrowseView onSectionClick={navigateToSection} />
                        ) : view === 'search' ? (
                            <SearchResults results={searchResults} onResultClick={navigateToSection} />
                        ) : view === 'quickref' ? (
                            <QuickReferenceView onNavigate={navigateToSection} />
                        ) : view === 'content' && selectedSection ? (
                            <ContentView 
                                section={selectedSection} 
                                onNavigate={navigateToSection}
                                quickRefMode={quickRefMode}
                                setQuickRefMode={setQuickRefMode}
                            />
                        ) : null}
                    </main>
                </div>
            );
        }

        function HomeView({ onNavigate, onSectionClick }) {
            const quickAccess = [
                { title: 'Quick Reference', icon: 'fa-bolt', id: 'quickref', color: 'bg-orange-500', isSpecial: true },
                { title: 'Medications', icon: 'fa-pills', id: 'medications', color: 'bg-yellow-500' },
                { title: 'Admissions', icon: 'fa-plus-circle', id: 'admissions', color: 'bg-blue-500' },
                { title: 'Transfers', icon: 'fa-exchange-alt', id: 'transfers', color: 'bg-green-500' },
                { title: 'Procedures', icon: 'fa-procedures', id: 'procedures', color: 'bg-red-500' },
                { title: 'Resuscitation', icon: 'fa-heartbeat', id: 'neonatal-resuscitation', color: 'bg-pink-500' },
            ];

            return (
                <div className="space-y-6">
                    <div className="bg-white rounded-lg shadow-md p-6">
                        <h2 className="text-2xl font-bold text-gray-800 mb-2">Welcome to the RNICU Guide</h2>
                        <p className="text-gray-600">
                            Your interactive clinical protocol resource. Search above, browse by category, or use Quick Reference for fast lookups.
                        </p>
                    </div>

                    <div>
                        <h3 className="text-lg font-semibold text-gray-800 mb-3">Quick Access</h3>
                        <div className="grid grid-cols-2 md:grid-cols-3 gap-4">
                            {quickAccess.map(item => (
                                <button
                                    key={item.id}
                                    onClick={() => item.isSpecial ? window.location.hash = 'quickref' : onSectionClick(item.id)}
                                    className="section-card bg-white rounded-lg shadow-md p-4 text-left hover:shadow-lg transition"
                                >
                                    <div className={`${item.color} w-12 h-12 rounded-full flex items-center justify-center mb-3 ${item.isSpecial ? 'quick-ref-badge' : ''}`}>
                                        <i className={`fas ${item.icon} text-white text-xl`}></i>
                                    </div>
                                    <h4 className="font-semibold text-gray-800">{item.title}</h4>
                                    {item.isSpecial && (
                                        <span className="text-xs text-orange-600 font-semibold">NEW!</span>
                                    )}
                                </button>
                            ))}
                        </div>
                    </div>

                    <div>
                        <div className="flex items-center justify-between mb-3">
                            <h3 className="text-lg font-semibold text-gray-800">Browse by System</h3>
                            <button
                                onClick={onNavigate}
                                className="text-indigo-600 font-semibold text-sm hover:underline"
                            >
                                View All 
                            </button>
                        </div>
                        <div className="grid grid-cols-1 md:grid-cols-2 gap-4">
                            {APP_DATA.sections.slice(1, 7).map((section) => (
                                <button
                                    key={section.id}
                                    onClick={() => onSectionClick(section.id)}
                                    className="section-card bg-white rounded-lg shadow-md p-4 text-left hover:shadow-lg transition"
                                >
                                    <h4 className="font-semibold text-gray-800 mb-2">{section.title}</h4>
                                    <p className="text-sm text-gray-600">
                                        {section.children?.length || 0} topics
                                    </p>
                                </button>
                            ))}
                        </div>
                    </div>
                </div>
            );
        }

        function BrowseView({ onSectionClick }) {
            return (
                <div className="space-y-6">
                    <h2 className="text-2xl font-bold text-gray-800">Browse All Sections</h2>
                    <div className="space-y-4">
                        {APP_DATA.sections.map(section => (
                            <div key={section.id} className="bg-white rounded-lg shadow-md p-6">
                                <button
                                    onClick={() => onSectionClick(section.id)}
                                    className="text-xl font-bold text-indigo-600 hover:underline mb-3 text-left w-full"
                                >
                                    {section.title}
                                    {section.id === 'medications' && (
                                        <span className="ml-2 text-sm text-gray-500">({APP_DATA.medications.length} medications)</span>
                                    )}
                                </button>
                                {section.children && section.children.length > 0 && (
                                    <div className="grid grid-cols-1 md:grid-cols-2 gap-2">
                                        {section.children.map(child => (
                                            child.type !== 'text' && (
                                                <button
                                                    key={child.id}
                                                    onClick={() => onSectionClick(child.id)}
                                                    className="text-left px-3 py-2 rounded hover:bg-gray-100 text-gray-700"
                                                >
                                                     {child.title}
                                                </button>
                                            )
                                        ))}
                                    </div>
                                )}
                            </div>
                        ))}
                    </div>
                </div>
            );
        }

        function SearchResults({ results, onResultClick }) {
            return (
                <div className="space-y-4">
                    <h2 className="text-2xl font-bold text-gray-800">
                        Search Results ({results.length})
                    </h2>
                    {results.map((result, idx) => (
                        <button
                            key={idx}
                            onClick={() => onResultClick(result.id)}
                            className="w-full bg-white rounded-lg shadow-md p-4 text-left hover:shadow-lg transition"
                        >
                            <h3 className="font-semibold text-indigo-600 mb-1">{result.title}</h3>
                            <p className="text-sm text-gray-500 mb-2">{result.path}</p>
                            {result.content && (
                                <p className="text-sm text-gray-700">{result.content}...</p>
                            )}
                        </button>
                    ))}
                </div>
            );
        }

        function QuickReferenceView({ onNavigate }) {
            const [selectedCategory, setSelectedCategory] = useState(null);

            const categories = [
                { id: 'medications', title: 'Medications', icon: 'fa-pills', count: Object.keys(APP_DATA.quickReference.medications || {}).length, color: 'bg-yellow-500' },
                { id: 'procedures', title: 'Procedures', icon: 'fa-procedures', count: Object.keys(APP_DATA.quickReference.procedures || {}).length, color: 'bg-red-500' },
                { id: 'protocols', title: 'Clinical Protocols', icon: 'fa-clipboard-check', count: Object.keys(APP_DATA.quickReference.protocols || {}).length, color: 'bg-blue-500' },
                { id: 'conditions', title: 'Common Conditions', icon: 'fa-stethoscope', count: Object.keys(APP_DATA.quickReference.conditions || {}).length, color: 'bg-green-500' },
            ];

            if (selectedCategory) {
                return <QuickReferenceCategoryView category={selectedCategory} onBack={() => setSelectedCategory(null)} onNavigate={onNavigate} />;
            }

            return (
                <div className="space-y-6">
                    <div className="bg-gradient-to-r from-orange-500 to-red-500 rounded-lg shadow-lg p-6 text-white">
                        <div className="flex items-center space-x-3 mb-2">
                            <i className="fas fa-bolt text-3xl"></i>
                            <h2 className="text-2xl font-bold">Quick Reference</h2>
                        </div>
                        <p className="text-orange-100">
                            Fast, action-oriented information for bedside use. Click any category to see condensed protocols.
                        </p>
                    </div>

                    <div className="grid grid-cols-1 md:grid-cols-2 gap-4">
                        {categories.map(cat => (
                            <button
                                key={cat.id}
                                onClick={() => setSelectedCategory(cat.id)}
                                className="bg-white rounded-lg shadow-md p-6 text-left hover:shadow-lg transition"
                            >
                                <div className="flex items-start justify-between mb-4">
                                    <div className={`${cat.color} w-14 h-14 rounded-full flex items-center justify-center`}>
                                        <i className={`fas ${cat.icon} text-white text-2xl`}></i>
                                    </div>
                                    <span className="text-2xl font-bold text-gray-300">{cat.count}</span>
                                </div>
                                <h3 className="text-xl font-bold text-gray-800 mb-2">{cat.title}</h3>
                                <p className="text-gray-600 text-sm">
                                    {cat.count} quick reference {cat.count === 1 ? 'entry' : 'entries'}
                                </p>
                            </button>
                        ))}
                    </div>

                    <div className="bg-blue-50 border-l-4 border-blue-500 p-4 rounded">
                        <div className="flex items-start">
                            <i className="fas fa-info-circle text-blue-500 mt-1 mr-3"></i>
                            <div>
                                <p className="text-sm text-blue-900 font-semibold mb-1">What is Quick Reference?</p>
                                <p className="text-sm text-blue-800">
                                    Quick Reference provides condensed, action-oriented information without the theory. 
                                    Perfect for quick lookups at the bedside. Each entry has a "Dig Deeper" link to the full content.
                                </p>
                            </div>
                        </div>
                    </div>
                </div>
            );
        }

        function QuickReferenceCategoryView({ category, onBack, onNavigate }) {
            const data = APP_DATA.quickReference[category] || {};
            const entries = Object.keys(data);

            return (
                <div className="space-y-6">
                    <button
                        onClick={onBack}
                        className="flex items-center text-indigo-600 font-semibold hover:underline"
                    >
                        <i className="fas fa-arrow-left mr-2"></i>
                        Back to Quick Reference
                    </button>

                    <h2 className="text-2xl font-bold text-gray-800 capitalize">{category}</h2>

                    <div className="space-y-4">
                        {entries.map(key => {
                            const entry = data[key];
                            return (
                                <QuickReferenceCard 
                                    key={key} 
                                    title={key} 
                                    data={entry} 
                                    category={category}
                                    onNavigate={onNavigate}
                                />
                            );
                        })}
                    </div>
                </div>
            );
        }

        function QuickReferenceCard({ title, data, category, onNavigate }) {
            const formatTitle = (str) => str.replace(/-/g, ' ').replace(/\b\w/g, l => l.toUpperCase());

            const handleDigDeeper = () => {
                const sectionId = title.toLowerCase().replace(/ /g, '-');
                onNavigate(sectionId);
            };

            return (
                <div className="bg-white rounded-lg shadow-md p-6 border-l-4 border-orange-500">
                    <div className="flex items-start justify-between mb-4">
                        <h3 className="text-xl font-bold text-gray-800">{formatTitle(title)}</h3>
                        <button
                            onClick={handleDigDeeper}
                            className="flex items-center text-indigo-600 text-sm font-semibold hover:underline"
                        >
                            <i className="fas fa-book-open mr-1"></i>
                            Dig Deeper
                        </button>
                    </div>

                    {data.indication && (
                        <div className="mb-4">
                            <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">Indication</h4>
                            <p className="text-gray-800">{data.indication}</p>
                        </div>
                    )}

                    {data.dosing && (
                        <div className="mb-4">
                            <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">Dosing</h4>
                            <ul className="list-disc list-inside space-y-1">
                                {data.dosing.map((item, idx) => (
                                    <li key={idx} className="text-gray-800">{item}</li>
                                ))}
                            </ul>
                        </div>
                    )}

                    {data.monitoring && (
                        <div className="mb-4">
                            <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">Monitoring</h4>
                            <ul className="list-disc list-inside space-y-1">
                                {data.monitoring.map((item, idx) => (
                                    <li key={idx} className="text-gray-800">{item}</li>
                                ))}
                            </ul>
                        </div>
                    )}

                    {data.notes && (
                        <div className="mb-4">
                            <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">Notes</h4>
                            <ul className="list-disc list-inside space-y-1">
                                {data.notes.map((item, idx) => (
                                    <li key={idx} className="text-gray-800">{item}</li>
                                ))}
                            </ul>
                        </div>
                    )}

                    {/* Render other fields dynamically */}
                    {Object.keys(data).filter(k => !['indication', 'dosing', 'monitoring', 'notes'].includes(k)).map(key => {
                        const value = data[key];
                        if (Array.isArray(value)) {
                            return (
                                <div key={key} className="mb-4">
                                    <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">{formatTitle(key)}</h4>
                                    <ul className="list-disc list-inside space-y-1">
                                        {value.map((item, idx) => (
                                            <li key={idx} className="text-gray-800">{item}</li>
                                        ))}
                                    </ul>
                                </div>
                            );
                        } else if (typeof value === 'object') {
                            return (
                                <div key={key} className="mb-4">
                                    <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">{formatTitle(key)}</h4>
                                    <div className="space-y-1 pl-4">
                                        {Object.keys(value).map(subKey => (
                                            <div key={subKey}>
                                                <span className="font-semibold text-gray-700">{formatTitle(subKey)}:</span>{' '}
                                                <span className="text-gray-800">{value[subKey]}</span>
                                            </div>
                                        ))}
                                    </div>
                                </div>
                            );
                        } else {
                            return (
                                <div key={key} className="mb-4">
                                    <h4 className="text-sm font-semibold text-gray-600 uppercase tracking-wide mb-2">{formatTitle(key)}</h4>
                                    <p className="text-gray-800">{value}</p>
                                </div>
                            );
                        }
                    })}
                </div>
            );
        }

        function ContentView({ section, onNavigate, quickRefMode, setQuickRefMode }) {
            // Check if there's quick reference content for this section
            const hasQuickRef = false; // We'll implement this check properly

            const renderContent = (item) => {
                if (item.type === 'text') {
                    return (
                        <p className="text-gray-700 mb-3 leading-relaxed">{item.content}</p>
                    );
                } else if (item.type === 'h2') {
                    return (
                        <div key={item.id} className="mb-6">
                            <h2 className="text-2xl font-bold text-gray-800 mb-4 border-b-2 border-indigo-200 pb-2">
                                {item.title}
                            </h2>
                            {item.children?.map((child, idx) => (
                                <div key={idx}>{renderContent(child)}</div>
                            ))}
                        </div>
                    );
                } else if (item.type === 'h3') {
                    return (
                        <div key={item.id} className="mb-4">
                            <h3 className="text-xl font-semibold text-gray-800 mb-3">
                                {item.title}
                            </h3>
                            {item.children?.map((child, idx) => (
                                <div key={idx}>{renderContent(child)}</div>
                            ))}
                        </div>
                    );
                }
                return null;
            };

            // Special rendering for Medications section
            if (section.id === 'medications' && section.medications) {
                return <MedicationsView medications={section.medications} />;
            }

            return (
                <div className="bg-white rounded-lg shadow-md p-6">
                    <div className="flex items-center justify-between mb-6 border-b-4 border-indigo-600 pb-3">
                        <h1 className="text-3xl font-bold text-gray-800">
                            {section.title}
                        </h1>
                    </div>
                    <div className="prose max-w-none">
                        {section.children?.map((child, idx) => (
                            <div key={idx}>{renderContent(child)}</div>
                        ))}
                    </div>
                </div>
            );
        }

        function MedicationsView({ medications }) {
            const [searchTerm, setSearchTerm] = useState('');
            const [viewMode, setViewMode] = useState('cards'); // 'cards' or 'table'

            const filteredMeds = medications.filter(med =>
                med.drug.toLowerCase().includes(searchTerm.toLowerCase())
            );

            return (
                <div className="space-y-6">
                    <div className="bg-white rounded-lg shadow-md p-6">
                        <h1 className="text-3xl font-bold text-gray-800 mb-4 border-b-4 border-yellow-500 pb-3">
                            <i className="fas fa-pills text-yellow-500 mr-2"></i>
                            Medications
                        </h1>
                        
                        <div className="flex flex-col sm:flex-row gap-4 items-start sm:items-center justify-between mb-6">
                            <div className="relative flex-1 w-full">
                                <i className="fas fa-search absolute left-3 top-1/2 transform -translate-y-1/2 text-gray-400"></i>
                                <input
                                    type="text"
                                    value={searchTerm}
                                    onChange={(e) => setSearchTerm(e.target.value)}
                                    placeholder="Search medications..."
                                    className="w-full pl-10 pr-4 py-2 border border-gray-300 rounded-lg focus:outline-none focus:ring-2 focus:ring-yellow-500"
                                />
                            </div>
                            <div className="flex space-x-2">
                                <button
                                    onClick={() => setViewMode('cards')}
                                    className={`px-4 py-2 rounded-lg font-semibold transition ${
                                        viewMode === 'cards'
                                            ? 'bg-yellow-500 text-white'
                                            : 'bg-gray-200 text-gray-700'
                                    }`}
                                >
                                    <i className="fas fa-th-large mr-2"></i>Cards
                                </button>
                                <button
                                    onClick={() => setViewMode('table')}
                                    className={`px-4 py-2 rounded-lg font-semibold transition ${
                                        viewMode === 'table'
                                            ? 'bg-yellow-500 text-white'
                                            : 'bg-gray-200 text-gray-700'
                                    }`}
                                >
                                    <i className="fas fa-table mr-2"></i>Table
                                </button>
                            </div>
                        </div>

                        <p className="text-gray-600 mb-4">
                            Showing {filteredMeds.length} of {medications.length} medications
                        </p>
                    </div>

                    {viewMode === 'cards' ? (
                        <div className="space-y-4">
                            {filteredMeds.map((med, idx) => (
                                <div key={idx} className="med-card">
                                    <h3 className="text-lg font-bold text-gray-800 mb-2">{med.drug}</h3>
                                    {med.dose && (
                                        <div className="mb-2">
                                            <span className="text-sm font-semibold text-gray-600">Dose: </span>
                                            <span className="text-gray-800">{med.dose}</span>
                                        </div>
                                    )}
                                    {med.remarks && (
                                        <div>
                                            <span className="text-sm font-semibold text-gray-600">Remarks: </span>
                                            <span className="text-gray-800">{med.remarks}</span>
                                        </div>
                                    )}
                                </div>
                            ))}
                        </div>
                    ) : (
                        <div className="bg-white rounded-lg shadow-md overflow-x-auto">
                            <table className="med-table">
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Dose</th>
                                        <th>Remarks</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    {filteredMeds.map((med, idx) => (
                                        <tr key={idx}>
                                            <td className="font-semibold">{med.drug}</td>
                                            <td>{med.dose}</td>
                                            <td>{med.remarks}</td>
                                        </tr>
                                    ))}
                                </tbody>
                            </table>
                        </div>
                    )}
                </div>
            );
        }

        ReactDOM.render(<App />, document.getElementById('root'));
    </script>
</body>
</html>
